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   INTRODUCTION 
Liver is one of the most important and massive visceral organ present in the 
substantial portion of abdomen. It is also known as "Hepar" made up of hepatocytes 
which carry out multiple metabolic processes essential for life 
[1]
. Liver acts as both 
secretory and excretory organ and so is described as the central laboratory of the body 
as it participates in the maintenance of homeostasis by controlling all types of 
metabolism
 [2]
. 
  Liver is considered to be one of the most vital organ that function as a centre of 
metabolism of nutrients and also excretion of drugs, other xenobioticts from the body 
there by providing protection against foreign substances by detoxifying and eliminating 
them
[3]
. 
As Liver mounts an immune response to portal pathogens, clinical consequence 
of severe Liver are therefore wide ranging and can be life threatening either suddenly as 
a result of our whelming acute Liver injury or gradually at the end stage of chronic 
Liver diseases. 
Jaundice which is the one of the symptom of Liver disease is a general condition 
that results from abnormal metabolism in retention of bilirubin. Jaundice causes a 
yellow discoloration of the skin, mucous membranes and sclera. The three principle 
types of Jaundice are pre hepatic, hepatic and post hepatic. Many of the liver diseases 
are accompanied by Jaundice caused by increased levels of bilirubin in the system
 [4]
. 
World Health Organisation defined health in its broader since in 1948 
constitution as ''A state of complete physical, mental and social wellbeing and not 
merely the absence of disease of infirmity"
[5]
. 
According to the latest WHO data published in May 2014, Liver disease deaths 
in India reached 2,16,865 or 2.44% of total deaths. A sedentary life style, increased 
alcohol consumption and obesity are contributing towards making India the world 
capital of Liver diseases by 2025. Therefore Liver disease worldwide has been 
recognized as a major health burden
 [6]
. 
 Conventional drugs used in the treatment of Liver diseases or sometimes 
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inadequate and can have serious adverse effects. Although there are lot of drugs 
available in modern medicine throughout the world, 
Modern medicines have a little to offer for alleviation of hepatic diseases, only 
the plant based preparations are employed for the treatment of liver disorders. Herbal 
medicines are the most cost effective form of traditional medicine. 
The researches have been in continuous search for some effective therapy for 
restoring the Liver functions
 [7]
. A large number of medicinal plants exist in nature of 
which are yet to be explored and validated for their potency and medicinal value
 [8]
. 
 Siddha is one of the oldest system of medicine practiced in India have been 
conceived by Siddhars or evolved souls who lived in the past. The word ''Siddha" comes 
from "Siddhi" which means an object to be attained or perfection of heavenly bliss.  
Siddha system of medicine is an ancient system of medicine found by Siddhars 
through their high intellectual, supernatural and spiritual powers. They lived for 
thousands of years and formulated many medicines for a healthy life. They strongly 
believed that healthy body is essential to attain the eternal life. Thus the great Siddhar 
Thirumoolar has written in his song as 
“உடம்பார்  அறி஬ின்  உ஬ி஭ார்  அறிலர் 
  திடம்பட  ம஫ய்ஞானம்  சே஭வும்  ஫ாட்டார் 
  உடம்பப  லரர்க்கும்  உபா஬ம்  அமிந்சத 
 உடம்பப  லரர்த்சதன்  உ஬ிர்லரர்த்  சதசன[9] ” 
- திருமூயர் 
 
So the physical and mental wellbeing is more important and Siddhars have 
gifted them to be mankind to lead a healthy life. Healthy lifestyle includes all day to day 
activities and food habits. 
Siddhars have achieved supreme knowledge in herbal medicines and enlightened 
spiritually as well. In short, herbs are a natural and primary therapeutic remedy for liver 
diseases. 
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Siddhars were great doctors of medicine, philosophers, and men with deep 
knowledge. 
 Very basic concept of Siddhars is     
    “ உணவே மருந்து; மருந்வே உணவு ” 
Food is being medicine and medicine is being food 
Siddhars denotes the jaundice as Kamalai in their poetries. The drugs which 
were indicated for Kamalai (jaundice) explore the hepatoprotective activity in research. 
Herbal drugs are most widely used than Allopathic drugs as Hepatoprotective 
because of their efficacy, better compatibility to maintain the normal functional status of 
Liver without side effects 
[10]
 
 A large number of medicinal plants have been tested and found to contain active 
principles with curative properties against a variety of diseases
 [11]
. Liver protective 
plants contains a variety of chemical constituents like phenols, coumarins, ligans, 
essential oil, monoterpenes, carotenoids, glycosides, flavonoids, organic acids, lipids, 
alkaloids and xanthenes
[12]
.Recent experience has shown that plant drugs are relatively 
non-toxic, safe and even from serious side effects
 [13]
. 
Some of the most valuable plants used for the treatment of liver problems are 
Phyllanthus amarus, Silybum marianum, Glycyrrhiza glabra, Curcuma longa, 
Terminalia chebula, Picrorhiza kurroa
 [14]
. 
One of the simple forms of internal medicine in Siddha system is Choornam. 
Choornam are fine dry powders of drugs. The term Choornam may be applied to the 
powder of a single drug or a mixture of two or more drugs which are powdered 
separately prior to their being mixed to homogenity. The Choornam should be very fine, 
amorphous and should be perfectly dry before the Choornam is prepared the process of 
purification as to be done. 
Purification of raw drugs is a process aimed at both purification as well as 
concentration of the raw drug. It usually involves process like cleaning, frying, soaking 
and grinding with herbal juices until impurities are removed. No medicinal preparation 
is done without prior suddhi process. This process helps raw material or crude drugs to 
lose their undesirable or toxic effects and thereby giving better efficacy
 [15]
. 
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One among the Choornam to treat liver disease is "Pitha Kamalai Choornam" 
which is taken from the compiling of siddha medicines written by one of the great 
siddhar "korakkar" from his "Korakkar maruththuvam"
[16]
. 
Pitha kamalai choornam consist of Piper nigrum, Cuminum cyminum, Curcuma 
longa, Feniculum vulgare, Zingiber officinale which acts as Hepatoprotective and Anti 
oxidant activities. 
Scientific validations are not available in the formulation. Even though the shelf 
life period of Choornam is limited, its potency is too high. So I have preferred to choose 
the “Choornam” form of medicine that will definitely act as a 
“HEPATOPROTECTIVE” to safeguard the people from liver damage. 
Despite tremendous advances in modern medicine, hepatic disease remains a 
worldwide health problem, thus the search for new medicines is still ongoing. As 
numerous formulations of medicinal plants are used to treat Liver disorders in Siddha 
medicine is available, I therfore exhibit "Pitha Kamalai Choornam" which is a poly 
herbal combination of drugs to undergo various significant hepatoprotective study so as 
to govern by standards of safety and efficacy
[17]
.   
 
                                                                               AIM AND OBJECTIVE  
 
HEPATOPROTECTIVE ACTIVITY OF PITHA KAMALAI CHOORNAM Page 5 
 
2. AIM AND OBJECTIVE 
Aim 
 The present investigation was aimed to validate the safety and efficacy of the 
Siddha herbal formulation ‘PITHA KAMALAI CHOORNAM’ for its Hepatoprotective 
activities in Wistar albino rats and Anti-oxidant activity in in vitro study. 
Objectives 
The objectives of this work were done through the following steps. 
 Collection of significant text from classical Siddha literature as well as 
Modern medical science literature that supported this study. 
 Description of pharmacognostic features of the plants in this formulation 
including the taxonomic identification, collection, purification of raw 
materials etc. 
 Preparation of the formulation according to the procedure described in 
Siddha literature. 
 Standardization of the trial drug by means of physico-chemical analysis, 
phyto chemical analysis. 
 Revealing the anions and cations present in the drugs through adjacent 
chemical analysis. 
 Elucidation of the chemical structure, microscopical structure of the drugs by 
means of instrumental analysis. 
 Evaluating the microbial lode, and activity of the trail drug. 
 Interpreting the results of acute and repeated 28 days oral dose toxicity of 
Pitha Kamalai Choornam according to OECD guidelines 423 and 407. 
 Detailing the study of pharmacological activities like CCL4,induced hepato 
toxicity, Paracetamol induced hepato toxicity  activity of the trial drug Pitha 
Kamalai Choornam in Wistar albino rats, and Antioxidant activity in in vitro 
study.  
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3. REVIEW OF LITERATURE 
3.1 GUNAPADAM ASPECT 
     பித்த காமாலை சூரணம் 
               “஧ாபப்஧ா ஧ித்தகா நால஬சூப ணத்லதப் 
               ஧ாடுகிற஫ன் பு஬த்தினற஦ ஧ண்஧ாய்க் றகளும் 
                    சீபப்஧ா திரிகடுகு யலகக்கு லநங்கான  
              சீபகநிபண் டலபனாம் நஞ்சற஭ாடு ஓநம் 
                   றசபப்஧ா யலகக்குப௃ல஫ சீப கந்தான் 
             ற஧ருடப௃க் கமஞ்சிலயப௅ம் ஒன்஫ாய்க் க஬ந்து 
                   ஧ாபப்஧ா எலுநிச்சஞ் சாற்஫ி ஬ாட்டி 
             கல஫னலயத்றத ப௄ன்றுதி஦ம் இப்஧டிறன சசய்றன!” 
 
“சசய்யதுதா ஦லப஧஬ந்தா ஦ப்஧ாய்த் சதல்஬ாம் 
தி஫நாக உ஬ர்த்திறன தூ஭ாக்கி  யடித்து 
உய்யதற்கு சனட்சடான்று சீ஦ிக஬ந்  திட்டு 
ஒடுங்காத ஧ித்தகா நால஬க்கு 
உய்னசயரு கடினாய்  சகாள்ளு  சகாள்ளு 
இருற஧ாது நண்ட஬ப௃ண் டனு஧ா஦ங் றகளு 
஥ய்யதில்ல஬ப் ஧மச்சாறு  றத஦ிற஬  னருந்து 
஥஬நா஦  னிஞ்சிசதன்஫  ஥ீரிலு  நருந்றத!” 
  
“அருந்தி஦ால் தீருகி஫ ற஥ாய்யலக னப்஧ா 
அல஫கிற஫ன்  ஧ித்தகா  நால஬யலக  னாறும் 
ச஧ாருந்தறய  சசால்லுகிற஫ாம்  சயள்ல஭நஞ்சள்  பத்தம் 
ச஧ால்஬ாத  ஥ீறபாடும்  ய஫ட்சினிது  சயல்஬ாம் 
தீபாத வூதுகா  நால஬றனாடு  னிலயகள் 
தீர்ந்துற஧ாம்  ஧த்தினந்தான்  சிறுகீலப  ப௅ப்ற஧! [18] “ 
-  ககோ஭க்கர் ஫ருத்துவம் 
Following are the Ingredients mentioned in the song 
 
1. Chukku  ( Zingiber officinale) 
2. Milagu   ( Piper nigrum ) 
3. Thippili  ( Piper longum ) 
4. Seeragam  ( Cuminum cyminum ) 
5. Manjal   ( Curcuma longa ) 
6. Omam   ( Trachyspermum ammi ) 
7. Poondu  ( Allium sativum ) 
8. Perunjeeragam ( Foeniculum vulgare ) 
9. Vendhayam  ( Trigonella foenum-graecum ) 
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10. Perungayam  ( Ferula asafoetida ) 
11. Kaduku  ( Brassica juncea ) 
Associate Ingredient 
Lemon juice (Citrus lemon) 
Chukku ( Zingiber officinale ) 
Synonyms : Arukkan, artharagam, ubakullam, ularndha inji, 
              kadubathiram, sundi, nagaram, vidamoodia amirdham, 
              verkombu. 
Parts used : Dried root 
Taste  : Pungent     
Character : Hot                                                               
Division : Pungent 
Action  : Stimulant, stomachic, carminative  
General properties: 
                “சூல஬நந்தம் ச஥ஞ்சசரிப்பு றதாடறநப் ஧ம்நமல஬ 
        ப௄஬ம் இலபப்஧ிருநல் ப௄க்கு஥ீர் - யா஬க஧ 
       றதாடநதி சாபந் சதாடர்யாத குன்ந஥ீர்த் 
       றதாடம்ஆ நம்ற஧ாக்குஞ் சுக்கு.” 
 
                                                 - அகத்தினர் குணயாகடம் 
 
Indications: 
Chukku cures Indigestion, Cough, Bronchial asthma, Sinusitis, Anemia, Cold 
and Fever. 
Medicinal uses: 
 Chewing chukku in mouth cures dental pain. 
 Swallowing chukku juice after chewing will cure tonsillitis. 
 Chukku powder when taken along with cow‟s milk is a good appetiser 
and also cures jaundice. 
 Decoction of chukku cures indigestion, vomiting, chronic fever[19A] 
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Milagu (Piper nigrum ) 
Synonyms : Kari, kayam, kolagam, masham, thirangal, malayali. 
Parts used : Seed, climbing stem 
Taste  : Bitter, pungent 
Character : Hot  
Division : Pungent 
Action  : Acrid 
  Carminative                                    
  Antiperiodic 
  Antidote 
  Anti vatha 
General properties: 
       “சீதசுபம் ஧ாண்டு சிற஬த்நங் கிபாணிகுன்நம் 
        யாதம் அருசி஧ித்தம் நாப௄஬ம் – ஓதுசன்஦ி 
        னாசந஧ஸ் நாபம் அடன்றநகம் காசநிலய 
        ஥ாசங் க஫ிநி஭கி஦ால்” 
                                        -  அகத்தினர் குணயாகடம். 
 
Indications: 
Milagu cures Cold and Fever, Peptic ulcer, Indigestion, Jaundice, Piles, Genital 
disease, Hemiplegia. 
Medicinal uses:  
 Black pepper is one among „ thirikadugam‟ 
 Powder of black pepper acts as appetiser 
 Black pepper oil cures vatha disease, head disease, ear disease 
 Black pepper, perunjeeragam along with honey cures piles[19B]. 
Thippili (Piper longum ) 
Synonyms : Aargadhi, Kaman, kudari, kolagam, koli, kozhaiaruki, 
   adhimarundhu. 
Parts used : Fruit                                        
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Taste  : Sour             
Character : Heat                                                                                            
Division : Sour  
Action  : Stimulant 
  Carminative 
  Expectorant 
General properties: 
      “ஈல஭ னிருந ஬ிலபப்புப் ஧சப்஧ிணிகள் 
   நா஭ சயாமினாநல் யாட்டுறந – னாளுப௃ல஫ 
   ஧ாங்கா ன஫ிந்துசசய்யரீ் ஧ண்டிதத்லதப் ஧ண்டிதறப 
   றயங்லகயாய்ப் ஧ான்கலண சநய்.”  
- றதபன் சயண்஧ா 
 
Indications: 
 Long pepper cures Cold, Cough, Bronchial asthma and Indigestion. 
Medicinal uses: 
 Long pepper given along with betal leaf juice and honey cures cold and 
fever 
 Long pepper powder boiled in cow‟s milk when taken cures delirium 
 Equal quantity of long pepper powder and chebulic powder, when taken 
on both morning and evening along with honey for three months cures 
Tuberculosis
 [19C]
. 
Omam ( Tachyspermum ammi ) 
Synonyms : Asamodham, thippium 
Parts used : Seed 
Taste  : Sour 
Character : Heat                                    
Division : Sour                                         
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Action  : Stomachic                                                       
  Antispasmodic 
  Carminative 
  Tonic 
  Antiseptic 
General properties: 
  “ சீதசுபங் காசஞ் சசரினாநந் தம்ச஧ாருநல்  
 ற஧தினிலபச் சல்கடுப்பு ற஧பாநம் – ஓதிருநல் 
 ஧ல்ச஬ாடு஧ல் ப௄஬ம் ஧கநிலயற஥ா சனன்சசப௅றநா? 
 சசால்ச஬ாடுற஧ாம் ஓநசந஦ச் சசால்.” 
              -          அகத்தினர் குணயாகடம்  
 
Indications: 
The bishops weed cures Cough, Asthma, Indigestion, Gastritis, Dysentery and 
Cholera 
Medicinal uses: 
 About 30-60ml of omatheenir cures indigestion, dysentery and cholera 
 1 to 3 drops of bishops weed oil acts as carminative 
 About 34gms of bishops weed and black pepper along with jaggery, 
when given twice a day for 10 days cures stomach ache and 
dysentery.
[19D]
 
Seeragam ( Cuminum cyminum ) 
Synonyms : Asai, seeri, pithanasini, posanakudori, methiyam 
Parts used : Seed 
Taste  : Sour, sweet                                       
Character : Cooling  
Division : Sweet                                    
Action  : Carminative 
  Stomachic 
  Astringent 
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General properties: 
  “ யாப௅சயாடு ஥ாசிற஥ாய் யன்஧ித்தஞ் றசபாது 
     கானம் ச஥கிமாது கண்கு஭ிருந் – தூனந஬ர்க் 
     காப஭கப் ச஧ண்நனிற஬! லககண்ட தித்தல஦ப௅ஞ் 
     சீபகத்லத ஥ீதி஦ப௃ந் தின். 
                                    - அகத்தினர் குணயாகடம். 
 
Indications: 
Cumin seed cures Vatha diseases, Nasal diseases, balances pitha kutram, gives 
coolness to eyes. 
Medicinal uses: 
 Cumin seeds alone when powdered and taken with sugar cures cough. 
 Cumin seeds soaked in eclipta alba juice, when powdered and about 
4gm taken along with 2gm of sugar and dried ginger powder cures fever 
and jaundice. 
 Powdered cumin seeds when taken with butter cures peptic ulcer. 
 Add cumin seeds in 1400ml of heated gingely oil, and then cool it. This 
oil when taken for head bath cures headache, eye diseases, giddiness and 
vomiting. 
 Cumin seeds are also one of the ingredients of panchadeepakini 
legiyam
[19E ]
. 
Perunjeeragam ( Foeniculum vulgare ) 
Synonyms : Sombu, venseeragam 
Parts used : Flower, seed, root 
Taste  : Aromatic, sweet and sour taste                         
Character :  Heat 
Division : Sour                                                                                  
Action  : Carminative                             
  Stomachic 
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General properties: 
      “ றனா஦ிற஥ாய் குன்நம் உரூட்லசநந் தம்ச஧ாருநல் 
   ற஧஦ப௃று காசம் ஧஬ீிகநிலபப் – ஧஦ீஉலப 
   றசர்க்கின்஫ யாதப௃ற஧ாஞ் சீர்ச஧ரின சீபகத்தால் 
   ப௄க்குற஥ா னில்ல஬ சநாமி.” 
- அகத்தினர் குணயாகடம். 
 
Indications:  
Cures Uterine disorders, abdominal pain, Fever, Indigestion, Dyspepsia, Cough, 
Liver diseases, Tonsillitis, Rhinitis. 
 Medicinal uses: 
 Sombutheenir:  1 part of Anise seed is mixed with 20 parts of water and 
allowed to the process of distillation. Dose : 15ml to 20ml. 
 Anise seed is slightly fried and powdered. About 2gms of this powder 
along with sugar cures uterine disorders, abdominal pain. 
 Distilled water taken from anise seeds flower, when given for children 
cures indigestion, worms and loose stools 
[19F]
. 
Manjal (Curcuma longa ) 
Synonyms : Arisanam, kansani, nisi, peetham 
Parts used : Rhizome 
Taste  : Sour, bitter 
Character : Heat                                                              
Division : Sour  
Action  : Aromatic                                      
  Antiseptic                                 
Carminative 
  Stimulant 
  Hepato tonic 
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General properties: 
  “ச஧ான்஦ி஫நாம் றந஦ி பு஬ா஦ாற்஫ ப௃ம்ற஧ாகும் 
   நன்னு புருட யசினநாம் - ஧ின்஦ிசனழும் 
   யாந்தி஧ித்த றதாடலநனம் யாதம்ற஧ாந் தீ஧஦நாங் 
   கூர்ந்தநஞ்ச ஭ின்கிமங்குக்கு. ” 
- அகத்தினர் குணயாகடம். 
 
Indications: 
Turmeric paste applied in the body gives colour and changes odour. It also 
serves as appetiser. It cures Headache, Sinusitis, Leucorrhea, Rhinitis, Insect bites and 
Wounds. 
Medicinal uses: 
 Turmeric powder cures wound when applied over it. 
 Turmeric mixed along with cooked rice and applied over tumour, gets 
healed. 
 Smoke of burnt turmeric cures sinusitis. 
 Paste of Turmeric and neem leaves cures chicken pox boils when 
applied. 
 Paste of Adathoda leaves and turmeric cures certain skin diseases[19G]. 
Poondu ( Allium sativum ) 
Synonyms  : Lasunam, kayam, ulli, vellai poondu, velvenkayam. 
Parts used : Bulb 
Taste  : Sour 
Character : Heat                                                
Division : Sour 
Action  : Carminative                                 
  Stomachic 
  Tonic 
  Stimulant 
  Expectorant 
 
                                                                                  REVIEW OF LITERATURE 
 
  HEPATOPROTECTIVE ACTIVITY OF PITHA KAMALI CHOORNAM Page 14 
 
General properties: 
“சன்஦ிசனாடு யாதந் தல஬ற஥ாவு தாள்ய஬ி 
   நன்஦ியரு ஥ீர்க்றகாலய யன்சீதம் – அன்஦றந! 
   உள்ளுள்஭ி கண்஧ாய் உல஭ப௄஬ றபாகப௃ம்ற஧ாம் 
   சயள்ளுள்஭ி தன்஦ால் சயருண்டு ”. 
- அகத்தினர் குணயாகடம். 
 
Indications: 
Garlic cures all the three Vatha, Pitha, Kabha diseases. Also cures Cough, 
Gastritis, Piles and Dysentery. 
Medicinal uses: 
 Equal quantity of garlic, pepper and eclipta leaf when taken regularly 
cures indigestion. 
 About 20-30 drops of garlic juice taken for 2-3 times a day cures cough, 
bronchial asthma and worms. 
 Garlic also cures tonsillitis [19H]. 
Vendhayam ( Trigonella foenum graecum ) 
Synonyms : Mendhiyum, medhi, vendhai. 
Parts used : Leaf, seed 
Taste  :  Bitter 
Character : Cooling                                               
Division : Sour                                                    
Action  : Diuretic                                     
  Refrigerant 
  Laxative 
   Demulcent 
  Tonic 
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General properties: 
“஧ித்தவுதி பம்ற஧ாகும் ற஧பாக் கணங்களும்ற஧ாம் 
  அத்திசுபந் தாகம் அகலுங்காண் – தத்துநதி 
  றயக இருநச஬ாடு யரீு கனம்தணிப௅ம் 
  ற஧ாகப௃றும் சயந்தனத்லதப் ற஧ாற்று ”. 
- அகத்தினர் குணயாகடம். 
 
Indications 
Cures body heat, Fever, Dysentery, Leucorrhoea, Blood pressure, Thirst. 
Medicinal uses: 
 Soak fried and dried fenugreek seeds in water and when taken regularly 
cures indigestion, heat, fever, leucorrhoea and dysentery. 
 17gm of fenugreek seed cooked in rice and taken increases blood. 
 Fried fenugreek seed taken along with wheat instead of coffee as 
beverages suppresses body heat
 [19I]
. 
 Perungayam (Ferula asafoetida.Linn) 
Synonyms : Athiyagraham, ranam, ramadam, Gandhi, kayam, 
sandhunasam, boodhanasam, valleegam. 
Parts used : Resin 
Taste  : Bitter 
Character : Heat                                                 
Division : Sour  
Action  : Carminative 
  Antispasmodic                                
  Expectorant 
  Diuretic 
  Anthelmentic 
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General properties: 
   “தந்தறய தந்த ப௄஬த்சதழும்஧ிணி 
   சருயகா஭ம் யிருச்சிகங்கீடம்நா 
  நந்தம்யாதம் உதாயர்த்தம் அல்குல்ற஥ாய் 
   நார்஧ணங்கட்ட குன்நம்நறகாதபம் 
  உந்துசகர்ப்஧த்தின் யித்திபஞ்சூல஬ச்சூர் 
   உதிபப்பூச்சி சிற஬த்துநத்துறும்ய஬ி 
  யந்தசநய்க்கடுப் ற஧ாடிலயப௃ற்றுறந 
   நாப௅஥ாறு஥ற் கானங்கிலடக்கிற஭ ”. 
- றதபன் குணயாகடம். 
Indications:  
Cures Gastritis, Indigestion, Uterine disorders, Ascites, Worms and Vatha 
diseases 
Medicinal uses: 
 Asafoetida given along with egg to cure dry cough. 
 Equal quantity of aloe juice, pepper and asafoetida cures amenorrhoea. 
 Asafoetida heated with gingely oil and used as ear drops cures ear 
ache.
[19J]
 
Kaduku (Brassica juncea ) 
Synonyms : Iyavi 
Parts used : Seed 
Taste  : Sour                                                
Character : Heat 
Division : Sour 
Action  : Emetic                                  
  Digestive 
  Stimulant 
  Rubefacient 
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General properties: 
              “இடிகாச ஥ாசிச்சூ ரீல஭க஧ம் ஧ித்தங் 
கடியாத சீதங் கடுப்ற஧ா – டுட஬ிற் 
஧டுறகாட்டு ற஥ாசனன்னும் ஧ங்கிலயக ல஭ப்புண் 
கடுறகாட்டு றநன்நருந்து காண் ”. 
     - அகத்தினர் குணயாகடம் 
 
Indications 
Cures Cough, Bronchial asthma, Pitha disease, Vatha disease Kabha disease and 
Ulcer in the body. 
Medicinal uses    : 
 About 2gm of mustard seed pasted and given along with water induces 
vomiting. 
 When pasted along with honey and given cures cough and Asthma. 
 Mustard oil is slightly irritative and creats blisters in skin when 
applied
[19K]
. 
Associate ingredient: 
Elumichai (Citrus lemon) 
Synonyms : Sambeeram 
Parts used : Leaf, fruit, juice, oil                                          
Taste  : Pungent 
Character : Heat 
Division : Sour  
Action  : Refrigerant 
General properties: 
      “ தீசதலு நிச்சங்காய் றடர்ப௃த்றதா டத்லதப௅ப௃ள் 
    யாதக஧ சூல஬லனப௅ம் நாசகாடின – சாதிசனனுஞ் 
    சர்த்திகுன் நத்லதப௅ப௃ள் தங்கநருந் திட்டலதப௅ம் 
    ஧ித்தசயப்ல஧ ப௅ந்தணிக்கும் ற஧சு ”.  
            -அகத்தினர் குணயாகடம். 
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Indications: 
 
Balance all the three Vatha, Pitha, Kabha thodam. It also cures vomiting 
and peptic ulcer. 
 
Medicinal uses     : 
 
 Lemon juice along with sugar cures nausea and vomiting. 
 Lemon fruit when taken as kaya kalpam for 6 months prevents aging and 
also cures many diseases. 
 Lemon juice and fried cumin seeds together cures vomiting and 
diarrhoea
 [19L]
. 
3.2. BOTANICAL ASPECT: 
Zingiber officinale 
Common name:  
Chukku 
Vernacular names: 
 Hindi : Adarak 
 Kan : Hasisunti, Ardraka 
 Mal : Inci, Erukkilannu 
 San : Ardrakam 
 Tam : Chukku 
 Tel : Allamu, Ardrakamu 
Botanical classification: 
 Kingdom : Plantae 
 Division : Angiosperms 
 Class  : Monocotyledons 
 Order  : Epigynae 
 Family  : Zingiberaceae 
 Genus  : Zingiber 
 Species : Officinale[20A] 
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The plant description: 
Distribution: 
Cultivated throughout India and run wild in some places in the Western Ghats. 
Description: 
A slender, perennial rhizomatous herb leaves linear, sessile, glabrous. Flower 
yellowish. The rhizomes are white to yellowish brown in colour, irregularly branched, 
somewhat annulated and laterally flattened. 
Parts used: 
Rhizomes (raw as well as dry) 
Chemical constituents: 
Indian dry ginger contains an aromatic volatile oil of light yellow colour having 
a characteristic odour and containing camphene, phellandrene, zingiberine, uneol and 
borneol. Gingerol – an oleo resin other resins and starch [24A] 
Properties and uses: 
 Dry ginger is acrid, thermogenic, emollient, appetiser, laxative, 
stomachic and carminative‟ 
 It is useful in dropsy, otalgia, asthma, cough, colic, diarrhoea, flatulence, 
anorexia, dyspepsia, cholera, nausea, vomiting, elephantiasis and 
inflammation. 
 Ginger with rock salt taken before meals, cleans the tongue and throat, 
increases the appetite and produces an agreeable sensation. 
 Dry ginger is much used as a carminative adjunct along with black 
pepper and long pepper under the name Trikaduku. 
Piper nigrum 
Common name: 
Milagu 
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Vernacular names: 
 Eng : Black pepper 
 Hind : Kalimark, mirc 
 Kan : Ollimonasu, miri 
 Mal : Kurumulaku 
 San : Maricam 
 Tam : Milaku 
 Tel : Miriyalu[20B] 
Botanical classification: 
 Kingdom :  Plantae 
 Division : Angiosperms 
 Class  : Dicotyledons 
 Sub class : Monocotyledons 
 Order  : Microembryeae 
 Family  : Piperaceae 
 Genus  : Piper 
 Species : nigrum 
The plant description: 
Distribution: 
Throughout India in every green forest up to 1500m and also widely cultivated. 
Description: 
A branching and climbing perennial shrub that branches stoutly and roots are at 
the nodes. Leaves are entire and 12.5-17.5 long and 5.0-12.5cm wide. Fruits are globose 
or ovoid, bright red when ripe, seeds usually globose.
 
Parts used:   
Fruits 
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Chemical constituents: 
Phytochemical investigation on the plant revealed the presence of piperettine, 
piperolein A and piperolein B, trichostachinepiperylin, feruperine, dihydroferuperine, 
N- trans feruloyltyramine, p- cymene,α – thujene, β- alanine, arginine, pipecolic acid, 
ascorbic acid, carotene.
[21A] 
Properties and uses: 
 The fruit has a sharp, pungent, slightly bitter taste, is a carminative, 
stamachic, aphrodisiac, purgative, alexipharmic. 
 Dried fruits known as black pepper in market are used as aromatic, 
stimulant and stomachic. 
 It is used in the treatment of dyspepsia, flatulence, malarial fever, 
jaundice, paraplegia and arthritis. 
 They also find local application for sore throat, piles and skin diseases. 
 It is used as antiperiodic in malarial fever and as an alterative in 
paraplegia and arthritic diseases. 
Piper longum 
Common name: 
Thippili 
Vernacular names: 
 Eng : Indian long pepper 
 Hind : Pipli, papal 
 Mal : Tippali 
 San : Pippali, Tippili 
 Tam : Pippili, Tippili 
 Tel : Pippallu 
Botanical classification: 
 Kingdom : Plantae 
 Division : Angiosperms 
 Class  : Dicotyledons 
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 Subclass : Monocotyledons 
 Order  :  Microembryeae 
 Family  : Piperaceae 
 Genus  : Piper 
 Species : longum [20C] 
The plant description: 
Distribution: 
Cultivated throughout India 
Description: 
A slender aromatic climber, root at the nodes, the branches are erect, 
subscandent, swollen at the nodes. Leaves alternate, flowers in solitary spikes, fruit 
berries, small, red when ripe.The mature spikes collected and dried from the 
commercial form of thippili, roots are known as tippilimulam. 
Chemical constituents: 
The plant contains essential oil consisting of long chain hydrocarbons, mono and 
sesquiterpenes. Other constituents are piperine, piplartine, piperlongumine, 
piperlonguminine, and its dihydro- derivative, pipernonaline, piperundecalidine, 
pipercide and guineensine, sesamin, β- sitostero [21B]. 
Properties and uses: 
 The roots are bitter, thermogenic, tonic, diuretic, purgative, expectorant, 
anthelmintic, stomachic, digestive and emmenagogue. 
 They are useful in vitiated conditions of vata, gout, lumbago, dyspepsia, 
apoplexy, stomachalgia and splenomegaly‟ 
 They are useful in anorexia, flatulent, colic, asthma, bronchitis, 
hiccough, gastropathy, epilepsy, fever, gonorrhoea and haemorrhoids. 
 It is an important ingredient in the preparation of medicated oil used 
externally in sciatica and paraplegia. 
 Powdered long pepper mixed with honey is efficacious in cold, cough, 
asthma and hiccough. 
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Curcuma longa 
Common name: 
Manjal 
Vernacular names: 
 Eng : Turmeric 
 Hind : Haldi, halda 
 Kan : Arisina 
 Mal : Mannal, paccamannal, varattumannal 
 San : Haridra, varavarnini 
 Tam : Mancal 
 Tel : Pasupu 
Botanical classification: 
 Kingdom : Plantae 
 Division  : Angiosperms 
 Class       : Monocotyledons 
 Order    : Epigynae 
 Family    : Zingiberaceae 
 Genus    : Curcuma  
 Species   : longa [20D] 
The plant description: 
Distribution: 
Cultivated throughout India 
Description: 
A perennial herb, 60-90cm in height, with a short stem and tufts of erect leaves, 
rhizome cylindrical, ovoid, orange coloured and branched. Leaves are simple, very 
large. 
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Parts used: 
Rhizomes (dry as well as raw) 
Chemical constituents: 
An essential oil,resin an alkaloid, curcumin, turmeric oil or turmerol. Turmeric 
oil contains phellandrene and an alcohol called turmerol. It also contains caproic acid 
with combined valeric acid 
[24B]
. 
Properties and uses: 
 The roots are bitter, thermogenic, tonic, diuretic, stomachic, digestive 
and emmenagogue, hepatoprotective. 
 They are useful in vitiated conditions of vata, gout, lumbago, dyspepsia, 
apoplexy, stomachalgia and spleenopathy. 
 They are useful in anorexia, bronchitis, hiccough, gastropathy, epilepsy, 
fever, gonorrhoea, haemorrhoids. 
 It is used both internally and externally in skin diseases due to impurity 
of the blood. 
 In small pox and chicken pox a coating of turmeric powder or thin paste 
is applied to facilitate the process of scabbing. 
Cuminum cyminum 
Common name: 
Seeragam 
Vernacular names:  
 Eng : Cumin seeds 
 Hin : Jira, saphedjira 
 Kan : Jirige 
 Mal : Jirakam 
 San : Jiraka 
 Tam : Jirakam 
 Tel : Jilakarra 
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Botanical classification:  
 Kingdom : Plantae 
 Division  : Angiosperms 
 Class     : Dicotyledons 
 Sub class : Polypetalae 
 Series      : Calyciflorae 
 Order     : Umbellales 
 Family     : Umbelliferae 
 Genus     : Cuminum 
 Species    : cyminum [20E] 
The plant description:  
Distribution:  
Cultivated throughout India 
Description:  
A small slender glabrous annual herb about 30cm in height with much branched 
angular or striated stem, leaves bluish green, two or three partite. Flowers are small 
white or rose coloured in compound umbels. Fruits are greyish tapering towards both 
ends. 
Parts used:  
Fruits 
Chemical constituents:  
Fatty oil, resin, mucilage, a valuable essential oil thymine contains cuminol or 
cumic aldehyde 56 p.c, a mixture of hydro carbons, cyme or cymol, terpene etc 
[22A]
. 
Properties and uses:  
 Seeds are carminative, aromatic, stomachic, stimulant and astringent. 
 Cumin seeds are largely used as a condiment or spice in curries, pickles 
etc. 
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 They are medicinally useful in hoarseness of voice, dyspepsia and 
chronic diarrhoea and cures jaundice. 
 Seeds are also cooling in effect and therefore foam an ingredient of most 
prescriptions for gonorrhoea. 
 Seeds mixed with lime juice are administered in cases of bilious nausea 
in pregnant females and after child birth, cumin seeds taken internally 
increases milk secretion. 
Foeniculum vulgare 
Common name: 
Perunjeeragam 
Vernacular names: 
 Eng : Fennel 
 Hind : Saumph 
 Kan : Badhesoppu 
 Mal : Perunjirakam 
 Tam : Sompu 
 Tel : Peddajilakarra 
Botanical classification:  
 Kingdom: Plantae 
 Division  : Angiosperms 
 Class     : Dicotyledons 
 Sub class : Polypetalae 
 Series     : Calyciflorae 
 Order     : Umbellale 
 Family     : Foeniculum 
 Species    : vulgare [20F] 
The plant description: 
Distribution: 
Cultivated throughout India 
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Description: 
A stout, erect, glabrous aromatic herb upto 1.8m in height, leaves 3-4 times 
pinnate with very narrow linear or subulate segments. Flowers are small. Fruits are 
oblong, ellipsoid or cylindrical, straight or slightly curved greenish or yellowish brown. 
Parts used: 
Fruits 
Chemical constituents: 
Ascorbic acid, riboflavin, α, β and γ tocopherol, β tocotrienol, choline, 
trigonelline, p- cymene, anethole, anisaldehyde, camphene, estragole, fenchone, 
fenchene, foeniculin, methylchavicol, chlorogenic, hydroxyl benzoic and hydroxyl 
cinnamic acids 
[22B]
. 
Properties and uses: 
 The fruits are sweet, acrid, bitter, emollient and refrigerant 
 They are used as anthelmintic, aromatic, carminative, emmanogogue, 
stimulant and stomachic. 
 It is beneficial in diseases related to chest and kidney. 
 Juice is used to improve eyesight, hot infusion given in amenorrhoea. 
 Oil from seeds is anodyne, diuretic, stimulant and vermicide. 
Ferula asafoetida 
Common name: 
Perungayam 
Vernacular names: 
 Eng : Asafoetida 
 Hind :  Hing 
 San :  Hingu 
 Kan :  Hingu 
 Mal : Kayam 
 Tam : Perunkayam 
                                                                                  REVIEW OF LITERATURE 
 
  HEPATOPROTECTIVE ACTIVITY OF PITHA KAMALI CHOORNAM Page 28 
 
Botanical name: 
 Kingdom: Plantae 
 Division : Angiosperms 
 Class    : Dicotyledons 
 Sub class: Polypetalae 
 Series    : Calyciflorae 
 Order    : Umbellales 
 Family    : Umbelliferae 
 Genus    : Ferula 
 Species   : asafoetida [20G] 
The plant description: 
Distribution: 
Cultivated in the north western part of India 
Description: 
The trees are attaining a height of 2-3m in length. Stem stout and much 
branched. Leaves are puberulous and minutely glandular or somewhat tomentose, the 
radical one is large and ternatisect, with segments oblong lanceolate and obtuse. Umbels 
on fleshy peduncles, the flower yellow. Flowers in april- may and fruits later. 
Parts used: 
Stem, leaves, root and gum resin. 
Chemical constituents: 
Luteolin and its glucopyranoside ( fruits ), seven S containing compounds in 
essential oil, α- pinene, phellandrene, butyl propenyldisulfide, a trisulfide, 
asaresinotannol, farnesiferol A, gummosin, kamolonol, mogoltadone, polyanthinin, 
polyanthin, umbelliferone, acetic acid. 
[22C]
 
Properties and uses: 
 It is used as anti spasmodic, anthelmintic, aphrodisiac, carminative, 
diuretic, emmanogogue, expectorant, mild laxative and nervine tonic. 
                                                                                  REVIEW OF LITERATURE 
 
  HEPATOPROTECTIVE ACTIVITY OF PITHA KAMALI CHOORNAM Page 29 
 
 It is useful in remedy for asthma, bronchitis, croup, flatulence, colic pain, 
spasmodic movement of the bowels and infantile convulsions. 
 An important ingredient in compounding medicinal preparations, 
prescribed in diarrhoea, flatulence, habitual abortion, indigestion and 
liver troubles. 
 Applied externally in ring worm. 
 It is valuable remedy for hysteria and nervous disorders of women and 
children and in the advanced stages of whooping cough, pneumonia and 
bronchitis of children. 
Trigonella foenum graecum 
Common name: 
Vendhayam 
Vernacular names:  
 Eng : Ferugreek 
 Hind : Meti, mutti 
 San : Methika, methi 
 Mal : Uluva 
 Tam : Ventayam 
 Tel : Mentulu, mentikura 
Botanical classification:  
 Kingdom:   Plantae 
 Division  :     Angiosperm 
 Class       :       Dicotyledons 
 Sub class :    Polypetalae 
 Order       :       Thalamiflorae 
 Series     :       Parietales 
 Family     : Cruciferae 
 Genus     :       Brassica 
 Species    :      juncea [20H] 
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The plant description: 
Distribution:  
Grown in Kashmir, Punjab and the upper gangetic plains and widely cultivated 
in many parts of India. 
Description: 
It is an erect aromatic annual herb of about 30-60 cm tall. Leaves pinnate, 3- 
foliolate, flowers axillary, 1 or 2, white or yellowish white, seeds 10-20 oblong with a 
deep groove across one corner, greenish brown. Flowers during January and fruits 
during march. 
Parts used: 
Seeds and leaves 
Chemical constituents: 
Young seeds mainly contain carbohydrates and sugar, mature seeds yield amino 
acids and fatty acids on hydrolysis, Carotenes, vitamins, saponins. fenugrin B and 
sapogenins such as diosgenin, gitogenin, neogitogenin, homoorientin, saponaretin and 
hipogenin, alkaloids trigonelline and choline.
[23]
 
Properties and uses: 
 It is used as mucilaginous, demulcent, diuretic, tonic, carminative, 
emmanogogue, astringent, emmolient and aphrodisiac. 
 It is useful in remedy for colic, flatutence, dysentery, diarrhoea, anorexia, 
cough, dropsy, enlargement of liver and spleen. 
 Used to treat rheumatism, lymphatism, rickets, anaemia and diabetes. 
 The alkaloids of fenugreek seeds stimulate the appetite by their action on 
the nervous system or reduce a diuretic or ureo-poetic effect 
Trachyspermum ammi 
Common name: 
Omam 
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Vernacular name: 
 Eng : Ajowan 
 Hind : Ajowan 
 San : Java 
 Beng : Jowan 
 Tamil : Omam 
Botanical classification  
 Kingdom : Plantae 
 Division   : Angiosperms 
 Class     : Dicotyledons 
 Sub class : Polypetalae 
 Order     : Calyciferae 
 Family     : Umbelliferae 
 Genus     : Trachyspermum 
 Species    : ammi[20I] 
The plant description: 
Distribution: 
Extensively cultivated over Punjab and West Bengal in India 
Description: 
It is a Pubescent or glabrescent herb. Root rusiform stem. Erect branched and 
leafy. Leaves are 2-3 pinnate, ultimate segments linear.Flowers are white, polygamous 
and sterile. Fruits are ovoid. Flowers and fruits from January to april. 
Parts used: 
Fruits, leaves and root. 
Chemical constituents: 
Camphene, careen, carvacrol, p-cymene, dipentene, myrcene, α and β pinenes, 
phenol, α and β phellandrene, γ terpinene, thymol, linoleic acid, oleic, palmitic, 
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petroselinic acids, resin acids, nicotinic acids, riboflavin, protein, sugars, tannins, 
flavones and sterol isolated from fruits. Phenolic glycosides from seed.
[22D]
 
Properties and uses: 
 It is used as anti diarrhoeal, antiseptic, antispasmodic, carminative, 
stimulant, stomachic and tonic. 
 Ajwan- ka – arak (aqueous extract) is a popular remedy for diarrhoea. 
 It is beneficial in bronchitis, atonic, dyspepsia, flatulence, hysteria and 
sore throat. 
 Oil is antiseptic, carminative and expectorant, efficacious in bronchial 
pneumonia other respiratory disorders. 
Allium sativum 
Common name: 
Poondu 
Vernacular names: 
 Eng : Garlic 
 Hind : Lasun 
 Kan : Belluli 
 Mal : Velluli 
 San : Lasunah 
 Tam : Vellaipuntu 
 Tel : Velluli 
Botanical classification: 
 Kingdom : Plantae 
 Division  : Angiosperms 
 Class    : Monocotyledon 
 Order    : Thalamyflorae 
 Series    : Coronarieae  
 Family    : Lilliaceae 
 Genus    : Allium  
 Species   : sativum[20J] 
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The plant description: 
Distribution: 
Cultivated throughout India 
Description:  
  A scapigerous foetid perennial herb with underground compound bulbs covered 
over by outer white thin scales and with simple, smooth, round stem, surrounded at the 
bottom by tubular leaf sheath, leaves simple, long, flat, linear, flowers small, white in 
the rounded umbels mixed with small bulbils, the entire umbel enclosed in a teardrop 
shaped membranous spathe, flowers usually sterile. 
Parts used:  
Bulbs 
Chemical constituents: 
An acrid volatile oil which is the active principle, starch, mucilage, albumen, 
sugar etc, volatile essential oil obtained by distilling the bruised bulbs contained allyl, 
propyl disulphide and other organic sulphidesor sulphur compounds. It is a clear dark 
brown or yellow colour of very intense garlic odour of repugnant taste 
[24C]
. 
Properties and uses: 
 The bulbs are acrid, bitter, sweet, astringent, salty, thermogenic, 
aperients, anodyne, aphrodisiac, anthelmentic, expectorant, febrifuge, 
diuretic, alexeteric, emmenagogue and tonic. 
 They are useful in vitiated conditions of kapha and vata. 
 It has a special influence over the bronchial and pulmonary secreations, 
useful in cases of dilated bronchi with fetid expectoration. 
 It improves appetite, helps in gaining weight, and renders sleep regular. 
 It acts as an emmenagogue it promotes the flood of menses, tonic, 
carminative and stimulant of the skin and kidneys. 
Brassica juncea 
Common name: 
Kadugu 
                                                                                  REVIEW OF LITERATURE 
 
  HEPATOPROTECTIVE ACTIVITY OF PITHA KAMALI CHOORNAM Page 34 
 
Vernacular names: 
 Eng : Indian mustard 
 Hind : Rayi 
 Kan : Sassive 
 Mal : Katuku 
 San : Sarsapah 
 Tam : Katugu 
 Tel : Avalu 
Botanical classification: 
 Kingdom : Plantae 
 Division : Angiosperm 
 Class  : Dicotyledons 
 Sub class : Polypetalae 
 Order  : Thalamiflorae 
 Series  : Parietales 
 Family  : Cruciferae 
 Genus  : Brassica 
 Species : juncea [20K] 
The plant description: 
Distribution: 
Cultivated throughout India 
Description: 
A glabrous annual with a few bristles at the base upto 1.5m in height, basal 
leaves long, broadly ovate, coarsely dentate, persistent middle leaves oblong, 8- dentate, 
upper leaves broadly linear, entire. Flowers yellow in racemes, fruits siliqua, breaking 
away from below upwards. Seeds attached to the replum. 
Parts used: 
Seeds, oil 
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Chemical constituents: 
Seeds contain a bland fixed oil, sinapin, sulphocyanide, lecithin, mucilage 
[24D]
. 
Properties and uses: 
 The seeds are acrid, bitter, thermogenic, anodyne, anti inflammatory, 
carminative, digestive, anthelmintic, aperients, sudorific and tonic. 
 They are useful in vitiated conditions of vata and kapha. 
 It is used in dengue fever, abdominal colic, anorexia, dyspepsia, 
intestinal worms, flatulence, inflammations, and morbid state of the 
cerebrospinal system, skin diseases, splenomegaly and persistent 
vomiting. 
 Mustard is used in larger doses as an emetic in cases of poisoning. 
 It will also cause hyperdipsia, burning sensation and other disorders due 
to the vitiation of pitha. 
Associate ingredient: 
Citrus lemon 
Common name: 
Lemon 
Vernacular names: 
 English : Lime 
 Beng.  : Kagzilebu 
 Guj.  : Khata limbu 
 Hindi  : Kaghzi nimbu  
 Kan.  : Nimbe 
 Mal.  :  Cherh-naragam 
 Tam.  :  Elurmichai 
 Tel.  :  Nimba. 
 Botanical classification: 
 Kingdom : Plantae 
 Division : Angiosperm 
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 Sereies  : Disciflorae 
 Family  : Rutaceae 
 Genus  : Citrus  
 Species : Lemon [20L] 
The plant description: 
Distribution: 
Cultivated all over India 
Description: 
An armed, straggling shrub or tree; leaves elliptic-oval, petiole winged 
flowerswhite or pink in lax racemes; hesperidium greenish yellow, round to  oval, rind 
paper- like, aromatic, oil glands conspicuous; seeds oval, pointed. 
Phytochemical constituents: 
The major constituents of the distilled oil are d-limonene, - and - pinenes, - 
terpinolene, -terpineol, -bis-abolene, 1,4-cineol, terpinen-4-ol, and mycrene. Lemon 
juice contains citric acid, sugars, polysaccharides, Organic acids, Phosphoric and malic 
acids, lipids, carotenoid, vitamins and flavonoids.
[24 E ]
 
Properties and uses: 
 Lemon-juice prevents or restrains influenza, malaria and cold.  
 Vitamin C in lemon strengthens the blood vessels and prevents internal 
haemorrhage. It is, therefore, extremely useful in high blood pressure, in 
which cerebro-vascular accidents commonly occur.  
 Lemon juice is useful for people with heart problems. This is because of 
its high potassium content.  
 It prevents vomiting and helps to cure hepatitis. 
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3.3 DISEASE REVIEW 
3.3.1 Siddha Aspect Disease Review 
Jaundice which is otherwise known as Kamila, kamalai, manjal kamalai is one 
among those diseases which occur due to derangement of pitha uyir thathu. This disease 
comprises of the yellow discolouration of eyes, tongue and whole body. 
Aetiology: 
Yugi Vaidhya Chinthamani states that jaundice will occur when one consumes 
more pitha- stimulating food and indulges in excessive sexual activity under conditions 
of severe anaemia. 
Consuming more food which stimulates pitha thathu, drinking unhygienic and 
impure water and seasonal changes cause this disease 
Intake of variable food and other deeds stimulates pttha thathu, pitha increases 
in its strength, joins kaba and becomes pitha kaba factor. This factor spoils the 
spreading vayu (paravu kal- Vyanan) and prevents it from doing its normal work and 
thus it spoils the strength of blood. Because of this, liver gets affected and so the bile is 
not able to flow in its normal route as there is an obstruction.  
Hence the bile mixes with the blood and jaundice occurs. The vatha factor gets 
affected and the disease occurs due to pitha vatha factor. Apart from this, the other vayu 
(gases) also get spoiled. Hence the duty of the doctor is to set right the altered pitha 
kabam and pitha vatham, in order to make the bile flow in its normal route and to 
increase the strength of blood by suitable treatment. The altered spreading vayu (gas) 
and other vayu (gases) should be brought to normal and made to do the normal regular 
work. Then medicines for the disease should be given. 
Premonitory symptoms 
 In this disease, excessive salivation, nausea, bitterness of tongue, anorexia, in 
digestion, dryness of the body and shrinking of skin like a frog. After that, eyes, nail 
beds, face and skin and also urine become yellow in colour. 
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“பருககவ உள்ரங்கோ லுள்ரங் கககள் 
பகர்முகங்ண் ணுடம்பு஫ிக வவளுப்பு கோணுங் 
கருககவ கோல்ககக கரோய்ச்ச யோகுங் 
கன஫ோக நடுக்கிக஬ இகரப்புண் டோக்குஞ் 
சுருககவ ஫யந்தோனும் வமண்டு கட்டுந் 
தூ஬முக ஫ஞ்சரிட நிம஫ தோகும் 
வவருககவ வகீ்க஫ோய்க் ககரப்புண்டோகும் 
஫ிகக்கோது ஫ந்தந்தகய கனப்புண்டோகும்." 
        -யூகிமுனி 
 Again, in this disease, palm, sole, face, eyes and the body will become pale; 
there would be severe fatigue in the extremities, shivering of the body, frequent 
dyspnoea, constipated and hardened faeces, and yellowish discolouration of face, 
oedema, lassitude, deafness and heaviness of head. 
[25]
  
Classification of the disease 
 In siddha literatures, it is classified in to 13 varieties. They are as follows; 
1. Vatha kamalai 
2. Pittha kamalai 
3. Kaba kamalai 
4. Vatha kaba kamalai 
5. Pittha kaba kamalai 
6. Mukkutra kamalai 
7. Manjal kamalai 
8. Uthu kamalai 
9. Varal kamalai 
10. Azhagu kamalai 
11. Sengamala kamalai 
12. Kumba kamalai 
13. Gunma kamalai 
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Curable and Incurable  
 Among the 13 varieties, jaundice, seven are curable and eight types are 
incurable. Curable types include udhu kamalai, varal kamalai, manjal kamalai, pitha 
kamalai, kabha kamalai, vatha kabha kamalai, pitha kabha kamalai. The other varieties 
are not easily curable. 
[26]
 
Treatment for jaundice ( Siddha aspect ) 
To induce vomiting and diarrhoea 
 Since vomiting is a symptom in this disease, it should not be induced though it is 
advocated in Siddha literatures. 
 To stimulate normal and easy bowel movements, the following substances 
which have laxative action can be given: 
 Phyllanthus emblica ( Indian gooseberry ) 
 Terminalia chebula ( Kadukkai ) 
 Anthemides flower ( Simai samanthi flower ) 
 Buds of  rose ( Roja ) 
 Grapes ( Kodi munthrigai ) 
 Picorrhiza kurroa ( Kadukurohini ) 
 Bark, leaves and flower of purging cassia ( Sarakkondrai) 
 Root of Indian jalap ( Sivathai ) 
 Flower of neem ( Veppam pu) 
 Tinospora cordifolia ( Sinthil ) 
A decoction of the above substances may be made and given for jaundice for laxative 
purpose. 
[27A]
 
Other medicines 
Malakudara oil 
The medicinal malakkudara oil in a dose of one teaspoonful with a small 
quantity of milk can   be given at bed time. The next day morning faeces will be passed 
out easily. 
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Malakudara mezhugu 
Malalakudara wax (mezhugu) of the size of a fever nut (kazhal kay-Caelpinia 
bonduc) can be given at bet time.  Easy motion will occur in the morning 
Thithippu bedi mezhugu 
Sweet diarrhoea wax (thithippu bedhi mezhugu) or sweet diarrhoea leghiyam  
(thithippu bedhi leghiyam) of the size of  Indian gooseberry can be taken at bedtime.  
Easy to motion will occur in the morning. It may be given in suitable doses in the 
morning and evening. 
Sanjivi tablets 
If the motion is not passed properly by the above methods, 2 Sanjivi tablets with 
hot water can be given for children. Motion will be passed easily. 
For adults, one among the following may be given in a dose of 2 tablets with hot 
water in the morning alone. Faeces will be passed easily. The medicines are 
vajjirakandi tablet, attabairava tablet, suka viresana tablet, jivarathina tablet, virechana 
bhupathy and lavangathy tablet.  When sanjivi tablet along with leaf juice of Euphorbia 
nivula (ilaikkalli) is given, vomiting and diarrhoea will be induced. Vomiting for two or 
three times will occur.  Diarrohoea will also occur.  Along with vomit or faeces, the bile 
fluid will also come out. 
Marukkarai kaai 
The unripened fruit of Randia dumetorum (marukkarai kaai) in its tender 
reddish form may be taken.  It may be soaked in lime juice and leaf juice of Euphorbia 
nivula(ilaikkalli) for two days in each.  Then it can be taken out and dried.  This can be 
ground and made into powder. ½ pinches can be given in the morning alone.  Diarrhoea 
and vomiting will occur. 
[27B]
 
Medicines for Jaundice 
Kizha nelli ney: 
 Juice of Phyllanthus amarus 1.35 liter (one measure) 
 Cow‟s ghee1.35 liter (one measure) 
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 Piper cubeba (valmilagu) 
 Nutmeg (Myristica fragrances) (jathikkay) 
 Cardamom (Eletaria cardamom) (elam) 
Each 17.5 gm (1/2 palam) is taken. All of them may be ground in a mortar with 
milk. Then this may be heated and processed for oil (thylam) and filtered. 16 ml (the 
standard volume of a small spoon (uchikarandi) may be consumed in the morning and 
evening. Jaundice will be cured. Salt-free diet is essential. 
[28A] 
Karisalai ney: 
 Juice of Eclipta 1.35 litre (one measure),  
 Cow‟s ghee 1.35 litre (one measure), 
 Thirikaduku (dry ginger, pepper, long pepper) each 35 gm (one palam), 
 Hyoscyamus niger (kurosani omam) 8.5 gm (1/4 palam),  
 Cubeb (valmilagu) 17.5 gm (½ palam) 
 The above drugs are taken and the ghee may be prepared as described mix the 
above two and take in doses of ¼ to ½ teaspoon two or three times a day with cow‟s 
milk or buttermilk or goat‟s milk or buttermilk.   
It can be given with honey also or it can be taken separately.  It can be used as 
an adjuvant for any otherr chenduram.  It will give an excellent cure for spleen and liver 
enlargement also.  
Karisalai matthirai: 
 Eclipta alba - one handful 
 Black cumin 
 Long pepper  
 Pepper  
 Garlic  
         Each ¼ palam(8.5 gm) 
Grind them all in the mortar and make tablets in the size of Solanum torvum 
(sundai), dry them in shade and put them in a wide-mouthed bottle; pour good quality 
gingili oil and close it with a lid and put it in sunlight.  One tablet each may be taken in 
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the morning and evening.  Dry jaundice along with oedema will get cured. Tamarind 
and salt should be avoided 
[28B]
. 
Kaiyanthakarai karkam: 
Tender leaves of Eclipta alba, tender leaves of Coldenia procumbens 
(seruppadai), turmeric and pepper- equal quantities of the above 4 substances may be 
taken  and macerated on a stone mortar. A lime- sized paste may be consumed along 
with goat‟s urine. Jaundice and oedematous jaundice will be cured 
Sikaikkay for jaundice: 
Four numbers of fresh fruit of soapnut (Acacia conenua) may be collected and 
the seeds inside the fruit may be removed. The seedless fruits may be macerated with 
water very well and it may be consumed with half a litre of cow‟s milk. If diarrhoea 
occurs, then it is good. This medicine may be consumed for 3 days. 
Rice with cow‟s milk may be taken. Salt and tamarind should be avoided. 
Jaundice of any type will be cured. 
Ponnangani for dry type of jaundice: 
The root of Alternanthera sessilis may be collected and macerated on a stone 
mortar. It is taken in lime fruit size and be soaked into 4 liters of cow‟s milk and is 
allowed to mix with it. The next day, the butter from it may be taken out and consumed. 
Jaundice with dryness will be cured. 
Pirandai for jaundice: 
Tender leaves of Cissus quandrangularis, Piper nigrum, Acorus calamus,  
Zingiber officinale – equal quantities of these ingredients may be taken and macerated 
on a stone mortar.  An areca nut sized ball of this paste may be covered in rice bran and 
consumed. 
Aridradhi Choornam: 
Turmeric (manjal), pericarp of Terminalia chebula (kadukkay thol), pericarp of 
Terminalia belerica (thandrikay thol) and pericarp of Indian gooseberry (nelli mulli), 
Pircorzhiazha kurroa (kadugurohini), rock salt (induppu) equal quatities  of the above 
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substances may be taken, dried and pounded in a stone mortar. One verukadi (cat‟s foot 
print) quantity is mixed with water and may be consumed.  Jaundice will be cured. 
Amanakkilai marundhu: 
Tender leaves of castor plant (amanakku kozhundhu), tender leaves of 
Trianthema protulacasturm (saranai kozhundhu), dry ginger and white onion- equal 
quantities of the above things may be taken and macerated on a stone mortar. The paste 
may be mixed with buffalo curd and consumed.  Jaundice will be cured 
[28C]
. 
Arunelli for jaundice: 
Phyllanthus distiches in the size of the fruit of Alexandrian laurel (punnai kay) 
may be taken and macerated on a stone mortar. This may be given along with ¼ of a 
measure of sour buttermilk for 3 days in the morning. Jaundice will be cured. Rice with 
goat‟s milk can be taken. Salt should be avoided [28D]. 
Karisalai Choornam: 
 Powder of dry leaves of Eclipta alba (karisalai) 35 gm 
 Powder of epicarp of Terminalia chebula (kadukkay) 15gm 
 Powder of pepper (milagu) 10 gm 
 Powder of the root of Lowsonia alba – henna plant (maruthonri) 10 gm 
Mix the all the above and grind it in the mortar to make it a fine powder. Take 
2gm of the above, add 200mg of rusted iron chenduram and take 2 times a day with 
buttermilk. Within 5 to 10 days, jaundice will get cured 
Jaundice powder (another process) 
 Charred turmeric – one part 
 Cubeb – fried, pounded and powdered – one part 
 Cumin seeds – fried, pounded and powdered – one part 
 Cane sugar powder – 4 parts 
 Calx of gypsum – 1 part 
Mix all the above five and make a single powder of them.  Jaundice will be 
cured when this powder is taken in doses of 10 to 15kundri (1.3g to1.9g) two to three 
times a day with cow‟s milk or goat‟s milk or honey or in orange juice. It can also used 
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as adjuvant to any other chenduram or any other medicines prescribed for jaundice.  By 
this, anaemia, oedema and liver diseases will get cured 
[29]
. 
Nandiyavattam for jaundice: 
Pericarp of the root of multiple-layered Tabernaemontana divaricata, pericarp 
of the root of Indian jalap which is cooked in milk, the outer part of Terminalia chebula 
– equal quantities of these 3 things may be dried and pounded in a stone mortar and the 
powder may be filtered by a muslin cloth.  
If this powder is consumed in a three finger pinch with hot water, jaundice, 
predominant pitha condition, and oedema can be cured. 
Coconut medicine for jaundice: 
A well – ripened coconut is taken, its eyes is opened and the coconut water is 
poured into a vessel. The root of Boerhavia  diffusa (mukkirattai) is rubbed with 
coconut water and a paste  is made.  
This paste is inserted into the coconut through the opened eyes and then the eyes  
are closed properly and a strong mud-sealing is made over it and dried. This is buried 
under the ground and kept for 3 days under the earth.  
It is then taken out on the fourth day and the sealing may be removed. The 
coconut is broken and the medicine inside the coconut may be divided into 3 equal 
parts. One part per day along with buffalo curd is consumed. Fat free diet is essential. 
Diet for jaundice: 
Salt should be restricted according to the strength of the patient. Porridge 
without salt and tamarind is good. Twice boiled rice can be given. As stated in 
aetiology, when the bile flow is obstructed in the bile duct, fat will not be digested as 
bile is not available for digestion.  Ghee, butter, oil and all other fatty substances should 
be avoided until the disease is cured completely.  
Tender vegetables which are not fried with mustard and gingelly oil, green, 
fruits, butter milk and goat‟s milk can be taken in. Ginger paste can be added to diet to 
induce appetite. To the diet, cane juice, lime juice and ginger can be added. Smoking, 
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tobacco chewing, and alcohol–like substances should be fully avoided. Rest is essential 
until the disease is completely cured 
[30]
. 
Liver disease and herbal plants 
Phyllanthus amarus 
Hepatoprotective effects of aqueous extract from Phyllanthus amarus is 
evaluated on ethanol-induced hepato-toxic rats. Hepatic injury were studied in in-vitro 
model where Phyllanthus amarus increased the 3- [4,5-dimethylthiazol-2-yl]-2,5 
diphenyltetrazolium bromide (MTT) reduction assay and decreased the release of 
aspartate transaminase (AST) and alanine transaminase (ALT) in rat primary cultured 
hepatocytes treated with ethanol. The results revealed that treatment of rats with 
Phyllanthus amarus extract orally brought cell recovery in ethanol-induced liver injury 
by bringing the levels of Aspartate transaminase (AST), Alanine transaminase (ALT), 
High-sensitivity human thyroglobulin (HTG) and Tumor necrosis factor (TNF-α) to 
normal. Histopathological study confirmed the beneficial effect of Phyllanthus amarus 
with its potential antioxidant activity 
[31]
. 
Eclipta prostrata 
Therapeutic efficacy of Eclipta prostrata was evaluated using male Wistar rats 
and it was found that the curative effect of Eclipta prostrata was comparable to that of 
the standard drug Silymarin. The optimum effective dosage was found to be 200mg of 
ethanolic extract per kg body weight of the experimental animals used. In this study,  
the plant Eclipta prostrata was found to produce significant liver protection. The drug 
was standardized pharmacognostically and the optimum dosage was found to be 200 
mg/kg body weight of the animal. Technically and economically feasible protocol was 
developed for optimization of the secondary metabolite of Eclipta prostrata.
[32  ] 
Curcuma longa 
Curcumin possesses hepatoprotective and choleretic properties. Curcumin has 
been demonstrated in-vivo to prevent lipid peroxidation from diverse agents such as 
carbon tetrachloride, and Aflatoxin from Aspergillus parasiticus. In animal models, 
curcumin proved to be a potent choleretic, increasing bile output by almost 100% in one 
study. 
[33]
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Cuminum cyminum 
Aqueous ethanolic extract of dried seeds of Cuminum cyminum revealed 
hepatoprotective activity in Nimesulide intoxicated albino rats. Cuminum cyminum 
extract reduced the level of liver markers ALP, SGOT, SGPT and TB. Cuminum 
cyminum extract at a dose level of 200 mg/kg, significantly (p < 0.001) reduced the 
level of all elevated parameters as compared to other doses. Cuminum cyminum extract 
in 300 mg/kg showed better reduction in the level of all the parameters as compared to 
the dose of100 mg/kg but less than dose of200 mg/kg [34]. 
Terminalia chebula 
Ethanolic extract of Terminalia chebula fruit showed strong hepatoprotective 
activity.  It also showed similar property against anti-tuberculosis drug Rifampicin, 
Isoniazid and Pyrazinamide (combination) induced toxicity. This is because of its 
prominent anti-oxidative and membrane stabilizing activities. Protective effects of 
aqueous extract of Terminalia chebula fruit on the tert-butyl hydroperoxide-induced 
oxidative injury was observed in cultured rat primary hepatocytes and rat liver 
models
[35]
. 
3.3.2 Modern aspect of diseases: 
Liver Diseases 
Liver diseases are a broad term re-counting any number of diseases affecting the liver. 
Many are escorted by jaundice caused by increased levels of bilirubin in the system. 
Liver disease may be classified as:- 
1. Hepatitis, inflammation of the liver, instigated mainly by various viruses but 
also by some poisons, autoimmunity or hereditary conditions. 
2. Cirrhosis is the foundation of fibrous tissue in the liver, replacing dead liver 
cells. The death of the liver cells can be affected by viral hepatitis, alcoholism or contact 
with other liver-toxic chemicals. 
3. Haemochromatosis, a hereditary disease causing the accretion of iron in the 
body, eventually leading to liver damage 
[36]
. 
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4. Cancer of the liver (primary hepatocellular carcinoma or cholangio carcinoma 
and metastatic cancers, usually from other Parts of the gastrointestinal tract). 
5. Wilson's disease, a hereditary disease which reasons the body to retain copper. 
6. Primary sclerosing cholangitis, an inflammatory disease of the bile duct, 
likely autoimmune in nature. 
7. Primary billiary cirrohisis, autoimmune disease of  bile ducts. 
8. Budd-Chiari syndrome, complication of the hepatic vein. 
9. Gilbert's syndrome, a genetic syndrome of bilirubin metabolism, found in 
about 5% of the population. 
10. Glycogen storage disease type II, the build-up of glycogen causes liberal 
muscle weakness (myopathy) throughout the body and touches various body tissues, 
particularly the heart, skeletal muscles, liver and nervous system. 
Causes for Liver diseases 
1. Infections 
2.  Autoimmune disorder 
3. Chemical agents (certain antibiotics, peroxidised oil, aflatoxin, carbon tetra 
chloride, chlorinated hydrocarbon, paracetamol etc 
            4. Excess consumption of alcohol. 
Hepatitis: 
It is the infection and damage of liver particularly involving the hepatocytes. It 
is usually due to various infective and toxic substances. The condition can be self 
limiting, healing on its own, or can progress to scarring of the liver. A group of viruses 
had known as the hepatitis viruses‟ origin most cases of liver damage worldwide. 
Hepatitis can also be due to toxins (notably alcohol), other infections or from 
autoimmune process. 
[37]
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Viral Hepatitis: 
Viral hepatitis is the cause of most cases of acute hepatitis. Types include 
Hepatitis A, Hepatitis B, Hepatitis C, Hepatitis B with D, Hepatitis E, Hepatitis F virus 
(existence unknown), and Hepatitis G or GBV-C. Hepatitis A or infectious jaundice is 
affected by a picornavirus transmitted by the fecaloral route.  
It causes an acute form of hepatitis and does not have a chronic stage. Hepatitis 
B is caused by a hepadnavirus, which can cause 500,000 to 1,200,000 deaths per year 
worldwide due to the complications of chronic hepatitis, cirrhosis, and hepatocellular 
carcinoma. Hepatitis C (originally "non-A non-B hepatitis") is caused by a virus with an 
RNA genome that is a member of the Flaviviridae family.  
Hepatitis C may lead to a chronic form of hepatitis, culminating in cirrhosis. 
Hepatitis D is caused by hepatitis delta agent, which is alike to a viroid as it can only 
propagate in the presence of the Hepatitis B virus. Hepatitis E produces symptoms 
similar to hepatitis A. Hepatitis F virus is a hypothetical virus linked to hepatitis. 
Several hepatitis F virus candidates emerged in the 1990s; none of these reports have 
been substantiated. Another potential viral cause of hepatitis, initially identified as 
hepatitis G virus 
[38]
 is probably spread by blood and sexual contact.  
There is very little evidence that this virus causes hepatitis, as it does not appear 
to replicate primarily in the liver 
[39]
. It is now classified as GB virus C. In addition to 
the hepatitis viruses, other viruses can also cause hepatitis, including cytomegalovirus, 
Epstein-Barr virus, yellow fever, etc. Non viral infection like Toxoplasma, Leptospira 
and Q fever also causes hepatitis. 
Infective Agents 
These are mainly viruses like, Type A and Type B, Non – A, Non – B, Delta 
agent, virus of yellow fever, Epstin – Barr virus, cytomegalovirus, virus of Herpes 
simplex, Rubella, Marburg agent and others like Leptospira icterohaemorrhagiae, 
Leptospira canicola, Taxoplasma gondii, Borrelia recurrentis, etc.. 
Toxic Agents 
 Chlorpromazine and other Phenothiazine derivatives, Monoamine oxidase 
inhibitors (MAO-inhibitors), Erythromycin, Tetracycline, INH, Rifampicin, Methyl 
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dopa, Chlorpropamide, Phenylbu-tazone, Indomethacin, Paracetamol, Thiouracil, 
Acetaminophen, Halothen, Alcohol, Carbon tetrachloride, etc.
[40  ] 
Table: 1. List of Hepatotoxic therapeutic agents and chemicals: 
                                Therapeutic agents Chemicals 
Allopurinol Methotrexate Alcohol 
Amiodarone Nicotinic acid Arsenic 
Azathioprine Nitrofurantoin Carbon tetrachloride 
Carbamazepine Paracetamol Chloroform 
Chlorpromazine Phenelzine Copper 
Chloroform Phenytoin  
Ciglitazone Pravastation  
Cimetidine Quinidine  
Dantrolene Rifampicin  
Erythromycin Salicylates  
Galactosamine Simvastatin  
Halothane Sodium valproate  
Iproniazid Sulphonamides  
Isoniazid Tetracyclines  
Ketoconazole Ethanol  
 
Cirrhosis: 
Cirrhosis can be defined as a chronic disease condition giving morphological 
alteration of the lobular structure characterized by destruction and regeneration of the 
parenchyma cells and increased connective tissue. Major morphological changes induce 
granular or nodular appearance and are characterized by the presence of septate or 
collagen throughout the liver 
[41]
. 
Liver Cancer: 
The liver is inclined to cancer induction by a variety of human made and 
naturally occurring chemicals. Chemical substances include, aflatoxin B, cycasin, and 
safrole etc among human made substance are DDT, carbon tetrachloride, chloroform, 
thioacetamide. Studies in experimental animals designate quite clearly that development 
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of cancer of the liver is associated with the number of obvious non-malignant lesions 
appearing prior to the occurrence of neoplastic malignancy. 
Hepatotoxicity: 
Hepatotoxicity implies chemical-driven liver damage. The liver plays a Central 
role in transforming and clearing chemicals and is disposed to the toxicity from these 
agents. Certain medicinal agents when taken in overdoses and sometimes even when 
introduced within therapeutic ranges may injure the organ. Other chemical agents such 
as those used in laboratories and industries, and natural chemicals (e.g. microcystins) 
can also induce hepatotoxicity. 
The mechanism of hepatotoxicity in liver can be labelled by two methods. 
1) Direct: - This group comprises the products (or their metabolic products) that 
produce direct injury to the plasma membrane, endoplasmic reticulum and other 
organelles of the hepatocytes. Direct hepatotoxicity may be exemplified as non-
selective destruction of the structural basis of hepatocyte metabolism. 
Some of the direct hepatotoxins comprise carbon tetra chloride, chloroform, 
tetrachloroethane, iodoform and elemental phosphorus. 
2) Indirect: -These are more selective, and are antimetabolic and related 
compounds that produce hepatic hurt by interference with specific metabolic pathway. 
The hepatic damage produced by indirect hepatotoxins may be mainly 
cytotoxicity expressed as necrosis or mainly cholestatic expressed as arrested bile flow 
with or without bile duct injury. 
A group of enzymes located in the endoplasmic reticulum, recognized as 
cytochrome P-450, is the most important family of metabolizing enzymes in the liver. 
Cytochrome P-450 is the terminal oxidase component of an electron transport chain. 
 It is not a single enzyme, but rather covers of a family of closely related 50 
isoforms, six of them metabolize 90% of drugs 
[42]
. There is a remarkable diversity of 
individual P-450 gene products and this heterogeneity allows the liver to perform 
oxidation on a vast array of chemicals (including almost all drugs).   
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Due to its unique metabolism and close relationship with the gastrointestinal 
tract, the liver is subject to injury from drugs and other substances. About 75% of blood 
coming to the liver arrives directly from gastrointestinal organs and then spleen via 
portal veins which carry drugs and xenobiotics in concentrated form. Several 
mechanisms are accountable for either inducing hepatic injury or worsening the damage 
process.  
Many chemicals damage mitochondria, an intracellular organelle that produces 
energy. Its dysfunction releases extreme amount of oxidants which in turn injures 
hepatic cells. Activation of some enzymes in the cytochrome P-450 system such as 
CYP2E1 also chief to oxidative stress injury to hepatocyte and bile duct cells lead to 
accumulation of bile acid inside liver 
[43]
.  
This promotes further liver damage. Non-parenchymal cells such as Kupffer 
cells, fat storing stellate cells and leukocytes (i.e. neutrophil and monocyte) also have 
role in the mechanism 
[44]
. 
More than 900 drugs have been concerned in causing liver injury, and it is the 
most common reason for a drug to be withdrawn from the market. Drug persuaded liver 
injury is responsible for 5% of hospital admissions and 50% of all acute liver 
failures
[45]
. 
The liver produces large quantities of oxygen free radicals in the course of 
detoxifying xenobiotic and toxic substances.  
Reactive oxygen species (ROS) has been exposed to be linked to liver diseases, 
such as hepatitis, cirrhosis, portal hypertension, viral contagions and other liver 
pathological conditions 
[46]
. They play an important role in the inflammation process 
after intoxication by ethanol, carbon tetrachloride or carrageenan.  
These radicals and the reactive species resultant from them react with cell 
membrane, induce lipid peroxidation and are responsible for various deleterious 
belongings in cells and tissues where they are generated. ROS induce alterations and 
loss of structural/functional architecture in the cell, leading directly to cytotoxicity 
and/or indirectly to genotoxicity, with numerous serious anomalies favouring 
disharmony and diseases 
[47]
. 
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 Hepatic injury caused by chemicals, drugs, and virus is a well-known 
toxicological problem to be occupied care of by various therapeutic measures. 
3.4 PHARMACOLOGICAL REVIEW 
Models of Liver Fibrosis 
Several approaches to induce fibrosis in animals are designated and these 
models can be divided according to their stimulus from inciting injury.  Liver fibrosis 
models are connected with  
(1) toxic damage (hepatocytes: CCl4 dimethylnitrosamine (DMN), 
galactosamine; bile duct epithehal cells:  thioacetamide (TAA)),  
(2) immunological-induced damage (heterogonous serum and experimental 
schistosomiasis), (3) biliary damage (common bile duct ligation (BDL) or 
occlusion)  
            (4) alcohol-induced damage (baboon ethanol diet or Tsukamoto / French model 
in rats) 
. Nowadays, fibrosis-related models are established that have their origin in fatty liver 
disease  
            (5), Fatty liver disease, in particular the 'malignant' inflammatory form non-
alcoholic steatohepatitis     (NASH), can increase to liver fibrosis and cirrhosis.  
 It is strongly associated with obesity and diabetes, two modern health problems 
in Western countries. Of the existing animal models for fatty liver disease, as reviewed 
by the genetic lepton-deficient (ob/ob) or lepton- resistant (db/db) mice. 
 The dietary methionine/ choline-deficient models are cast-off in the majority of 
published research.
[48]
  Progressive fibrosis was reported only in themethionine/choline-
deficient models in 100% of the mice. 
 BDL and CCl4 are the most widely used rodent models 
[49]
 in liver fibrosis 
research to assess the effectively of experimental drugs on the pathogenesis, since these 
models represent features of human pathogenesis.  Therefore, these models are the best 
categorized with respect to histological, biochemical, cell and molecular changes 
connected with the development of fibrosis 
[50]
.   
In the past years, there is a tendency in fibrosis - related research to shift from 
rat to mice models, and most of the models originally described ferrates are now applied 
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in mice.  Moreover, new testing models arise due to the development of transgenic or 
knock-out mice models, which were developed to elucidate the pathogenesis and 
common pathways in liver fibrosis.  Examples of knockouts with spontaneous 
formation of liver fibrosis are mdr2-/- mice 1hx2-/- mice,   and the mice models for 
NASH mentioned above. 
Acute and Chronic Models with Carbon Tetrachloride (CCl4) 
CCl4 intoxication results in hepatocyte necrosis and apoptosis with damage 
predominantly in zone III (around central vein) of the liver.  The mechanism behind this 
hepatocyte damage is the activation of CCl4 by cytochrome P450, which results in the 
formation of trichioromethyl radical in these cells and this free radical initiates lipid 
peroxidation
[51]
 . 
The damage to hepatocytes by CCl4 is replicated by high plasma alanine  
transaminase (ALT) and aspartate transminase (AST) levels after CCl4  administration,  
CCl4causes also fatty changes in the hepatocytes.  This initial damage is followed by 
hepatic stellate cell activation and tissue fibrosis. 
 The CCl4 model is related with tremendous inflammation, a feature that is also 
often seen in livers of patients with liver fibrosis.  Disadvantages of this model are the 
variations obtained in disease induction in the animals and the relatively high rate of 
mortality alter CCl4 administration > 20%. 
 In animal models CCl4 treatment is used to get different stages of the fibrotic 
process, ranging from early damage and HSC activation until advanced cirrhosis.  The 
fibrotic stage obtained in the rodents depends on the number of injections of CCl4 that 
are administered.   
The models for CCI4 that are used in liver fibrosis research, are (1) acute 
damage (72 hours after a single injection of CCI4) with HSC activation (2) early and 
establish fibrosis (4-6 week of twice weekly CCl4 dosing),  (3) early cirrhosis (8 week 
of twice weekly CCl4dosing)  and (4) advanced micronodular cirrhosis (12 week of 
twice weekly CCl4dosing). 
 In addition for each of these models (5) spontaneous recovery from fibrosis can 
be studied after cessation of dosing of CCl4.This latter model is a valuable model to 
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determine drug induced acceleration of recovery from established fibrosis after removal 
of the inciting stimulus.  
 This is similar to treatment situations in patients with liver fibrosis in case their 
inciting stimulus can be eradicated for instance after alcohol abstinence or after antiviral 
therapy beside hepatitis virus infections. 
 CCl4 is administered to the animals via intraperitoneal, subcutaneous or oral 
administration or by inhalation.  For intraperitoneal injections, CCl4 is diluted in olive 
oil and given indosages of 0.5 - 1.0 ml / kg to rats and mice.  Often supplementation of 
phenobarbital in drinking water (resulting in induction of hepatocyte cytochrome P450) 
is used to get more reproducible fibrosis improvement and to accelerate the speed of 
fibrosis development.  Usually, phenobarbital concentrations of 0.3 - 0.4 g/I in drinking 
water are used and started I week before the initial exposure to CCl4.   
In case of inhalation of CCl4 the animals are placed in an inhalation chamber 
twice a week with a progressively increasing exposure time (1.5 min).  Also with this 
procedure, supplementary phenobarbital in drinking water is added. To reduce early 
toxicity and mortality, some research groups vary with the dose of CCL4 in time.  In 
these cases, gradually growing dosages in the first weeks are administered to the rats. 
Bile Duct Ligation (BDL)  
The second well-studied experimental animal model of liver fibrosis is the bile 
duct ligation model. This model corresponds with the human pathology of 
biliarycirrhosis, such as extrahepatic biliary atresia and primary sclersoing cholangitis.  
Ligation of the bile duct causes acute epithelial impairment and the detergent action of 
the subsequently released bile salts in the liver is likely associated with the 
solubilization of plasma membranes and hepatocyte cell death.  
 This latter is envisaged by elevated ALT and AST levels in plasma, in particular 
proximately after ligation (first week).  Characteristics of obstruction of the bile are the 
appearance of bile products, such as bilirubin into the blood circulation, which causes 
jaundice in these animals 
[52]
. 
 The initial damage is followed by a massive expansion of the bile duct epithelial 
cells and periductal my fibroblasts, which can be referred to as portal expansion (stage 
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1) in total this results in marked liver enlargement, which can be up to twice the weight 
as compared to normal.  
 Then, bile duct epithelial cells and my fibroblasts in the portal tract are 
increasingly expanding which results in a gradual remodelling of the liver architecture 
by linking adjacent portal tracts (biliary cirrhosis stage IV). 
 To ligate the bile duct, the abdomen of the rat is opened under general anesthesia 
(preferably N2O/O2/halothane inhalation to agree quick recovery from narcosis) to 
identify the common bile duct.  The bile duct turns from the helium of the liver, where 
the hepatic ducts meet, through the pancreas, into the lower end of the duodenum.  Of 
note, threat has no gall bladder in contrast to other rodents.   
Three ligatures are located and tied around the bile duct; two close to the liver 
and one close to the duodenum. The first ligatures will prevent formation of a reservoir 
of bile outside the liver.  After tight closure, the bile duct is cut between the second and 
third ligation in order to prevent restoration of the bile flow by bile duct formation 
around the ligature.  Subsequently, the abdomen is closed over and analgesics can be 
given to the rats.   
We use a local anaesthetic compound (Marcaine which contains bupivacaine), 
but also systemic acting analgesics are sometimes administered (e.g. Temgesic 
(containing buprenorphine). For mice, the procedure is a little bit more complicated 
because a mouse possesses a gall bladder, and consideration should be [paid to tightly 
ligate the whole duct, in general more than three ligatures are needed, to prevent rupture 
of the bladder and subsequent problems. 
 Already in the first days after ligation, proliferation of bile duct epithelial cells, 
activation and proliferation of HSC and my fibroblasts, and deposition of extra cellular 
matrix can be detected microscopically starting in the portal areas of the liver (zone 3).  
After one week, a fibrous expansion of the portal areas is visible and after about 10-14 
days, portal- portal bridging is visible.  
 Three to four weeks after ligation, these rates develop advanced cirrhosis 
characterized by extensive proliferation of the bile ducts, around which the activated 
and transformed HSC are detectable (Markers: a - smooth muscle action and PDGF beta 
receptor) and around which the interstitial collagens (types I and III) are deposited. 
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 A major advantage of the BDL   model is the relatively fast development of 
fibrosis (within 3 weeks) in rats.  Furthermore, the model is quite reproducible, and the 
mortality due to the ligation procedure in rats is low (<10%).  Disadvantages of the 
BDL models are the limited inflammation associated with this type of fibrosis 
development and the excessive expansion of bile duct epithelial cells.  
 Another drawback with regard to drug screening is that the BDL-induced 
disease is difficult to reverse with experimental drugs, and a reason for this may be 
because the initiating stimulus (ligation of the bile duct) remains present during 
treatment periods and causes continuous damage as subsequent fibrosis that troubles the 
potential treatment effects. 
Dimethylnitrosamine (DMN): 
DMN induces liver damage leading to fibrosis and cirrhosis.  Characteristic for 
this model is that ongoing administration of this toxic compound finally leads to the 
development of hepatocellular carcinoma in rodents.   
DMN induces liver injury by starting damage to the hepatocyte.  It is 
metabolized primarily in hepatocytes by Cytochrome P450 (isotype 2E1) to more toxic 
compounds with formation of reactive oxygen species in hepatocytes and sub-sequent 
this will lead to lipid peroxidation.  In difference to the hepatotoxin CC14, DMN 
administration does not cause fatty changes, steatosis in the hepatocytes
[53]
.  To induce 
the fibrosis, DMN (10 microliter/kg body wt., i.p) is given 3 days a week for 3 weeks to 
rats. 
 After administration of DMN, hemorrhagic necrosis is evident in centrolobular 
part (zone III) of the liver.  Incomplete septa appear after 7 days and micronodular 
cirrhosis is developed after 3 weeks of treatment with DMN.  Increased numbers of 
HSC and my fibroblasts are found in the formed septa.  Influx of inflammatory cells, 
mainly lymphocytes, is noted early in DMN - induced liver injury. 
 Advantages of this model are that the disease induction is quite reproducible in 
the animals, and this model is associated with a prominent inflammatory reaction. 
Furthermore, this model can be used to study the transition from cirrhosis to 
hepatocellular carcinoma, and the effect of drugs on this process. 
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HSC in Culture (In Vitro System): 
 HSC are key players in fibrosis and these cells predominantly orchestrate the 
development of the disease.  To evaluate the ant fibrotic efficacy of experimental drugs, 
these primary cultured cells are useful in assessing specific effects on HSC activities.  In 
particular, the primary isolated HSC are valuable in drug research, because in vitro they 
spontaneously transform into my fibroblasts, and this transformation process is related 
with cellular activation proliferation and matrix production resembling cellular activities 
that also happen in vivo.  
 This transformation does not occur in the various HSC cell lines that are also 
used in literature.  Proximately after isolation they signify a inactive stage, e.g. as 
present in the normal healthy liver, with vitamin A droplets as their main characteristic.  
During culture on plastic for about 10-14 days a cell with fibroblast -like features is 
attained. This transformed cell displays different cellular activities as compared to the 
original isolated one. 
 The procedure to isolate HSC is well described by various fibrosis research 
groups Briefly, HSC are isolated from livers of normal rats weighing at least 500g in 
order to achieve a good separation from the other hepatic cells.  
 The liver is digested with pronase, collagenase and DNase by in situ perfusion. 
Pronase is essential in the isolation, yet it affects the viability of other hepatic cells (i.e. 
hepatocytes) and therefore this procedure can only be used isolate HSC from the liver.  
After several centrifuge steps, the cells suspension is subjected to a Nycodenz 
gradient to gather the HSC on top of the Nycodenz layer.  The separation is based on 
the low density of the HSC as compared to other liver cells, as a consequence of their 
high cellular lipid content.  Instead of Nycodenz, also other compounds are used e.g 
Stractan, Metrizamide, or Percoll, to separate the HSC from the other cells by density 
gradients. 
  The yield of HSC after collagenase / pronase digestion and Nycodenz 
separation is about 20-40 x 10E6 cells per rat liver. 
  The yield of HSC attained from a mouse liver is much smaller and to isolate 
and purify proper amounts of HSC, about 5 mice have to be used at the same time in 
one total  isolation (Geerts, personal communication) 
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 The purity after isolation can be established by phase contrast microscopy or by 
staining of the cells with markers for hepatic cell types.  The isolated cells are cultured 
in DMEM containing 10% FCS 100 U/ml penicillin, and 100 ug/ml streptomycin. After 
10-14 days in culture, the cells exhibition an activated phenotype as assessed by light 
microscopy and acquires the presence of alpha-smooth muscle action. 
 Additionally, it is also conceivable to isolate HSC from human livers.  Often 
(parts of) human livers are used that are unbecoming for transplantation are derived 
from tumor-free parts of the human liver and separated after partial hepatectomy.   
Roughly, two methods are used to isolate human stellate cells. (i)  out-growth of 
the cells by culturing small pieces of the livers in medium and (ii) a combined digestion 
with collagenase / pronase, after which HSC were separated from other liver non - 
parenchymal cells by centrifugation over density gradients similar to threat procedure.  
Of note, the first method will yield a combination of various (myo) fibroblastic cells 
including HSC and myofibroblasts.  
 These cells are afterward cultured in DMEM< supplemented with 5% Fetal Calf 
Serum and 5% G Human Serum.  The fibroblastic nature of the cells can be 
microscopically evaluated, and tested for the expression of a smooth muscle action. 
Liver Slice System 
A second in vitro test system which was recently developed to assess effects of 
anti fibrotic drugs is the liver slice preparation.  Drug studies with tissue slices (8mm 
diameter, 250 un thickness that is about 10-12 cell-layers thick)  comprising stellate 
cells in their natural environment that uphold there in vivo cellular functional and 
anatomic relationships, may provide additional information about the hepatocellular 
specificity of the experimental drug and their effects on all hepatic cells.  
Hepatoprotective and antioxidant effects of tender coconut water (TCW) were 
examined in carbon tetrachloride (CCl4)-intoxicated female rats. 
 Liver damage was showed by the increased levels of serum glutamate 
oxaloacetate transaminase (SGOT), serum glutamate pyruvate transaminase (SGPT) and 
decreased levels of serum proteins and by histopathological studies in CCl4 intoxicated 
rats.  
                                                                                  REVIEW OF LITERATURE 
 
  HEPATOPROTECTIVE ACTIVITY OF PITHA KAMALI CHOORNAM Page 59 
 
Augmented lipid peroxidation was presented by elevated levels of thiobarbituric 
acid reactive substance (TBARS) viz, malondialdehyde (MDA), hydroperoxides (HP) 
and conjugated dienes (CD), and also by significant reduction in antioxidant enzymes 
activities, such as superoxide dismutase (SOD), catalase (CAT) and also reduced 
glutathione (GSH) content in liver.  
          Darkening of urine On the other hand, CCl4 intoxicated rats treated with TCW 
retained almost normal levels of these constituents. Decreased activities of antioxidant 
enzymes in CCl4 intoxicated rats and their reversal of antioxidant enzyme activities in 
TCW treated rats, shows the effectiveness of TCW in combating CCl4 induced 
oxidative stress. 
 Hepatoprotective outcome of TCW is also evidenced from the histopathological 
studies of liver, which did not show any fatty infiltration or necrosis, as observed in 
CCl4  intoxicated rats 
[54]
. 
Exams and Tests Physical Examination 
 Nutritional assessment  
 Yellowing of the sclera is usually the first detectable sign of jaundice.  
 Darkening of urine  
 Skin examination for icterus  
 Stigmata of chronic liver disease  
 Abdominal examination  
 Enflamed and tender liver  
 Fluid in the abdomen (ascites) that can become infested 
 Blood tests  
 These may initially include  
 Complete blood count – TC ,DC, ESR, Cholesterol  
 Liver function test 
 In women, a pregnancy test may be obtained.  
 Urine analysis: Urine analysis for bile salts and bile pigments  
 
Laboratory Tests 
 Abdominal ultrasound  
 Autoimmune blood markers  
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 Hepatitis virus serologists 
 Liver function tests  
 Liver biopsy to check for liver destruction 
 Paracentesis if fluid is in abdomen  
 Tests for Liver Function  
Bilirubin:  
Bilirubin is one of the most important factors indicative of hepatitis. It is a red-
yellow pigment that is normally metabolized in the liver and then defecated in the urine.  
In patients with hepatitis, the liver cannot process bilirubin, and blood levels of 
this substance rise. High levels of bilirubin cause the yellowish skin tone known as 
jaundice. 
Liver Enzymes (Aminotransferases):  
Enzymes known as aminotransferases, including aspartate (AST) and alanine 
(ALT), are free when the liver is damaged. Measurements of these enzymes, 
particularly ALT, are the least expensive and most non-invasive tests for determining 
sternness of the underlying liver disease and monitoring treatment effectiveness. 
Enzyme levels vary, however, and are not always an accurate indicator of disease 
activity.  
Alkaline Phosphatase (ALP): High ALP levels can indicate bile duct blockage. 
GGT (gamma glut amyl transpeptidase) is often elevated in those who use alcohol or 
other liver-toxic substances to excess.  
Serum Albumin:  
Serum albumin measures protein in the blood (low levels indicate poor liver 
function). Total protein, Serum total protein,  protein in the blood (low levels indicate 
poor liver function).  
Prothrombin Time (PT):  
The PT test measures in seconds the time it takes for blood clots to form (the 
longer it takes the greater the risk for bleeding 
[55]
. 
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3.5 LATERAL RESEARCH 
Piper nigrum 
 Anti asthmatic activity: 
   Oral administration of piperine in different proportion to mice suppressed and 
reduced the infiltration of eosinophil, hyper responsiveness and inflammation due to the 
suppression of the production of histamine, interleukin-5, immunoglobin E and 
interleukin-4
[56]
. 
 Anti bacterial activity: 
The extracts of black pepper were evaluated for antibacterial activity by Disc  
diffusion method. The results indicate inhibition on the growth of gram positive bacilli 
like Staphylococcus aureus, Bacillus cereus, Staphylococcus faecalis and gram negative 
bacilli like Pseudomonas aeruginosa, Salmonella typhi and Escherica coli
[57]
. 
 Antidiarrhoel property  
The antidiarrhoeal activity was done against castor oil induced diarrhoea in 
mice. In such induced situation piperine sequentially prevent the small intestine fluid 
accumulation.
[58]
  
Curcuma longa 
 Anti inflammatory activity: 
The laboratory studies have identified a number of different molecules involved in 
inflammation that are inhibited by curcumin including phospholipase, lipoxygenase, 
cyclooxygenase, thromboxane, prostaglandins. The human studies have found some 
evidence of anti inflammatory activity of curcumin.
[59] 
Zingiber officinale 
 Anti oxidant: 
The co2 extract from ginger has high polyphenol content. It manifested a very good 
scavenging DPPH and reduced its reducing capacity. It also showed antioxidant activity 
comparable with that of BHT 
[60]
. 
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 Antihypertensive activity 
Ghayur has reported that the crude extract of ginger induces the ca2+ channel-
Blocking (CCB) activity that lowers the blood pressure which ultimately reduces the 
hypertension in the patients 
[61]
. 
Cuminum cyminum 
  Anti bacterial: 
Essential oil of Cuminum cyminum contains p-mentha-1, cuminaldehyde, 
terpene, pinene which shows a Anti bacterial activity against clavibacter, 
curtobacterium, rhodococcus, erucinia, xanthomonas, agro bacterium which are 
responsible for plant or cultivated disease worldwide.
[62]   
 Nephroprotective activity: 
The cumin seeds extracts and the coriander leaf extract incobination shows 
nephroprotective activity in profenofos induced neprotoxicity in swiss albino mice. The 
biochemical assessment shows the nephroprotective activity of cumin and coriander. In 
comparison to control group mice group creatinine, urea, uric acid were increased in 
profenofos treated group and profenofos control group. But in cumin, and coriander 
treated group it shows declination in the level of creatinine & urea level 
[63]
. 
Ferula asafoetida 
 Anti ulcer: 
This herb comes under the WHO recognised plant drugs. Asafoetida is very 
useful in the digestion process. Many researchers proved its efficacy in gastric irritation 
and acid peptic disease 
[64]
. 
Trigonella foenum graecum 
 Anti plasmodic activity: 
Some of the alkaloids and tannins like phenolic compoumds from Trigonella 
foenum graecum showed potential antiplasmodial properties against in vitro culture of 
chloroquine sensitive and resistant P. Falciparum
[65]
. 
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Piper longum 
 Anti cancer activity: 
The alcohol extract of Piper longum and piperine inhibits solid tumour  
 development in mice induced with Dalton‟s lymphoma ascites cells and increases the 
life span of mice 
[66]
. 
 ACE inhibition and Anti-oxidant activity 
Hydro alcoholic extract of Piper longum showed ACE inhibitor activity in a 
concentration dependent manner, in liberation of hippuric acid from HHL catalyzed by 
the ACE method. Particularly Piperine extract showed most active. The anti-oxidant 
activity of piperine extracts showed maximum anti-oxidant activity by the scavenging 
effect on the stable DPPH free radical activity method
[ 67 ]
.  
Allium sativum 
 Anti diabetic effect: 
S- allyl cystiene sulphoxide ( SACS ) a sulphur containing amino acid of garlic 
which is the precursor of allicin and garlic oil, has been found to show significant anti 
diabetic effects in alloxan diabetic rats.
[68] 
3.6 PHARMACEUTICAL REVIEW 
Choornam 
Definition 
Choornam is a fine powder of drugs. The “Choornam” may be applied to the 
powders of a single drug or a mixture of two or more drugs, which are powdered 
separately prior to their being mixed to homogeneity. 
Method of preparation 
Equipment required 
1. The drug enumerated in the recipe in clean and well dried state. 
2. A mortar and pestle. 
3. A fine sieve or fine cloth of close mesh. 
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Process of preparation 
The drugs which are to be used in the preparations should be taken from recently 
collected material. Drugs which are aged by prolonged storages or changed in colour, 
taste and scent, and those that are insects infested or attacked by fungi should be 
positively rejected.However drugs like Embelia fruits, Senna, Long Pepper, Jaggery and 
cows ghee are preferred from fairly aged stock, provided they are not infested with 
pests, deteriorated or spoiled or developed racidity. 
In general the aromatic drugs are slightly fried in order to enhance their aroma 
and milling properties. Any extraneous material, organic or inorganic, should be 
removed from the drugs by close inspection. 
The chooranam should be so fine to be called amorphous and should never be 
damp. The fineness of the sieve should be 100 mesh or still finer. 
Purification of the prepared Chooranam 
“தாச஦ன்஫ சூபணத்தின் சுத்திக்றகளு 
தப்஧ாறத சபக்சகல்஬ாஞ் சூபணித்து 
஥ாச஦ன்஫ யாயின்஧ா஬ாற் ஧ிலசந்து 
஥஬நா஦ சட்டினிற஬ ஧ால஬யிட்டு 
யாச஦ன்஫ சுத்தச஬ம் ஧ாதியிட்டு 
ய஭நாக றநற்சீல஬ றகாடு கட்டிப் 
஧ாச஦ன்஫ சூபணத்லதப் ஧ிட்டுற஧ால் லயது 
஧த஫ாறத சயந்சதடுக்கச் சித்தினறந!” 
-அகஸ்தினர் லயத்தின இபத்தி஦ச்சுருக்கம் 
The prepared Choornam is mixed with the milk,in a pot with half a quantity of 
milk and half a quantity of water is taken. The mouth of the pot is covered with a thin 
cloth material. Above this cloth the mixed Choornam is placed. The pot is placed over 
the stove and heated. 
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“ஆநப்஧ா பயிப௅஬ர்த்திப் ச஧ாடி தான்சசய்து 
அப்஧ற஦ சந஦ாய்ச் சர்க்கலபலனச்றசர்த்து 
஥ாநப்஧ா சகாண்டு யபறதாரம் ற஧ாச்சு 
஥ன்஫ாகச் சுத்திசசய்னாச் சூபணந்தான் 
தாநப்஧ா றபாகத்லத சயல்஬ா தப்஧ா 
த஭நா஦ யினதிசனல்஬ாம் ஧ாரிக்கும்஧ார் 
றயநப்஧ா சுத்திசசய்து சகாண்டான஦ால் 
சயகுசுறுக்காய் தீருநா யினாதிறகளு”[69] 
-அகஸ்தினர் லயத்தின இபத்தி஦ச்சுருக்கம் 
Then the Choornam is placed in the sunlight and powdered. Equal amount of 
sugar is added and taken internally to cure all diseases. If the drug is taken without 
purification the disease does not cure. If taken after purification the disease cures easily. 
Storage 
The prepared Choornam should be allowed to cool by spreading and mixing, 
prior to packing. They should be stored in tightly stopper glass, polythene or tin 
containers, or in polythene or cellophane bags and sealed. These bags should in turn be 
enclosed in cardboard boxes. 
The Choornam to facilitate easy handling and to assure exact dosage 
administration, could be pressed into tablets, could be packed in bottles or tubes made 
either of glass or plastic or packed in strip of metal foil or plastic sheets. 
In industry the tablets are made, counted & packed by electronic devices. 
Then Choornam is said to retain its potency for three months and then gradually 
deteriorate. However if properly packed & stored they keep good for a year.
 
According to AYUSH guidelines shelf life of Choornam is one year 
[70]
. 
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Table: 2. ANALYTICAL SPECIFICATIONS OF CURNA/CHOORNAM 
 
 
Sl. No TESTS 
1. 
 
2. 
3. 
4. 
5. 
6. 
7. 
 
8. 
 
9. 
 
 
 
 
10. 
 
 
11. 
 
 
 
 
12. 
 
 
 
13 
Description 
Macroscopic, Microscopic 
Loss on drying at 1050 C 
Total – ash 
Acid – insoluble ash 
Water-soluble extractive 
Alcohol – soluble extractive 
Particle size (80-100 mesh for Churna; 40-60 
mesh  for churna) 
Identifications, TLC/HPTLC-with marker (wherever 
possible) 
Test for heavy/Toxic metals 
Lead 
Cadmium 
Mercury 
Arsenic 
Microbial contamination 
Total bacterial count 
Total fungal count 
Test for specific Pathogen 
E. coli 
Salmonella spp. 
S.aureus 
Pseudomonas aeruginosa 
Pesticide residue 
Organochlorine pesticides 
Organophosphorus pesticides 
Pyrethroids 
Test for Aflatoxins (B1,B2,G1,G2) 
 
 
 
                                  MATERIALS AND METHODS                                                                
 
HEPATOPROTECTIVE ACTIVITY OF PITHA KAMALAI CHOORNAM Page 67 
 
 
              4. MATERIALS AND METHODS 
 
Materials: 
            In this dissertation the preparation drug „Pitha Kamalai Choornam’ is taken 
as a trial drug for hepatoprotective, from Korakkar Maruththuvam  Published by 
Siddha Maruththuva Nool Veliyeettu Pirivu, Indian Medicine and Homeopathy, 
Chennai-600106, Page No: 126-127. 
Ingredients: 
1.     Chukku  -    Dried ginger ( Zingiber officinale ) -15 gm 
2.     Milagu  -    Black pepper ( Piper nigrum )  -15 gm 
3.     Thippili  -    Long pepper ( Piper longum )  -15 gm 
4.     Kadugu  -    Indian mustard ( Brassica juncea ) -15 gm 
5.     Vellai poondu -    Garlic ( Allium sativum )   -15 gm 
6.     Perungayam -    Asafoetida ( Ferula asafoetida )  -15 gm 
7.     Vendhayam -    Fenugreek (Trigonella foenum graecum)-15 gm 
8.     Seeragam  -    Cumin seeds ( Cuminum cyminum ) -15 gm 
9.     Perunjeeragam -    Anise seeds ( Foeniculum vulgare ) -15 gm 
10.     Manjal  -    Turmeric ( Curcuma longa )  -15 gm 
11.     Omam  -    Bishops weed ( Tachyspermum ammi) -15 gm 
Other Ingredient: 
        Elumichai charu –     Lemon juice (Citrus lemon)                                                     
Collection of the Drug: 
  All raw materials were collected from Ramasamy Pillai shop, Parris corner, 
Chennai, Tamilnadu. 
Identification and Authentification of the Drug: 
All the raw materials were identified and authenticated by the Botanist and 
Proffesor in Gunapdam Department in Government Siddha Medical College, 
Arumbakkam, and Chennai-106.The specimen sample of all the herbs have been 
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preserved in PG Gunapadam department individually for future reference. 
(Ref No: GSMC/ PGGM/0096-107/2014-2017) 
Purification of the Drug: 
 All the drugs mentioned here were purified as per the Siddha literature.
[71]
 
 Milagu,Thippili, Kadugu, Vendhayam, Narseeragam, Perunjeeragam were 
cleaned well without any dust and impurities. 
 Outer skin of Chukku is removed. 
 Outer skin of Poondu is removed 
 Impurities from Manjal is removed 
 Perungayam is roasted. 
 
4.1 PREPARATION OF THE TRIAL DRUG PITHA KAMALAI CHOORNAM: 
Procedure: 
The above mentioned purified drugs were slightly roasted, finely powdered 
separately and mixed well, and then the mixture was ground with the lemon juice for few 
hours and again allowed to dry and powdered. Then the Choornam is purified by 
pittaviyal method as per Siddha literature and again, dried, sieved through thin clean 
white cloth and collected in a air tight container. Finally Pitha Kamalai Choornam is 
labelled as PKC. 
         
 
 
                      
                  Powdering                                   Sieving 
                                  MATERIALS AND METHODS                                                                
 
HEPATOPROTECTIVE ACTIVITY OF PITHA KAMALAI CHOORNAM Page 69 
 
                          
                                   Pitha Kamalai Choornam 
 
Purification of the Choornam: 
The “Pitha Kamalai Choornam” was purified by pittaviyal method (steam 
cooking in milk) as per Siddha classical literature. A mud pot was taken and it was half 
filled by milk and mixed with equal quantity of pure water. The mouth of the pot was 
sealed by a cloth. This chooranam was placed over a clean dry cloth and tied firmly 
around the mouth of mud pot. The gap between mud pots was tied with a wet cloth to 
avoid evopration.The mud pot was kept on fire and boiled until the cow‟s milk reduced in 
the lower pot. 
The same drug was later dried and powdered then sieved again. It was used for the 
further study
 [72]
. 
Storage of the Drug: 
 The prepared test drug was stored in a clean, air tight glass container.The 
contents were inspected frequently to avoid moisture and insects. 
Administration of the Drug: 
 Form of the medicine: Choornam 
        Route   : Enteral 
        Dose   : 2 -3 gms twice a day 
        Adjuvant  : Lemon juice, honey, ginger juice. 
        Indication  : Jaundice        
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4.2 STANDARDIZATION OF THE DRUG 
        Standardisation of the drug brings the validation to be used as a medicine by 
subjecting the drug to many analysis and determining its quality and effectiveness. 
Standardization includes many studies such as its organoleptic properties, physical 
characteristics and phytochemical properties and also to assess the active principles and 
elements present in the drug. The standardization brings the efficacy and potency of the 
drug. 
4.2.1 Organoleptic characters: 
      The organoleptic characters of the sample drug were evaluated. 1 gm of the drug 
was taken and the colour, texture, particle size and other morphology were viewed by 
naked eye under sunlight.Then the result is noted. 
4.2.2 Physicochemical analysis: 
      Physicochemical studies of the trial drug have been done according to the AYUSH 
guidelines
 [73]
. 
Determination of the Ash Values: 
Total ash 
     3g of the test drug was accurately weighed and incinerated in a crucible dish at a 
temperature not exceeding 450
0
 C until it was free from carbon. It was then cooled and 
wieghed .The % w/w of ash with reference to the air dried powder was calculated. 
Water soluble ash 
     The total ash was obtained as the above method for preparation of total ash. The ash 
was boiled with 25ml of water for 5 minutes. The insoluble ashes were collected using 
filter paper. It was then washed with hot water and transferred to the silica crucible. It was 
then ignited for 15 minutes at temperature not exceeding 450
0
 C. For determination of 
weight of the water soluble ash the silica crucible and residue were weighed until constant 
weight was attained.  
The weight of the water soluble ash is determined by subtracting the weight of 
insoluble ash from the weight of total ash. 
Acid insoluble ash 
    The total ash was obtained as the above method for preparation of total ash. The ash 
was boiled for 5 minutes with 25ml 10% HCl. The insoluble ashes were collected using 
filter paper and washed with hot water. It was then transferred to the silica crucible and 
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ignited for 15minutes at temperature not exceeding 450
0
 C. The silica crucible and 
residue were weighed until constant weight is attained. 
Determination of Extractive Value: 
Alcohol soluble Extractive value 
      3g of test drug powder was weighed and macerated with 100ml of ethanol in a 
closed container for 24 hours. The resulting solution was shaken continuously for 6 hours. 
It is then allowed to stand and soak for 18 hours. The solution is filtered and evaporated of 
the filtrate in a flat bottomed shallow dish and dried at 105
0
 C. Then the content was 
cooled and weighed. 
Water soluble Extractive value 
      3g of test drug powder was weighed and macerated with chloroform and water, 
respectively, at 80
0
 C for 24 hours. The resulting solution was shaken continuously for 6 
hours and allowed to stand and soak for 24hours then filtered. The solution from both 
chloroform and water respectively was filtered and evaporated of the filtrate in a flat 
bottomed shallow dish. It was dried at 105
0
C then cooled and weighed. 
Loss on Drying     
    The powdered drug was taken and dried in the oven at 100 – 1050C to constant 
weight. The result was noted. 
Physical characterisation: 
Solubility: a. A little of the sample was shaken well with distilled water. 
    b. A little of the sample was shaken well with Con HCl and Con H2SO4.  
       Sparingly Soluble character indicates the presence of silicate. 
pH value: Potentiometrically ph value was determined by a glass electrode and a suitable 
pH meter. 
Action on heat: A small amount of the sample was taken in a dry test tube and heated 
gently. If there was a strong white fumes evolving it indicates the presence of carbonate. 
Flame test: A small amount of the sample was made into a paste with con.Hcl in a watch 
glass. It is then introduced into non-luminous part of the Bunsen flame. A appearance of 
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bluish green flame indicates the presence of copper. 
Ash test: A filter paper was soaked into a mixture of sample and cobalt nitrate solution. It 
was then introduced into the Bunsen flame and ignited. Appearance of yellow colour 
flame indicates the presence of Sodium. All these results were tabulated. 
4.2.3 phytochemical analysis: 
         The Phytochemical screening of the extract gives general idea regarding the 
nature of chemical constituents present in the crude drug. The phytochemical tests were 
done as the method illustrated
 [74]
. 
Test for Alkaloids 
        A small portion of solvent free extracts were stirred separately with few drops of 
dilute hydrochloric acid and filtered & tested carefully with various alkaloidal reagents. 
Mayer’s reagent           - Cream precipitate 
Dragendroff’s reagent     - Orange brown precipitate 
Hager’s reagent           - Yellow precipitate 
Wagner’s reagent         - Reddish brown precipitate 
Test for Carbohydrates and Reducing Sugars 
        The minimum amount of extracts were dissolved in 5ml of distilled water & 
filtered. The filtrate was subjected to test for carbohydrates & glycosides. 
a) Molisch’s test 
       The filtrate 1ml was treated with 2-3 drops of 1% alcoholic alpha naphthol 
& 2ml concentrated sulphuric acid was added along the sides of test tube. Violet 
ring was obsrved at the junction of 2 layers which showed the presence of 
carbohydrate. 
b) Benedict’s test 
       The filtrate 1ml was treated with Benedict‟s reagent and heated gently. 
Orange red precipitate indicates the presence of reducing sugars. 
c) Fehling’s test 
       The filtrate 1 ml was treated with equal volume of Fehling‟s solution A 
and B and heated gently. Orange red precipitate indicates the presence of reducing 
sugars. 
Test for glycosides 
              The extract was hydrolyzed with dil HCl and subjected to test for 
glycosides. 
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a) Modified Borntrager’s test 
       To the hydrolysate extract,1 ml of Ferric chloride solution was added and 
immersed in boiling water for about 5 minutes. The mixture was cooled and 
extracted with equal volume of benzene. The benzene layer was seperated and 
treated with ammonia solution. Formation of rose pink colour in the ammoniacal 
layer indicates the presence of Anthranol glycosides. 
b) Legal’s test 
       The hydrolysate extract was treated with Sodium nitropruside in pyridine 
and sodium hydroxide. Formation of pink to blood red colour indicates the 
presence of Cardiac glycosides. 
 Test for Saponins 
 The extract 0.5 ml was shaken with 5 ml distilled water. The presence of 
saponins was indicated by formation of copious lather. 
 Test for Tannins 
 Gelatin test 
 To the extract, 1% gelatin solution containing sodium chloride was added.  
Formation of white precipitate indicates the presence of tannins. 
 Test for Phenolic compounds 
       To 0.5 ml of extract, 1 ml of alcoholic ferric chloride solution was added. 
Formation of bluish green or bluish black indicates the presence of Phenolic compounds. 
Test for Phytosterol 
Ferric chloride – acetic acid test 
      1 ml of extract is treated with 1ml of chloroform and then, 2 ml of ferric chloride 
acetic acid reagent is added followed by 1 ml of conc. Sulphuric acid. Appearance of 
reddish pink colour shows the presence of phytosterol. 
Test for Diterpenes 
Copper acetate test 
     1 ml of extract was dissolved in water and treated with 3-4 drops of Copper acetate 
solution, Formation of emerald green colour indicates the presence of diterpenes. 
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Test for Triterpenes 
Salkowski’s test 
     1 ml of extract is treated with 1 ml of chloroform followed by 1 ml of conc sulphuric 
acid, shaken and allowed to stand. Appearance of golden yellow colour shows the 
presence of triterpenes. 
Test for Flavonoids 
a) Alkaline reagant test 
To 1 ml of extract, 1 ml of 10% sodium hydroxide solution was added. Formation 
of dark yellow colour indicates the presence of flavonoids. 
b) Lead acetate test 
To 1 ml of extract, 3-4 drops of 10% lead acetate solution was added. Formation 
of yellow precipitate indicates the presence of flavonoids. 
c) Ferric chloride test 
To 1 ml of extract, 3-4 drops of ferric chloride solution was added. Formation of 
dark green colour indicates the presence of flavonoids. 
d) Shinoda test 
To 1 ml of extract, few mg of magnesium turnings was added followed by few 
drops of conc. hydrochloric acid and boiled for five minutes in a boiling water 
bath. Formation of red colour indicates the presence of flavonoids. 
Test for proteins and Free Amino Acids 
a) Xanthoproteic test 
To 1 ml of extract, 3-4 drops of conc. nitric acid was added. Formation of yellow 
precipitate indicates the presence of proteins. 
b) Million’s test 
To 0.5 ml of extract, 2.5 ml of Million‟s reagent was added. Formation of white 
precipitate and the precipitate warmed indicates the presence of proteins. 
c) Biuret test 
To 0.5 ml of extract, 2.5 ml of diluted reagent was added. Appearance of purple 
colour or brick red precipitate showed the presence of proteins and free amino 
acids. 
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Test for Quinones 
Sodium hydroxide test 
       To 0.5 ml of extract, 1 ml of 10% sodium hydroxide was added. Appearence of 
blue or green or red colour shows the presence of quinones. 
4.2.4 TLC/ HPTLC finger print studies 
HPTLC finger printing was carried out as per the reference.
 [75] 
Preparation of spray reagent-vanillin-sulphuric acid reagent 
Vanillin (1g) was dissolved in ice cold ethanol (95ml).  Add to 5ml of cooled 
concentrated sulphuric acid. Ice was added and stirred well. The solution was stored in 
refrigerator. 
Chromatographic conditions  
Instrument   : CAMAG (Switzerland). 
Sample applicator  : Camag Linomat - IV applicator with N2 gas 
                                      Flow. 
Photo documentation System : Digi store - 2 documentation system with Win 
                                      Cat and video scan software. 
Scanner   : Camag HPTLC scanner - 3 (030618), Win 
Cats-IV 
Development Chamber       : Camag HPTLC 10X10, 10 X 20 twin trough 
 Linear Development Chamber 
Quantity applied  : 5, 10 µl for extracts and 5 µl for standards 
Stationary phase : Aluminium plate pre-coated with silica gel 
60(E. Merck) 
Plate thickness  : 0.2 mm. 
Mobile Phase :   For Chloroform extract - Toluene: Ethyl 
    Acetate (9:1) and ethanol extract – Toluene:  
    Ethyl acetate (1:1)   
Scanning wavelength  : 254 nm 
Laboratory condition  : 26 ± 5
o
C and 53 % relative humidity 
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   The plate was developed up to a height of 8 cm, air dried, spots were observed under 
the UV light at 254 and 366 nm. Finally the plates were derivatized using 
vanillin-sulphuric acid reagent heated at 105° till colour spots appeared. 
4.2.5 Bio-chemical analysis 
Methodology for chemical analysis 
Preparation of extract 
5gm of KVNC wass weighed accurately and placed in a 250ml clean beaker and 
added with 50ml of distilled water. Then it was boiled well for about 20 minutes. Then it 
was cooled and filtered in a 1000ml volumetric flask and made up to 100ml distilled 
water. 
   Table.No:3. Test for basic radicals 
  
PROCEDURE 
 
OBSERVATION INFERENCE 
Test for Potassium:  
A pinch of sample is treated with 2ml of sodium 
nitrate solution and then treated with 2ml of 
cobalt nitrate in 30% of glacial acetic acid. 
 
Formation of Yellow 
colour precipitate 
Presence of 
Potassium 
Test for Calcium: 
Taken2 ml of extract in a clean test tube. Then 
acetic acid and potassium 
chromate solution were added 
 
No Yellow precipitate 
Presence of 
Calcium 
Test for Magnesium: 
2ml of extract w 
as taken in a clean test tube, few drops of 
Magnason reagent was added in drops. 
 
Formation of Blue  
colour precipitate 
 
 
Presence  of 
Magnesium 
Test for Ammonium: 
2mlof extract was taken in a test tube and added 
few ml of Nessler's reagent. 
 
Appearance of Brown 
colour 
 
 
Presence of 
Ammonium 
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Results were tabulated in Table no: 10  
 
PROCEDURE OBSERVATION INFERENCE 
Test for Sodium: 
2 pinches of Pitha kamalai Choornam was 
mixed with HCl and made it into paste.  And 
introduced into the blue flame of Bunsen 
burner. 
 
 
Appearance of intense 
Yellow colour 
 
 
 
Presence of 
Sodium 
Test for Iron (Ferrous):   
2ml of extract was taken in a clean dried test 
tube and conc. HNO3 and ammonium 
thiocyanate were added. 
Appearance of Blood 
red colour 
Presence of 
Ferrous iron 
Test for Zinc: 
  2 ml of the extract was taken in a test tube and 
Potassium ferro cyanide solution was added.  
 
Formation of White 
colour precipitate 
 
Presence  of 
Zinc 
Test for Aluminium: 
To the 2m1of the extract was taken in a test tube 
sodium hydroxide drops were added to it. 
 
White precipitate 
obtained 
 
Presence of 
Aluminium 
Test for Lead: 
2 ml of extract was taken in a test tube and 
added with 2ml of potassium iodide solution 
 
Formation of yellow 
colour precipitate 
Presence of 
Lead 
Test for Copper:   
To a small portion of a extract dilute 
hydrochloric acid was added and then hydrogen  
sulphide gas is passed through the solution. 
 
Black precipitate 
 
Presence of 
Copper 
Test for Mercury: 
2m1 of the extract was taken in a test tube and 
treated With 2ml of sodium hydroxide solution. 
 
Formation of Yellow 
precipitate 
 
Presence of 
Mercury 
Test for Arsenic:       
2m1 of the extract was taken in a test tube and 
treated with 2ml of sodium hydroxide solution. 
Formation of brownish 
red precipitate 
Presence of 
Arsenic 
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Table.No:4. Test for acidic radical 
 
Results were tabulated in Table no: 11 
 
 
PROCEDURE   OBSERVATION INFERENCE 
Test for Sulphate:  
2 ml of the extract was taken in clean, dry 
test tube and 5 % barium chloride solution 
was added to it. 
 
Formation of white 
precipitate 
 
Presence of 
Sulphate 
Test for Chloride:  
The extract was taken in a test tube and 
then treated with Silver nitrate solution. 
 
Formation of White 
precipitate 
 
Presence of 
Chloride 
Test for Phosphate: 
The extract was taken in a test tube and 
treated with ammonium molybdate and 
conc. HNO3. 
 
Formation of Yellow 
precipitate 
 
Presence of 
Phosphate 
Test for Carbonate :           
The substance was taken in a clean dry test 
tube and then treated with Conc. HCl. 
 
Formation of 
Effervescence 
Presence of 
Carbonate 
Test for fluoride &oxalate: 
2ml of extract was taken in a test tube and 
added with 2ml of dil. acetic acid, 2ml 
calcium chloride solution and then heated. 
 
Formation of cloudy 
appearance 
 
Presence of 
Fluoride & 
Oxalate 
Test for Nitrate: 
1gm of the Pitha kamalai Choornam was 
heated with copper turnings and 
concentrated H2SO4 and observed the test 
tube vertically down. 
 
Characteristic changes 
 
Presence of 
Nitrate 
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4.2.6. Availability of the bacterial load: 
Enumeration of bacteria by plate count – Agar plating technique 
The plate count technique was one of the most routinely used procedure because 
of the enumeration of viable cells by this method
 [76]
. 
Principle:  
This method is based on the principle that when material containing bacteria are 
cultured, every viable bacterium develops into a visible colony on a nutrient agar 
medium. The number of colonies therefore is the same as the number of organisms 
contained in the sample. 
Dilution:  
 A small measured volume is mixed with a large volume of sterile water or saline 
called the diluent or dilution blank. Dilution is usually made in multiples of ten. A single 
dilution was calculated as follows: 
             
        Volume of the sample 
   Dilution =  
     Total volume of the sample and the diluent 
 
Requirements: 
 Sample or Bacterial suspension 
 9 ml dilution blanks (7) 
 Sterile petri dishes (12) 
 Sterile 1 ml pipettes(7) 
 Nutrient agar medium (200 ml) 
 Colony counter  
Procedure: 
 
 Label the dilution blanks as 10-1, 10-2, 10-3, 10-4, 10-5, 10-6, 10-7. 
 Prepare the initial dilution by adding 1 ml of the sample into a 9 ml 
dilution blank labeled 10
-1
 thus diluting the original sample 10 times. 
 Mix the contents by rolling the tube back and forth between hands to 
obtain uniform distribution of organisms. 
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 From the first dilution transfer 1 ml of the suspension while in motion, to 
the dilution blank 10
-2
 with a sterile and fresh 1 ml pipette diluting the 
original specimen to 100 times. 
 From the 10-2 suspension, transfer 1 ml of suspension to 10-3 dilution blank 
with a fresh sterile pipette, thus diluting the original sample to 1000 times. 
 Repeat this procedure till the original sample has been diluted 10,000,000 
times using every time a fresh sterile pipette. 
 From the appropriate dilutions transfer 1ml of suspension while in motion, 
with the respective pipettes, to sterile petri dishes. Three petri dishes are 
used for each dilution. 
 Add approximately 15 ml of the nutrient medium, melted and cooled to 
45
0
c, to each petri dish containing the diluted sample. Mix the contents of 
each dish by rotating gently to distribute the cells throughout the medium. 
 Allow the plates to solidity. 
  Incubate these plates in an inverted position for 24-48 hours at 370c. 
Observation: 
 Observe all the plates for the appearance of bacterial colonies. Count the number 
of colonies in the plates. 
 Calculate the number of bacteria per ml of the original suspension as follows: 
                Number of colonies (average of 3 replates) 
 Organisms per millimeter =  
       Amount of plated × dilution 
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4.2.7. Sophisticated instrumental analysis 
FT-IR (Fourier Transform Infra-Red) 
A. FOURIER TRANSFORM INFRARED SPECTROSCOPY (FTIR) 
        
Figure no: 3.1 FTIR Spectroscopy analyser 
 
 
Fig: 3.2 FTIR-MECHANISMS 
 
Instrument details: 
Model   : SHIMADZUFT-IR Spectrometer 
Scan Range   :  MIR 450-4000 cm-1 
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Resolution   :  1.0 cm-1  
Sample required : 50 mg, solid or liquid. 
 
Fourier transform - Infra red (FTIR) spectroscopy study was carried out in IIT 
Campus Chennai, Tamil Nadu by using SHIMADZU FTIR Spectrometer. 
Sample Preparation 
A small amount (2-4mg) of Pitha kamalai Choornam sample was mixed with 7 
drops of distilled water. After dissolvation, the solution was taken in a small test tube and 
transfers this solution with a pipet onto the IR plates. The KBr plates must be 
methodically cleaned after this process to prevent contamination of next concentration 
sample. 
It is the preferred method of infrared spectroscopy. FT-IR is an important and 
more advanced technique. It is used to identify the functional group, to determine the 
quality and consistency of the sample material and can determine the amount of 
compounds present in the sample. It is an excellent tool for quantitative analysis. 
[77] 
In FT-IR infrared is passed from a source through a sample. This infrared is 
absorbed by the sample according to the chemical properties and some are transmitted. 
The spectrum that appears denotes the molecular absorption and transmission. It forms 
the molecular fingerprint of the sample. Like the finger print there is no two unique 
molecular structures producing the same infrared spectrum. It is recorded as the 
wavelength and the peaks seen in the spectrum indicates the amount of material present. 
FT-IR is the most advanced and the major advantage is its 
 Speed 
 Sensitivity 
 Mechanical Simplicity 
 Internally Calibrated 
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 SEM (SCANNING ELECTRON MICROSCOPE) 
 
                          Fig: 4.1    SEM INSTRUMENT 
         
 
                  Fig: 4.2 SEM MECHANISMS 
           
     In scanning electron microscope high-energy electron beam was focused through a 
probe towards the sample material. Variety of signals was produced on interaction with 
the surface of the sample. This results in the emission of electrons or photons and it is 
collected by a appropriate detector.  
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The types of signal produced by a scanning electron microscope include  
 Secondary electrons 
 back scattered electrons 
 characteristic x-rays,light 
 specimen current 
 Transmitted electrons. 
This gives the information about the sample and it includes external morphology, 
texture, its crystalline structure, chemical composition and it displays the shape of the 
sample
 [78]
. 
XRD (X-RAY POWDER DIFFRACTION) 
Definition 
X-ray powder diffraction is most widely used for the identification ofunknown 
crystalline materials (e.g. minerals, inorganic compounds). Determination of unknown 
solids is important to studies in geology, environmental science, material science and 
biology. 
Applications: 
 Characterization of crystalline materials [79] 
 Identification of fine-grained minerals such as clays and mixed layer clays 
that are difficult to determine optically 
 Determination of unit cell dimensions. 
With specialized techniques, XRD can be used to: 
 Determine crystal structures using Rietveld refinement 
 Determine of modal amounts of minerals (quantitative analysis) 
 Characterize thin films samples by: 
 determining lattice mismatch between film and substrate and to inferring 
stress and strain 
 determining dislocation density and quality of the film by rocking curve 
measurements 
 measuring super lattices in multilayered epitaxial structures 
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 determining the thickness, roughness and density of the film using 
glancing incidence X-ray reflectivity measurements 
 Make textural measurements, such as the orientation of grains, in 
apolycrystalline sample. 
Strengths and Limitations of X-ray Powder Diffraction 
Strengths 
 Powerful and rapid (< 20 min) technique for identification of an unknown 
mineral 
 In most cases, it provides an unambiguous mineral determination 
 Minimal sample preparation is required 
 XRD units are widely available 
 Data interpretation is relatively straight forward. 
Limitations 
 Homogeneous and single phase material is best for identification of 
unknown 
 Must have access to a standard reference file of inorganic compounds 
 Requires tenths of a gram of material which must be ground into a powder 
 For mixed materials, detection limit is ~ 2% of sample 
 For unit cell determinations, indexing of patterns for non-isometric crystal 
systems is complicated. 
Sample Collection and Preparation 
Determination of an unknown requires: the material, an instrument for grinding, 
and a sample holder. 
 Obtain a few tenths of a gram (or more) of the material, as pure as possible 
 Grind the sample to a fine powder, typically in a fluid to minimize 
inducing extra strain (surface energy) that can offset peak positions, and to 
randomize orientation.  
 Powder less than ~10 μm(or 200-mesh) in size is preferred place into a 
sample holder or onto the sample surface. 
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ICPOES (INDUCTIVELY COUPLED PLASMA OPTIC EMISSION 
SPECTROSCOPY) 
Manufacturer: Perkin Elmer 
Model:       Optima 5300 DV ICP-OES Inductively Coupled Plasma Spectrometer 
(ICP) 
Principle: 
An aqueous sample is converted to aerosols via a nebulizer. The aerosols are 
transported to the inductively coupled plasma which is a high temperature zone (8,000– 
10,000ºC). The analysts are heated (excited) to different (atomic and/or ionic) states and 
produce characteristic optical emissions (lights). These releases are separated based on 
their respective wavelengths and their strengths are measured (spectrometry). The 
intensities are proportional to the concentrations of analyses in the aqueous sample. The 
quantification is an external multipoint linear standardization by comparing the emission 
intensity of an unknown sample with that of a standard sample. Multi-element calibration 
standard solutions are prepared from single- and multi element primary standard 
solutions. With respect to other kinds of analysis where chemical speciation is relevant 
(such as the concentration of ferrous iron or ferric iron), only total essential concentration 
is analysed by ICP-OES. 
Application: 
It is the Analysis of major and minor Elements in solution samples. 
Objectives: 
 Determine elemental concentrations of different metals. 
 Learn principles and operation of the ICP-OES instrument 
 Develop and put on a method for the ICP-OES sample analysis 
 Enhance the instrumental conditions for the analysis of different elements 
 probes the outer electronic structure of atoms 
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Mechanism:  
In plasma emission spectroscopy (OES), a sample solution is presented into the 
core of inductively coupled argon plasma (ICP), which generates temperature of 
approximately 8000°C. At this temperature all elements become thermally excited and 
emit light at their characteristic wavelengths. This light is collected by the spectrometer 
and passes through a diffraction grating that serves to resolve the light into a spectrum of 
its essential wavelengths. Within the spectrometer, this deflected light is then collected by 
wavelength and amplified to yield an strength of  measurement that can be converted to 
an elemental concentration by comparison with standardization values 
The Inductively coupled plasma optical emission spectrometric (ICP-OES) 
analysis was done in SAIF, IIT MADRAS, and Chennai-36 using Perkin Elmer Optima 
5300 DV
[80]
. 
Sample preparation: 
Inductively Coupled Plasma Spectroscopy techniques are the so-called "wet" 
sampling methods whereby samples are introduced in liquid form for analysis. 
100 mg Pitha kamalai Choornam was occupied in a clean, dry test tube. To this, 3 
ml Nitric acid was added and mixed well and allowedfor few minutes untill the reactions 
were completed. And then, 25 ml of Refined water, was added to prepare digested 
solution. The digested sample solution was shifted into plastic containers and labeled 
properly. It was completed in Bio-chemistry lab, Govt. Siddha Medical College, 
Chennai-106 
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Fig 5.2 Mechanism of ICP-OES analyser 
 
 
Fig: 5.1 ICP-OES ANALYSER (Perkin Elmer Optima 5300 DV) 
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4.3. TOXICOLOGICAL STUDIES 
4.3.1. Acute oral toxicity – OECD guidelines - 423  
Introduction:  
The acute toxic class method is a stepwise procedure with the use of 3 animals of 
a single sex per step. Depending on the mortality and/or the moribund status of the 
animals, on average 2-4 steps may be necessary to allow judgment on the acute toxicity of 
the test substance. Morbid animals or animals obviously in pain or showing signs of 
severe and enduring distress shall be humanely killed, and are considered in the 
interpretation of the test  results  in  the  same  way  as  animals  that  died  on  
test.  The method allows for the determination of an LD50 value only when at least two 
doses result in mortality higher than 0% and lower than 100%. 
Acute toxicity study was carried out as per OECD guideline. (Organization for 
Economic Co - operation and Development,Guideline - 423
[81]. 
The experimental protocol was approved by the institutional ethical committee 
(IAEC) under CPCSEA (approval no: IAEC/XLV111/12/CLBMCP/2016) 
Animal: Healthy Wistar albino female rat weighing 200–220 gm Studied carried out at 
three female rat under fasting condition, signs of toxicity was observed for every one hour 
for first 24 hours and every day for about 14 days from the beginning of the study. 
Principle:  
It is the principle of the test that based on a stepwise procedure with the use of a 
minimum  number  of  animals  per  step,  sufficient  information  is  obtained  
on  the  acute toxicity  of  the  test  substance  to  enable  its  classification.  The 
substance is administered orally to a group of experimental animals at one of the defined 
doses.  The substance is tested using a stepwise procedure, each step using three animals 
of a single sex. 
Absence or presence of compound-related mortality of the animals dosed at one 
step will determine the next step, i.e.; − no further testing is needed − dosing of three 
additional animals with the same dose − dosing of three additional animals at the next 
higher or the next lower dose level. The method will enable a judgment with respect to 
classifying the test substance to one of a series of toxicity classes.   
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Methodology   
Selection of animal species:  
The preferred rodent species was rat, although other rodent species may be used. 
Healthy young adult animals of commonly used laboratory strain Swiss albino rat were 
obtained from Animal house of king‟s institute, Guindy, Chennai. Female should be 
nulliparous and non-pregnant.  
 Each animal at the commencement of its dosing should be between 8 and 12 
weeks old and its weight should fall in an interval within±20 % of the mean weight of the 
animals.  The studies were conducted in the animal house of C.L.Baid Metha college of 
pharmacy, Duraipakkam, Chennai. 
Housing and feeding conditions:   
The  temperature  in  the  experimental  animal  room  should  be  22ºC  
(+3ºC). Although  the  relative  humidity  should  be  at  least  30%  and  
preferably  not  exceed  70% other than during room cleaning the aim should be 
50-60%. Lighting should be artificial, the sequence being 12 hours light, 12 hours dark. 
For feeding, conventional laboratory diets may be used with an unlimited supply of 
drinking water. Animals may be grouped and tagged by dose, but the number of animals 
per cage must not interfere with clear observations of each animal.   
Preparation of animals:   
  The animals are randomly selected, marked to permit individual identification, and kept 
in their cages for at least 7 days prior to dosing to allow for acclimatization to the 
laboratory conditions. 
Experiment Procedure: 
Administration of doses 
Pitha kamalai Choornam” prepared as per the classical Siddha literature was 
suspended in 2% CMC with uniform mixing and was administered to the groups of 
Wistar albino rats. 
It was given in a single oral dose by gavage using a feeding needle. Animals were 
fasted prior to dosing. Following the period of fasting, the animals were weighed and then 
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the test substance was administered. After the substance has been administered, food was 
withheld for a further 3-4 hours. The principle of laboratory animal care was followed. 
Observations were made and recorded systematically and continuously observed as per 
the guideline after substance administration.  
The visual observations included skin changes, mobility, and aggressiveness, 
sensitivity to sound and pain, as well as respiratory movements. They were deprived of 
food, but not water 16–18 hours prior to the administration of the test suspension.  
Finally, the number of survivors was noted after 24 hours and these animals were 
then maintained for a further 14 days and observations made daily. The toxicological 
effect was assessed on the basis of mortality.  
Number of animals and dose levels 
Since this test drug has been under practice for long time and likely to be 
non-toxic, a limit test at one dose level of 2000 mg/kg body weight will be carried out 
with 6 animals   (3 animals per step). 
Duration of Study                            :   48 hours 
Evaluation                                   :   14 Days 
Limit test 
 The limit test was primarily used in situations where the experimenter has 
information indicating that the test material is likely to be nontoxic, i.e., having toxicity 
only above regulatory limit doses. A limit test at one dose level of 2000 mg/kg body 
weight was carried out with three animals per step. The test substance-related mortality 
was not produced in animals, so further testing at the next lower level need not be carried 
out. 
Observations 
 The animals were observed individually after dosing at least once during 
the first 30mins and periodically during the first 24 hours. 
 Special attention: First 1-4 hours after administration of drug.  
 It was observed daily thereafter for a total of 14 days, except when they 
needed to be removed from the study and killed humanely for animal 
welfare reasons or are found dead. 
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a. Mortality 
Animals will be observed intensively at 0.5, 2.0, 4.0, 6.0, 12.0, 24.0 and 48.0 hour 
following drug administration on day 1 of the experiment and daily twice thereafter for 14 
days.   
b. Body weight 
Body weights will be recorded at day: ‐1, day 1, 2, 7 and 14 of the study 
c. Cage-side observation 
These include changes in skin and fur, eyes and mucous membranes and also 
respiratory, circulatory, autonomic and central nervous systems, somatomotor activity 
and behaviour patterns. Attention should be directed to observations of tremors, 
convulsions, salivation, diarrhoea, lethargy, sleep and coma. 
d. Gross necropsy 
All animals (including those which die during the test period are removed from 
the study) will be subjected to gross necropsy. Gross necropsy includes examination of 
the external surface of the body, all orifices, cranial, thoracic and abdominal cavities and 
their contents, brain, eye, thymus, lungs, heart, spleen, liver, kidneys, adrenals, testes and 
uterus of all animals 
Histopathology 
Microscopic examination will be carried out in organs to show the evidence of 
any toxicity in gross pathology. 
Data and reporting 
All the data were summarised in tabular form showing the animals used, number 
of animals displaying signs of toxicity, the number animals found dead during the test or 
killed for humane reasons, a description and the time course of toxic effects and 
reversibility, and necroscopic findings. 
Test substance and Vehicle  
  In order to ensure the uniformity in drug distribution in the medium the 
suspension was made by mixing “Pitha kamalai Choornam” with 2% CMC solution and 
it was found suitable for dose accuracy.  
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Justification for choice of vehicle 
The vehicle selected as per the standard guideline is pharmacologically inert and 
easy to employ for new drug development and evaluation technique
 [82]
. 
4.3.2. Repeated dose 28 days oral toxicity study of “pitha kamalai Choornam” on 
rats – (oecd-407 guidelines) [83]. 
Justification for Dose Selection 
The results of acute toxicity studies in Wistar albino rats indicated that “Pitha 
kamalai Choornam” was non-toxic and no behavioral changes was observed up to the 
dose level of 2000 mg/kg body weight. On the basis of body surface area ratio between rat 
and human, the doses selected for the study were100mg/kg, 200 mg/kg and 400 mg/kg 
body weight. The oral route was selected for use because oral route is considered to be a 
proposed therapeutic route. 
Preparation and administration of dose 
   “Pitha kamalai Choornam” at three doses respectively was suspended in 2 ml of 
2% CMC in distilled water. It was administered to animals at the dose levels of 100, 200 
and 400 mg/kg. The test substance suspensions were freshly prepared every day for 28 
days. The control animals were administered vehicle only. Administration was by oral 
(gavage), once daily for 28 consecutive days. 
Methodology 
Randomization, Numbering and Grouping of Animals 
 Ten rats (Five Male and Five Female) were in each group randomly divided into 
four groups for dosing up to 28 days. Animals were allowed acclimatization period of 7 
days to laboratory conditions prior to the initiation of treatment. Each animal was fur 
marked with picric acid. The females were nulliparous and non-pregnant. 
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Observations 
Experimental animals were kept under observation throughout the course of study 
for the following: 
Body Weight: Weight of each rat was recorded on day 0, at weekly intervals throughout 
the course of study and at termination to calculate relative organ weights. From the data, 
group mean body weights and percent body weight gain were calculated. 
Clinical signs: All animals were observed daily for clinical signs. The time of onset, 
intensity and duration of these symptoms, if any, were recorded. 
Mortality: All animals were observed twice daily for mortality during entire course of 
study. 
Functional Observations: At the end of the 4
th
 week exposure, „sensory reactivity‟ to 
graded stimuli of different types (auditory, visual and proprioceptive stimuli), „motor 
reactivity‟ and „grip strength‟ were assessed. 
Laboratory Investigations: Following laboratory investigations were carried out on day 
29 in animal‟s fasted over-night. Blood samples were collected from orbital sinus using 
sodium heparin (200IU/ml) for Blood chemistry and potassium EDTA (1.5 mg/ml) for 
Haematology as anticoagulant. Blood samples were centrifuged at 3000 r.p.m. for 10 
minutes. On 28th day of the experiment, 24hours urine samples were collected by placing 
the animals in the metabolic cage with free access to tap water but no feed was given.  
 The urine was free from fecal contamination. Toluene was used as a preservative 
while collecting the sample. The sediments present in the urine were removed by 
centrifugation and the collected urine was used for biochemical estimations.  
On 29th day, the animals were fasted for approximately 18 hours, then slightly 
anesthetized with ether and blood samples were collected from the retro-orbital plexus 
into two tubes: one with EDTA for immediate analysis of haematological parameters, the 
other without any anticoagulant and was centrifuged at 4000 rpm at 4 °C for 10 minutes to 
obtain the serum. Serum was stored at 20 °C until analyzed for biochemical parameters. 
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Haematological Investigations: 
 Blood samples of control and experimental rats was analyzed for hemoglobin 
content, total red blood corpuscles (RBC), white blood corpuscles (WBC) count and 
packed cell volume (PCV). 
Biochemical Investigations: 
 Serum was used for the estimation of biochemical parameters. Samples of 
control and experimental rats were analyzed for protein, bilirubin, urea, BUN, creatinine, 
triglyceride, cholesterol and glucose levels was carried using standard methods. 
Activities of glutamate oxaloacetate transaminase/ Aspartate aminotransferase 
(GOT/AST), glutamate pyruvate transaminase/ Alanine amino transferase (GPT/ALT) 
and alkaline phosphatase were estimated as per the colorimetric procedure.  
Urine analysis: 
 Urine samples were collected on end of treatment for estimation of normal 
parameters. The estimations were performed using appropriate methodology.  
Necropsy: 
All the animals were sacrificed on day 29. Necropsy of all animals was carried out 
and the weights of the organs including liver, kidneys, spleen, brain, heart, and lungs were 
recorded. The relative organ weight of each animal was then calculated as follows;                  
                   Absolute organ weight (g) 
Relative organ weight = ____________________________________________ ×100 
                         Body weight of animal on sacrifice day (g) 
Histopathology:  
Histopathological investigation of the vital organs was done. The organ pieces 
(3-5µm thick) of the highest dose level of 400 mg/kg were preserved                        
and were fixed in 10% formalin for 24 hours and washed in running water for 24 hours.                                        
Samples were dehydrated in an auto technique and then cleared in benzene to remove 
absolute alcohol.  Embedding was done by passing the cleared samples through three 
cups containing molten paraffin at 50°C and then in a cubical block of paraffin made by 
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the “L” moulds. It was followed by microtome and the slides were stained with 
Haematoxylin-eosin.  The organs included heart, kidneys, liver, ovary, pancreas, brain, 
spleen and stomach, of the animals were preserved they were subjected to 
histopathological examination
 [84]
. 
Statistical analysis: 
 Findings such as clinical signs of intoxication, body weight changes, food 
consumption, hematology and blood chemistry were subjected to One-way ANOVA 
followed by Dunnet‟s multicomparision test using a computer software programme 
GRAPH PAD INSTAT-3 version. 
4.4. PHARMACOLOGICAL STUDIES 
4.4.1. Hepatoprotective activity of “Pitha kamalai Choornam” (Pkc) in ccl4 induced         
hepatotoxicity rats 
Experimental design:  
Animals were divided into six groups of 6 rats each. Group I animals served as 
control and received liquid paraffin (LP) subcutaneously at the dose of 3 ml/kg body 
weight of each animal. Group II animals received CCl4+ LP (for 14 days) at the dose 1 ml 
CCl4/kg body weight, in a suspension of double the volume of LP (which served as 
vehicle) subcutaneously at lower abdomen on every 14 days of the treatment .  
Group III and IV animals received subcutaneous administration of CCl4+ LP. 
They also received test drugs orally at the dose of 100, 200 mg/kg body weight 
respectively as a suspension of water. Group VI received in addition to CCl4 suspension, 
silymarin (100 mg/kg body weight) daily. Silymarin was used as a standard reference 
drug. 
 The animals were kept starved overnight on 14
th
 day of experiment. On the next 
day the animals were sacrificed by decapitation, and the blood was collected by cutting 
the jugular vein. The liver and kidney in each case were dissected out, blotted of blood, 
washed in saline and stored in a freezer. Liver, kidney and serum were used for various 
biochemical estimations. 
Biochemical parameters studied 
 The activities of serum glutamate pyruvate transaminase, and serum glutamate 
oxaloacetate transaminase were estimated using standard methods. Estimation of serum 
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ALP, serum bilirubin and electrolytes were also carried out to assess the acute hepatic 
damage caused by CCL4. 
Statistical analysis 
 The data obtained from the study were subjected to statistical analysis by one 
way ANOVA followed by Dunnet„t‟ test, and results were expressed in terms of 
Mean±SEM values. Statistical analysis was performed using INSTAT- V3 Software 
programme
 [85]
. 
4.4.2. Experimental design for hepatoprotective activity of “Pitha Kamalai 
Choornam” against paracetamol induced hepatotoxicity in rat’s model. 
 Paracetamol induced hepatotoxicity in rats model was used for evaluation of 
hepato-protective activity for the Pitha Kamalai Choornam . Animals were divided into 
five groups, each group containing five animals.  
Group I (normal) received distilled water or 2% CMC for 14 days. Group II 
(Control) received paracetamol 1ml/kg, i. p. 1:1 dilution with coconut oil on 5th day. 
Group III received standard marketed drug silymarin (25mg/kg per day, p.o.) for 14 days 
and paracetamol induction on 5
th
 day.  Groups IV- V, received Pitha Kamalai Choornam 
(5mg/kg and 10mg/kg p.o) for 14 days and paracetamol induction on 5th day. After 14 
days of experimental period blood sample had been collected individually for all the 
animals by retro-orbital puncture method and the blood was allowed to clot for 30 
minutes; serum was separated by centrifuging and was used for various parameter 
estimations. Later all the animals were sacrificed by cervical dislocation, liver samples 
were collected and the individual weights of the livers were estimated. For 
histopathological study, liver tissue was quickly removed after autopsy and fixed in 10% 
formalin in saline.  
Biochemical parameters studied 
 The activities of serum glutamate pyruvate transaminase, and serum glutamate 
oxaloacetate transaminase were estimated using standard methods. Estimation of serum 
ALP, serum bilirubin and electrolytes were also carried out to assess the acute hepatic 
damage caused by CCL4. 
 
                                  MATERIALS AND METHODS                                                                
 
HEPATOPROTECTIVE ACTIVITY OF PITHA KAMALAI CHOORNAM Page 98 
 
Statistical analysis 
 The data obtained from the study were subjected to statistical analysis by one 
way ANOVA followed by Dunnet„t‟ test, and results were expressed in terms of 
Mean±SEM values. Statistical analysis was performed using INSTAT- V3 Software 
programme
 [86]
. 
4.4.3. ANTIOXIDANT ACTIVITY OF “PITHA KAMALAI CHOORNAM” 
DPPH ASSAY (2, 2-diphenyl -1-picrylhydrazyl) 
     The radical scavenging activity of different extracts was determined by using DPPH 
assay
 [87]  
 the decrease in the absorption of the DPPH solution after the addition of an 
antioxidant was measured at 517 nm. 
Ascorbic acid (10mg/ml DMSO) was used as reference. 
Principle  
1,1-diphenyl-2-picryl hydrazyl is a stable free radical with red colour which turns 
yellow when scavenged. The DPPH assay uses this character to show free radical 
scavenging activity. The scavenging reaction between (DPPH) and an antioxidant (H-A) 
can be written as, DPPH + [H-A] →DPPH-H + (A). 
Antioxidants react with DPPH and reduce it to DPPH-H and as consequence the 
absorbance decreases. The degree of discoloration indicates the scavenging potential of 
the antioxidant compounds or extracts in terms of hydrogen donating ability. 
Reagent Preparation 
0.1mM DPPH solution was prepared by dissolving 4mg of DPPH in 100ml of 
ethanol.  
Procedure 
    Different volumes of plant extracts were made up to 40µl with DMSO and 2.96ml 
DPPH (0.1mM) solution was added. The reaction mixture incubated in dark condition at 
room temperature for 20 minutes. After 20 minutes, the absorbance of the mixture was 
read at 517nm.3ml of DPPH was taken as control. 
Calculation 
% inhibition = control-test × 100 
     Control                                                                                          
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 RESULTS AND DISCUSSION 
   The well known Traditional medicine Pitha Kamalai Choornam had been 
subjected to various studies and standardization to establish the works of Siddhars to be 
true. Literary collections, Physicochemical Studies, Elemental analysis, Bio-chemical 
analysis, Toxicity studies, and Pharmacological studies are done to prove the 
Hepatoprotective activity of Pitha Kamalai Choornam. Literary collections about the 
drug from various text books give hope about its activity. The studies strongly 
supported the fact through these results. They are discussed below. 
 Discussion on review of literature 
The extensive review on botanical aspect gave information about the 
microscopical, macroscopical, medicinal uses, constituents and the importance of the 
herbs in folklore and the details of the herbs in detail. Most of the herbs included in the 
formulation exerted Hepatoprotective action.  
The review of the herbs in the texts depicted through the songs of Siddhars some 
2000 years ago, strengthened the facts mentioned in the modern botanical aspect. 
Siddhars explained the medicinal properties of the plants through taste and most of the 
drugs included in the formulation have acrid taste and comes under the category of heat 
provocating medicines.  
 Literary collections about the drug from various text books were done. Siddha 
literatures related to the drug bring the evidence and importance of its utility in 
treating the jaundice.  
 Botanical aspect explains the identification, description, active principle and 
medicinal uses of the plants.  
 Gunapadam review brings the effectiveness of the drug in treating jaundice.  
 Pharmaceutical review describes about the chooranam and its properties.  
 The pharmacological review explains about the methodology of 
Hepatoprotective Activity and the drugs used. 
  Modern and siddha aspect of the disease was also reviewed. 
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 Standardization of the test drug 
 Standardisation of the drug is more essential to derive the efficacy, potency of 
the drug by analysing it by various studies. Following are the results of physicochemical 
and phytochemical analysis. Physical characterisation and estimation of basic and acidic 
radicals have been done and tabulated.  
Toxicological results of the drug and pharmacological activity of the drug were 
derived. Its result has been tabulated and interpretation was made below. Thus it is to 
give a complete justification to bring the effectiveness of the trial drug Pitha Kamalai 
Choornam. 
The extensive review on botanical aspect gave information about the 
microscopical, macroscopical, medicinal uses, constituents and the importance of the 
herbs in detail. Most of the herbs included in the formulation are hepatoprotective in 
activity. The results of these studies have strongly proved the fact. They are discussed 
below. 
 Milagu is indicated for  diseases of Liver 
 Thippili has action of Liver tonic 
 Seeragam is indicated for curing Jaundice 
 Manjal is a proven drug for curing jaundice 
 Chukku is a herb used for biliousness 
 Perunjeeragam is indicated for curing Jaundice 
 Vendhayam is used in the treatment of biliousness 
 Poondu is known to have liver tonic action 
Discussion on pharmacological aspect 
 The pharmacological aspect of the drug says about the mode of action, side 
effects, which were used worldwide since ancient times. 
 The current pharmacological methods available for carrying out the 
Hepatoprotective activity studies were explained clearly and the suitable animal 
for carrying out the activities were discussed to be Wistar strain of albino rats. 
 They are also more sensitive compared to other animals and hence they were 
chosen for the study.  
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 Results from the pharmacological studies denote the effects of Pitha Kamalai 
Choornam showed promising effects in treating liver damage. Moreover, the 
increased levels of the serum enzymes were significantly decreased by the 
treatment with Pitha Kamalai Choornam implying that the drug prohibited the 
liver damage. 
 Discussion on Pharmaceutical review 
 This review explained the preparation of Choornam in detail including the 
purification of raw drugs, methods of manufacturing Choornam and the  Siddha 
parameters for the standardization of analyzing Choornam.  
 The purification of drugs like chukku by the removal of skin of ginger is 
justified by the fact that the proteolytic enzymes are removed. 
 Roasting of aromatic substances may result in certain chemical changes and 
increase in antioxidants.  
 The powdered drugs were filtered through the white cloth so as to reduce the 
size of the particle in turn which enhances the bio-availability. 
 The shelf life of the drug is improved by proper purification methods and 
preservation.  
Discussion on Materials and Methods 
 The preparation of the drug was done carefully so as to achieve the highest 
potency. Choornam are fine dry powders of drugs. The term Choornam may be 
applied to the powders of single drug or a mixture of two or more drugs. 
 The impregnation with lemon juice is to enrich the therapeutic potentiality of the 
drug. 
 The lemon juice not only contains citric acid but also many minerals like 
sodium, potassium and pantothenic aid which helps in the chemical 
detoxification and purification. 
 Also the citric acid forms ligand with the toxic substances so that it weakens the 
bonds and disassociates them. 
 On purification (pittaviyal), the weight of the Choornam is different from the 
exact value but not from the mean value when calculated. 
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 The Choornam were also subjected to Siddha parameters of the testing like, 
Choornam tends to be amorphous, It should be never damp, The fitness of the 
sieve should be 100 mesh or still finer. 
 The standardization of the drugs was achieved through various procedures like 
analyzing the organoleptic characters, physico-chemical characters, elements 
present in the drug and the results and discussion of standardization parameters 
is described below. 
Organoleptic character 
Pitha Kamalai Choornam showed the following characters.  
                                   Table: 5. Organoleptic characters 
Colour Yellow 
Odour Pleasant  
Taste Bitter 
Texture Fine powder 
Particle size Completely pass through sieve no 92 
 
Table: 6. Physicochemical Analysis 
S.NO Parameter Result 
1 Ph 5.63 
2 Ash(%) 4.98 
3 Acid Insoluble ash (%) 0.597 
4  Water soluble ash 2.02 
5  Loss on drying(at 105
0
 C) 8.74 
6 Alcohol soluble extractive 36.60 
7 Solubility         Positive 
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I. Distilled water          Soluble 
II. Benzene Soluble 
III. Chloroform Soluble 
IV. Carbontetrachloride Soluble 
V. Xylene Soluble 
VI. Petroleum ether Soluble 
VII. Propylene ether Non Soluble 
8 Action on heat Negative 
9 Flame test Negative 
10 Ash test Negative 
 
Interpretation 
 The physicochemical analysis of the drug result reveals the solubility, ph, 
Moisture, Solubility, Water soluble ash and Acid insoluble ash. 
 pH: 
  It is a measure of hydrogen ion concentration; it is the measure of the acidic or 
alkaline nature. 7.0 is neutral, above 7.0 is alkaline and below is acidic. The pH 
of the drug Pitha Kamalai Choornam is 5.63 which is weak acidic in nature. 
Acidic drug is essential for its bioavailability and effectiveness. Acidic drugs are 
better absorbed in stomach
 [88]
. 
 Ash:  
Ash constitutes the inorganic residues obtained after complete combustion of a 
drug. Thus Ash value is a validity parameter describe and to assess the degree of 
purity of a given drug. Total ash value of plant material indicated the amount of 
minerals and earthy materials present in the drug. The total ash value of Pitha 
Kamalai Choornam is 4.98 which determine the absence of inorganic content. 
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 Water soluble ash:  
Water-soluble ash is the part of the total ash content, which is soluble in water. It 
is 2.02 for PKC 
 Moisture ( Loss on drying):  
The total of volatile content and moisture present in the drug was established in 
loss on drying. Moisture content of the drug reveals the stability and its shelf-
life. High moisture content can adversely affect the active ingredient of the drug. 
Thus low moisture content could get maximum stability and better shelf life. 
Loss on drying of PKC is 8.74
[89]
.  
Phytochemical analysis 
     Table: 7. Phytochemicals screening test 
SNO Phytochemicals               Test         Result 
1. Alkaloids Mayer’s test          Present 
2. Carbohydrates Molisch’s test          Present 
3. Glycosides Modified Borntrager’s test          Absent 
4. Saponins Froth test          Absent 
5. Phenols Alcoholic ferric chloride test          Present 
6. Phytosterols Ferric chloride acetic acid 
test 
         Absent 
7. Triterpenes Salkowski’s test          Present 
8. Flavanoids Alkaline reagent test          Present 
9. Proteins and amino 
acids 
Xanthoproteic test          Present 
10. Quinones Sodium hydroxide test          Absent 
 
Interpretation 
Phytochemicals are natural bioactive compounds found in plants and fibres 
which act as a defense system against diseases and more accurately, to protect against 
diseases. The phytochemical analysis reveals the presence of Alkaloids, Glycosides, 
Phenol, Triterpenes, Flavanoids and Quinones
 [90]
. 
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 Alkaloids 
 Alkaloids possess antispasmodic, analgesic, bactericidal effects. 
 Alkaloids are the active principles producing many essential effects in protecting 
the body 
[91]
. 
Phenols 
 Phenol groups are the essential part of many anti-oxidant compounds 
 They possess rich Anti-Oxidant property and protect body from oxidative stress. 
 Effective anti-hyperglycaemic agent [92]. 
Flavonoids 
 It is the most important group of polyphenolic compounds in plants. 
 Flavonoids have potent Anti-Oxidant activity and it is its important function. 
 Flavonoids can exert their Anti-Oxidant activity by scavenging the free radicals, 
by chelating metal ions or by inhibiting enzymatic systems responsible for free 
radical generation. 
 It also possesses anti-microbial activity which is confirmed by the various anti-
microbial assays.  
 Flavanoids are immunomodulator[93]. 
Phytosterols 
 Phytosterols are plant sterols, phytosterols have anti-inflammatory effect, 
phytosterols reduce oxidative stress 
 Phytosterols have an anti-oxidant property 
 Various bioactivities of phenolic compounds are responsible for their 
chemopreventive properties 
[94]
. 
Triperpenes 
 The Triterpenes are the best immunomodulator and  have anti-oxidant property. 
 Triterpenes suppress the inflammatory response and has Anti microbial activity. 
 It serves as Anti bacterial agent [95]. 
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Carbohydrates 
 Carbohydrates are important in the storage of glucose. 
 Carbohydrates play important role in homeostasis of glucose and fatty acids in 
liver
 [96]
. 
Protein and amino acids 
 Proteins are very useful in the liver regeneration and energy production. 
 They boost glutathione production to protect the liver. 
 Protein is an amalgamation of amino acids. It is an important component of 
every cell in the body. Body uses protein to build and repair tissues
 [97]
. 
TLC/HPTLC Analysis of chloroform extract: 
HPTLC analysis 
Chloroform extract was apllied in TLC aluminium sheet silica gel 
60(E.MERCK) and plate was developed using the solvent system Toluene: Ethyl 
acetate (9.1). After development the plate is allowed to dry in air and examined under 
UV-254nm, 254nm and visible light (Vanillin- Sulphuric acid). 
 TLC Photo documentation : Pitha kamalai chooranam  
Stationary Phase - Silica Gel 60 F254 
Mobile Phase – Toluene: Ethyl acetate: Formic Acid (9:2:0.2 v/v/v) 
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λ = 254 nm λ = 366 nm λ = 520 nm 
Fig 6: TLC Photo documentation 
Table: 8. Rf Values for the chloroform extract 
         Rf Colour Rf Colour Rf Colour 
0.51 Dark 0.27 Blue 0.06 Violet 
0.60 Dark 0.35 Blue 0.28 Voilet 
0.67 Light 0.37 Green 0.33 Voilet 
  0.41 Orange 0.38 Light violet 
  0.44 White 0.43 Light violet 
  0.50 Yellow 0.48 Yellow 
  0.71 Green 0.52 Light violet 
  0.74 Orange 0.60 Light violet 
  0.81 Pink 0.65 Blue 
    0.72 Pink 
 
Under UV 254nm, it shows 3 major spots at Rf 0.51, 0.60, 0.67 major compounds are 
found. 
Under UV 366nm, it shows 9 major spots at Rf 0.27, 0.35, 0.37, 0.41, 0.44,0.50, 0.71, 
0.74, 0.81 major compounds are found. 
UV Under 520nm, it shows 10 major spots at Rf 0.06, 0.28, 0.33, 0.38, 0.43, 0.48, 0.52, 
0.60, 0.65.,0.72 major compounds are found. 
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HPTLC finger print analysis for chloroform extract 
            The finger print chromatogram was recorded at 366 mm. It showed 10 peaks of 
which peaks at Rf and were the major peaks and others were moderately smaller 
peaks.λ= 366nm 
 
Fig 7: 3 D Chromatogram of 254 nm 
 
 
 
Fig 8: HPTLC Chromatogram of  chloroform extract scanning at 254  nm 
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Table: 9. Peak Table@254 nm: 
 
Interpretation 
 The quantitative analysis of compounds present in the PKC has been 
performed by HPTLC. The method may be applied to identify the PKC from 
other manufacturing process. It provides the identification of constituents, 
determination of impurities and quantitative determination of active 
substance present in PKC.
[98]
 
 The Rf value of the PKC supports the better standardization of the drug. 
 The present study revealed that PKC showed best results in Toluene: Ethyl 
Acetatae (9:2) Solvent system. After scanning and visualizing the plates in 
absorbance mode at 254nm, 366nm and 520nm. Best results were shown at 
visible light range. 
 TLC plate showed different colour phytoconstituents of chloroform extract 
of PKC. The bands revealed presence of two green, three blue and two 
yellow, two orange, two pink, three violet bands showing the presence of 
alkaloids, glycosides, phenols, triterpenes, flavonoids and quinines. 
 The results from HPTLC finger print scanned for chloroform extract of 
PKC. There are thirteen polyvalent phytoconstituents and corresponding 
ascending order of Rf values start from 0.02 to 0.92 in which highest 
concentration of the phytoconstituents was found to be 28.96% and 27.95% 
with its corresponding Rf value found to be 0.02 and 0.92 respectively.   
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  Table: 10. Results of basic radicals studies 
S.NO Parameter Observation Result 
1 Test for Potassium Yellow colour 
precipitate 
Positive 
 
2 Test For Magnesium 
. 
White colour precipitate 
 
Positive 
3 Test for Iron (Ferrous) Blood red colour Positive 
 
4 Test For Zinc 
 
Formation of white 
precipitate 
Positive 
 
Interpretation 
 The basic radical test shows the presence of Potassium, Magnesium, Iron, Zinc. 
Presence of these traces of minerals play an important role in the functioning of various 
enzymes in biological system and also have immunomodulatory function and hence the 
susceptibility to the course and the variety of viral infections. 
Potassium 
 Potassium is a vital electrolyte and is important for maintaining the integrity 
of cell membranes. 
 Potassium is absorbed through the small intestine. Severe lack of potassium 
can disturb liver function and if potassium level falls below 30% to 40% 
causes liver disease
 [99]
. 
Magnesium 
 Magnesium is essential for liver to prevent liver diseases. It enhances 
immune system. 
 Depletion of magnesium levels leads to Cirrhosis, Fatty liver syndrome[100]. 
Iron  
 It is essential for oxygen transport, energy production, other cellular growth 
and proliferation. 
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 Iron is an essential element for blood production and also needed for energy 
metabolism. 
 Liver performs three main functions in iron homeostasis. 
Zinc 
 Liver plays a central role in zinc homeostasis. 
 Zinc is actually present within all bodily tissue and needed for healthy cell 
division. 
 It acts like an Antioxidant within the body. 
 Zinc also has a big impact on hormonal balance [101]. 
   Table: 11. Test for acid radical studies 
S.NO Parameter Observation Result 
1 Test for Sulphate Formation of white precipitate Positive 
 
Interpretation: 
           The acidic radicals test shows the presence of Sulphate. Presence of Sulphate is 
essential for liver protection by reducing increased serum enzymes of liver. 
Availability of bacterial and fungal load in Pitha Kamalai Choornam 
Table: 12. Bacterial and fungal dilutions 
         MICROBES      DILUTION         RESULT 
         BACTERIA            10
-4 
                 6 
         BACTERIA            10
-6 
                 5 
         FUNGI            10
-2 
                 2 
         FUNGI            10
-3 
                 3 
Interpretation: 
 The availability of bacterial load in the PKC has been performed by Agar 
plate techniques. 
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 As PKC is made from plant material it is more prone to contamination. The 
contamination of herbal drugs by microorganism not only cause bio 
deterioration but also reduces the efficacy of drugs. 
 The toxin produced by microbes’ makes herbal drugs unfit for human 
consumption because the contaminated drug may develop unwanted disease 
instead of disease being cured. 
 The contamination of PKC has been examined by bacterial and fungal load. 
 Total bacterial load in 10-4 dilution is 6 and 10-6 dilution 5. 
 Total fungal load in 10-2 dilution is 2 and 10-3 dilution is 3. 
This result shows the presence of bacterial and fungal load in the trial drug 
(PKC). They are within the normal limits 
[102]
.  
 INSTRUMENTAL ANALYSIS 
FTIR Spectrum Analysis 
 
Fig 9: FTIR Spectrum analysis  
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 Table 13:  FT-IR INTERPRETATION 
      
Absorption peak cm
-1 
                  
                Stretch 
 
     
     Functional group  
         3361 O-H Stretch, Strong, 
Alcohol broad N-H Stretch 
        Alcohol 
        Amine 
         2972   C-H Stretch, Strong          Alkane 
         2932   C-H stretch, Strong         Alkane 
 
         2887   C-H Stretch, Strong        Alkane 
 
         2658 O-H Stretch, Strong , very 
broad 
Carboxylic acids 
 
         2413 -C≡C-Stretch, variable, not 
present in symmetrical 
alkynes 
 
        Alkynes 
         2194 -C≡C-Stretch, variable, not 
present in symmetrical 
alkynes 
  
         Alkynes 
         1904 C=O Strtch, Strong         Amide 
        
         1648  C=O Stretch, Strong 
       -C=C- Stretch 
         Amide 
        Alkenes 
         1380 C-F Stretch     Alkyl halide 
         1467 C=C Stretch, medium- 
weak 
     Aromatic 
         1341 C-F Stretch 
N-O, Symmetric Stretch 
   Alkyl halide 
   Nitro compounds 
         1308 C-F Stretch 
C-N, Stretch 
   Alkyl halide 
Aromatic amines 
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  Absorption peak cm
-1
                 Stretch 
 
     Functional group 
         1162 C-N, Stretch, Medium-
Weak 
C-H Wag(-CH2) 
     Amine 
 
   Alkyl halide 
        1130 C-N, Stretch, Medium- 
Weak C-O, Stretch, Strong 
           Amine 
Ether, Carboxylic acids, 
esters, ethers 
         1001 C-O, Stretch, Strong Ether, Carboxylic acids, 
esters, ethers 
          952 =C-H bending     Alkene 
         816 =C-H bending     Alkene 
         678 =C-H bending 
 
    Alkene 
    
         492 C-Br Stretch     Alkyl halide 
 
Interpretation 
FTIR instrumental analysis was done. The test drug was identified to have 20 
peaks. They are the functional groups present in the trial drug Pitha Kamalai 
Chooranam. 
The above table shows the presence of phenols, alkane, acid, alkynes, amide, 
aromatic, alkyl halide, ether, alcohol and alkene which represents the peak value 
 OH group has higher potential towards inhibitory activity against 
microorganisms.  
 Phenols possess highly Anti-Oxidant property which enhances the drug 
effect against the disease. 
 Amines enhance the drug effect against the disease [103]. 
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 SEM: (SCANNING ELECTRON MICROSCOPE) 
                           
              Fig: 10. SEM (SCANNING ELECTRON MICROSCOPE) 
Interpretation for SEM 
 Micro particles are defined as particulate dispersion or solid particles with a 
size in the range of 100-1000nm in diameter.  
 The above SEM studies of microscopic resolution showed objects of sizes 
ranging from 3µm - 5µm. 
 Size and surface of micro particles can be easily manipulated to achieve both 
passive and active drug targeting. 
 They control and sustain, the release of drug during the transportation and at 
the site of localization, alters drug distribution in the body and subsequent 
clearance of the drug so as to achieve increased drug therapeutic efficacy 
thereby bio-availability and reduced side effects
[104]
 
 Hence Pitha Kamalai Choornam which is prepared biologically contains 
nanoparticles to enhance the pharmacological action in the target site. 
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 XRD (X-Ray Diffraction studies) 
           
                                          Fig 11: XRD 
Interpretation 
         The structure, the size and shape of the particles are highly dependent on the 
route of synthesis and high lights the efficacy of the drug. The micro particles may 
enhance bio absorption of the drug. 
         The major diffraction peaks are identified after XRD analysis PKC concluded 
the range 20-50nm in association with organic molecules propably plays an 
important role in making it biocompatible and nontoxic at therapeutic doses. Other 
elements present in PKC act as additional supplement and possibly helps in increase 
the efficacy of the formulation. 
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Table 14: ICP-OES results of Pitha Kamalai Choornam 
S.NO                 Elements            Detected levels 
1. Aluminium                         BDL 
2. Arsenic                         BDL 
3. Calcium                       01.450 
4. Cadmium                         BDL 
5. Copper                         BDL 
6. Mercury                         BDL 
7. Potassium                       44.801 
8. Magnesium                       01.304 
9. Sodium                       34.300 
10. Nickel                       BDL 
11. Lead                       BDL 
12. Phosphorus                     18.301 
 
Discussion: 
 The above results indicate that the trial drug is extremely safe as it contains 
heavy metals within specified limits. 
 The presence of Ca(01.450 mg/l), K(44.801 mg/l), Mg(01.304 mg/l), 
Na(34.300 mg/l), P(18.301 mg/l) is physiologically important. In Pitha 
Kamalai Choornam , the heavy metals like As, Cd, Hg, Pb, S and Ni were 
below detectable level. This reveals the safety of the drug. 
 From the above results the heavy metals are observed with in permissible 
limits. Hence the safety of the drug is ensured. 
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TOXICITY STUDY RESULTS 
Acute oral toxicity studyof Pitha Kamalai Choornam – OECD 423 
 Dose finding experiment and its behavioural Signs of acute oral Toxicity 
Table: 15. Observation done:  
   
S.NO 
             Group 
       CONTROL 
      
Observation 
     
S.NO 
     Group 
TEST GROUP 
          Observation 
   1        Body weight         Normal       1     Body weight     Normally increased 
 
   2    Assessments of posture         Normal       2    Assessments 
of posture 
     Normal 
   3    Signs of Convulsion 
   Limb paralysis 
        Normal       3     Signs of      
Convulsion 
  Limb 
paralysis 
     Absence of sign (-) 
   4    Body tone         Normal       4     Body tone      Normal 
   5    Lacrimation         Normal       5     Lacrimation      Absence 
   6    Salivation         Normal       6     Salivation     Absence 
   7     Change in skin color    No significant   
colour change 
   7    Change in 
skin colour 
No significant color 
change 
   8      Piloerection          Normal       8    Piloerection      Normal 
   9     Defecation         Normal 
 
      9     Defecation      Normal 
    10     Sensitivity response         Normal      10     Sensitivity   
response 
     Normal 
   11      Locomotion         Normal      11    Locomotion      Normal 
   12    Muscle gripness         Normal      12    Muscle   
gripness 
    Normal 
   13     Rearing         Mild      13    Rearing     Mild 
   14     Urination        Normal      14    Urination     Normal 
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Table: 16. (Observational study Results) 
 
No Dose 
mg/kg 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
1. Control + - - + - + - - - - - - - - - - - - - - 
2. 2000mg 
 
+ - - + - + - - - - - - - - - - - - - - 
1. Alertness 2. Aggressiveness 3. Pile erection 4. Grooming 5. Gripping  6. Touch 
Response 7. Decreased Motor Activity 8. Tremors  9. Convulsions 10. Muscle Spasm 
11. Catatonia 12. Muscle relaxant 13. Hypnosis 14. Analgesia 15.Lacrimation 16. 
Exophthalmos 17. Diarrhea 18. Writhing 19. Respiration 20. Mortality. 
(+  Present, -  Absent) 
Table: 17. Body weight of wistar albino rats group exposed to Pitha Kamalai 
Choornam 
 
 
 
     
 
           
           N.S- Not Significant,**(p > 0.01), *(p >0.05), n = 10 values are mean ± S.D 
          (One-way ANOVA followed by Dunnett’s test)   
 
 
 
 
 
 
 
DOSE 
 
DAYS 
1 7 14 
CONTROL 320.2±42.30 322.4 ± 60.10 323.6 ±52.10 
HIGH DOSE 302.4± 1.21 302 ± 2.04 304.2 ± 2.10 
P value (p)* 
NS NS NS 
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Table: 18. Water intake (ml/day) of Wistar albino rats group exposed to Pitha 
Kamalai Choornam 
DOSE 
 
DAYS 
1 6 14 
CONTROL 58 ± 1.02 58±9.20 59.4±1.04 
HIGH DOSE 59.4±2.20 59.8±3.40       59.9±6.24 
P value (p)* NS NS NS 
                 
   N.S- Not Significant,**(p > 0.01), *(p >0.05), n = 10 values are mean ± S.D  
               (One-way ANOVA followed by Dunnett’s test) 
Table: 19. Food intake (gm/day) of Wistar albino rats group exposed to Pitha 
Kamalai Choornam 
DOSE 
 
DAYS 
1 7 14 
CONTROL 61.04±2.62 62.2±4.76 64.3±6.26 
High DOSE 69.4±4.23 70.4±6.22 71.6±4.18 
P value (p)* NS NS NS 
 
                N.S- Not Significant,**(p > 0.01), *(p >0.05), n = 10 values are mean ± S.D  
               (One-way ANOVA followed by Dunnett’s test) 
Interpretation of Acute toxicity studies 
 The acute oral toxicity potentials of Pitha kamalai Chooranam in female 
Wistar albino rats were studied effectively.  
 In the sighting study, the test substance was administered in sequential 
manner to one animal each at 2000 mg kg-1 body weight followed by two 
animals at 2000 mg kg-1 body weight.  
 According to OECD guidelines, for acute oral toxicity LD50 dose of 
2000mg/kg of the drug is found to be safe. 
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 From the maximum tolerable dose 2000mg/kg of Pitha kamalai Chooranam 
1/5th or 1/10th of the dose was considered as therapeutic dose for further 
study. 
 The treated animals were observed for mortality, untoward clinical/toxic 
signs, and alterations in body weight gain and necropsy findings during the 
study. 
 The treated animals survived throughout the study period and did not reveal 
any treatment related major abnormal clinical signs at the test dose levels. 
 Morphological characters like changes in skin, eyes, fur, nose appeared 
normal. 
 The rats did not reveal any observable signs of central nervous system.  
 The rats showed signs of alertness, grooming and touch response at the dose 
level of 2000mg/kg of body weight. 
 The overall percentage of body weight gain in rats treated with the drug 
every weekly was found to be normal indicating that the test animals were in 
a healthy condition during the days of observation period. 
  The weight gain of the animal was showed in Table. The changes in water 
and food intake recorded and it did not show any distinct deviations. 
  On necropsy, no abnormalities were observed. In conclusion, acute oral 
toxicity testing of screened drug did not produce any treatment-related 
adverse effects. 
  This indicates that the dosages administered were below toxic level and 
proves the safety of the drug. 
 Hence the test drug Pitha kamalai Chooranam is a safe herbal drug and can 
be used for long time administration.  
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Repeated dose 28-day oral toxicity of Pitha Kamalai Choornam OECD – 407 
             The results of acute toxicity studies in Wistar albino rats indicated that Pitha 
kamalai Chooranam was non-toxic and no behavioural changes was observed up to the 
dose level of 2000 mg/kg body weight. On the basis of body surface area ratio between 
rat and human, the doses selected for the study were 200 mg/kg and 400 mg/kg body 
weight. The oral route was selected for use because oral route is considered to be a 
proposed therapeutic route. Then Sub acute oral 28 days repeated dose toxicity study 
was done and the results were tabulated below. 
Weight gain of rats  
Table: 20. Body weight of wistar albino rats group exposed to Pitha Kamalai 
Choornam 
 
NS- Not Significant, **(p > 0.01),*(p >0.05), n = 10 values are mean ± S.D 
(One way ANOVA followed by Dunnett’s test) 
 
 
DOSE 
 
DAYS 
1 7 14 21 28 
CONTROL 235.2±18.46 236.5 ± 35.10 236.6 ± 45.60 238.7± 56.16 238.4±66.15 
LOW DOSE 248.2 ± 65.24 250.7 ± 66.28 254.6± 55.34 256 ±56.34 256.8±35.36 
MID DOSE 252.4± 18.34 253.3 ± 16.24 253.4± 14.12 255.2 ±15.20 256.4±54.10 
HIGH DOSE 261.6± 62.24 261.4±42.22 262.4 ± 52.24 263 ± 54.28 264 ± 74.60 
P value (p)* 
NS NS NS NS NS 
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Table: 21. Water intake (ml/day) of Wistar albino rats group exposed to Pitha 
Kamalai Choornam 
DOSE 
 
DAYS 
1 6 14 21 28 
CONTROL 60.1 ± 8.72 60±1.52 60.2±1.40 61±1.32 61.4±1.62 
LOW DOSE 65.1±1.21 65.6±4.22 66.6±1.02 65.2±2.06 66.4±1.20 
MID DOSE 62.1±1.02 62.3±1.21 62.1±2.62 63.4±4.32 63.4±1.64 
HIGH DOSE 64.1±1.81 64.2±1.32 64.4±1.14 64.6±1.62 65.8±2.02 
P value (p)* NS NS NS NS NS 
 
   N.S- Not Significant, **(p > 0.01), *(p >0.05), n = 10 values are mean ± S.D (One way 
ANOVA followed by Dunnett’s test) 
 
Table: 22. Food intake (gm/day) of Wistar albino rats group exposed to Pitha 
Kamalai Choornam 
 
DOSE 
 
DAYS 
2 7 23 22 28 
CONTROL 34±4.14 34.2±6.12 34.3±2.18 34.2±1.14 34±5.62 
LOW DOSE 36.3±1.64 36.3±1.51 36.2±1.51 36.5±1.62 36.5±1.22 
MID DOSE 34.1±2.12 34.2±3.50 34.2±2.14 34.2±2.16 35.2±1.64 
HIGH DOSE 32.4±1.62 32.1±1.64 32.6±2.36 32.6±1.20 36.4±2.32 
P value (p)* NS NS NS NS NS 
 
N.S- Not Significant, **(p > 0.01), *(p >0.05), n = 10 values are mean ± S.D 
(One way ANOVA followed by Dunnett’s test 
 
Interpretation of weight, water and food intake 
 The overall percent of body weight gain in rats treated with the drug was 
found to be normal and showing a steady increase in weight indicating that 
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the test animals were in a healthy condition during the 28 days of 
observation period.  
 There is no significant change in water intake by the animals during the 
period of study. 
 The weight increase of the animals showed that the intake of food by the 
animals was good during the period of 28 days study. 
Table: 23. Haematological parameters of Wistar albino rats group exposed to 
Pitha Kamalai Choornam 
Category Control Low dose Mid dose High dose 
Haemoglobin(g
/dl) 
13.4±0.71 13.30±0.14 13.4±0.13 13.72±0.13 
Total WBC 
(×10
3   
l) 
09.41±0.22 09.32±0.22 09.34±0.22 09.30±1.10 
Neutrophils 
(%) 
21.13±0.60 21.02±0.52 22.11±1.42 22.02±2.71 
lymphocyte 
(%) 
82.10±1.26 82.12±1.42 83.10±2.44 83.20±2.54 
Monocyte (%) 1.1±0.03 1.1±0.01 1.2±0.04 1.1±0.03 
Eosinophil (%) 0.8±0.03 0.8±0.04 0.9±0.05 0.9±0.08 
Platelets 
cells10
3
/µl 
900.17±3.18 902.11±4.62 902.11±2.20 902.22±2.64 
Total RBC 
10
6
/µl 
9.32±0.11 9.47±0.33 9.50±0.64 9.60±0.46 
PCV% 48.10±0.2 48.62±5.30 48.8±4.70 48.4±.71 
MCHC g/Dl 36.5±1.61 36.2±1.51 36.8±1.30 36.13±1.60 
MCV fL(µm
3
) 58.2±2.02 58.2±1.80 58.7±1.10 59.7±1.30 
     
N.S- Not Significant, **(p > 0.01), *(p >0.05), n = 10 values are mean ± S.D 
(One way ANOVA followed by Dunnett’s test)  
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Interpretation 
 The haematological parameters of animals were done. The results of 28 days 
oral toxicity study was tabulated above. 
 The Blood investigations of RBC, WBC, Hb, Platelets and ESR are normal 
that is within the limits. 
 The differential count, PCV, MCV showed no significant changes. 
 Thus the trial drug Pitha Kamalai Choornam was good and safe drug for 
oral administration 
Table: 24. Biochemical Parameters of Wistar albino rats group exposed to Pitha 
Kamalai Choornam 
BIOCHEMICAL 
PARAMETERS 
CONTROL LOW 
DOSE 
MID DOSE HIGH 
DOSE 
GLUCOSE (R) (mg/dl) 138.10±2.02 138.12±2.1
0 
138.9±12.06 138.12±5.25 
T.CHOLESTEROL 
               (mg/dl) 
140.14±5.10 140.15±5.2
0 
140.40±1.68 139.21±1.10 
TRIGLYCERIDES 
(mg/dl) 
74.15±1.82 74.11±1.32 74.15±1.22 73.16±1.21 
LDL 78.6±2.13 78.7±2.05 78.10±1.03 77.40±01.32 
VLDL 14.2±1.52 14.20±2.41 14.02±1.32 14.04±12.15 
HDL 28.12±4.32 28.32±2.50 28.46±1.20 29.51±1.23 
Ratio 1(T.CHO/HDL) 3.73±1.16 3.72±1.80 3.73±1.32 3.74±2.33 
Ratio 2(LDL/HDL) 
 
1.92±1.22 1.92±1.20 1.93±2.20 1.94±06.02 
Albumin(g/dL) 6.21±0.22 6.22±0.52 6.4±7.20 6.55±6.48 
 
NS- Not Significant,**(p > 0.01), * (p >0.05), n = 10 values are mean ± S.D 
(One way ANOVA followed by Dunnett’s test) 
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Interpretation 
The biochemical parameters are within the normal range. This shows that the 
trial drug shows safe and non toxic effects on general body metabolism.  
Table: 26. Liver Function Test of of Wistar albino rats group exposed to PKC 
PARAMETERS CONTROL LOW DOSE MID DOSE HIGH DOSE 
T BILIRUBIN 
(mg/dl). 
0.08±0.01 0.08±0.03 0.07±0.03 0.07±0.01 
SGOT/AST(U/L) 64.11±1.53 62.12±0.22 60.24±1.54 58.74±1.53 
SGPT/ALT(U/L) 79.21±1.02 77.34±1.04 71.44±1.16 66.38±0.21 
ALP(U/L) 137.11±2.21 137±2.20 132±1.24 130.03±6.02 
T.PROTEIN(g/dL) 7.2.40±0.14 7.4±0.41 7.4±0.60 7.5±0.61 
 
NS- Not Significant, ** (p > 0.01), * (p >0.05), n = 10 values are mean ± S.D 
(One way ANOVA followed by Dunnett’s test 
Interpretation 
        The total bilirubin, bilirubin direct and bilirubin indirect showed that normal range. 
Thus the liver function test of PKC shows normal in this 28 day repeated oral toxicity. 
Table: 25. Renal function test of of Wistar albino rats group exposed to Pitha 
Kamalai Choornam 
PARAMETERS CONTROL LOW DOSE MID DOSE  HIGH DOSE 
UREA (mg/dl) 14.50±0.29 14.50±0.29 14.46±1.18 14.42±1.22 
CREATININE(mg/dl) 0.42±0.02 0.41±0.04 0.43±0.03 0.44±0.09 
BUN(mg/dL) 19.1±0.02 19.10±0.34 19.6±0.42 19.26±1.02 
URIC ACID(mg/dl) 4.02±0.04 4.06±0.21 4.4±0.12 4.20±0.10 
 
NS- Not Significant, **(p > 0.01), * (p >0.05) , n = 10 values are mean ± S.D 
(One way ANOVA followed by Dunnett’s test) 
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Interpretation 
The renal function test of the animals shows the normal limits thus the trial drug 
was safe and not produce any nephro toxicity, thus it suggests that the trial drug 
was safe for long term administration.         
Table: 27. Urine Analysis 
Parameters Control PKC 200mg/kg PKC 400mg/kg 
Transparency Clear Clear Clear 
Specific gravity 1.010 1.010 1.010 
PH 6.4 6.8 6.5 
Protein Nil Nil Nil 
Glucose Nil Nil Nil 
Bilirubin -ve -ve -ve 
Ketones -ve -ve -ve 
Blood Absent Absent Absent 
Pus cells Absent Absent Absent 
RBC Nil Nil Nil 
Epithelial cells Nil Nil Nil 
Casts Nil Nil Nil 
Others Nil Nil Nil 
Colour Yellow Yellow Yellow 
     
Interpretation of urine analysis 
The urine analysis of the animals showed within the normal limits.                                                                                                                                                                                                                                                                                                                                    
Interpretation 
     The above slides show the histopathology studies of sub-acute toxicity . Ther is no 
toxicological abnormality seen in the vital organs after administration of the test drug 
Pitha Kamalai Choornam . Thus the safety of the drug is revealed so that it can be 
administered for long time without any side effects. 
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PHARMACOLOGY ACTIVITY 
Pharmacological activity study result ccl4 induced hepatotoxicity 
Table: 28. Level of Serum Enzymes value (AST, ALT, and ALP) with PKC 
Groups Treatment ASTU/liter ALT U/liter ALP U/liter GGT U/liter 
Group 1 Normal 36.16±0.09 27.10±1.35  
 
85.21±2.98 
 
4.12±1.45 
Group 2 CCL4+ LP 152.21 ±1.54*  193.58±1.00*  
 
176.92±1.9 
 
12.20±1.42* 
Group 3 CCL4+Low 
dose(PKC) 100mg/kg 
136.42±0.64
*
 
 
162.12±1.12 
 
184.16±2.16
 
 
7.11±1.10* 
Group 4 CCL4+Highdose(PK
C) 200mg/kg 
76.21±0.16 
 
45.76±2.17  
 
97.12±2.15 
 
 
4.97±1.01* 
Group 5 CCL4+Silymarin100
mg/kg 
49.38±1.24 
* 
 
30.17±0.68  
 
91.62±1.83 
 
4.16±2.11
* 
 
Statistical analysis ANOVA followed by Dunnett t-test.  
* P< 0.05; ** P˂ 0.01; *** P < 0.001 as compared with group I, a group II  
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Table: 29. Effect of Total Protein and Bilirubin with PKC 
Groups Treatment Total Protein(g/dl) Bilirubin(mg/dl) 
Group 1 Normal 5.07±0.28 0.27±0.01  
 
Group 2 CCL4+ LP 1.82 ±0.46  1.7±0.07  
 
Group 3 CCL4+Low dose(PKC) 
100mg/kg 
4.51±0.16 
 
1.35±0.01 
 
Group 4 CCL4+Highdose(PKC) 
200mg/kg 
5.10±0.10
* 
 
0.75±0.01 
* 
 
Group 5 CCL4+Silymarin100mg/kg 6.29±0.57
** 
 
0.47±0.01
**
  
 
 
Statistical analysis ANOVA followed by Dunnett t-test.  
* P< 0.05; ** P˂ 0.01; *** P < 0.001 as compared with group I, a group II  
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Group I: Control rat showing normal central vein and normal hepatocytes 
Group II: Showing dilated central vein and hepatocytes with degeneration  
Group III: Liver tissue of rats treated with PKC at 100 mg /kg showing mild degree of 
necrosis (N) with normal cells (C)  
Group IV: Central vein showing normal hepatocytes with regenerating hepatocytes and 
mild inflammation in the portal area.  
Group V: Photo micrograph of liver tissue treated with silymarin showing normal 
hepatocytes , portal vein (V), portal Artery. 
Interpretation 
 The serum marker enzymes, AST, ALT, ALP, GGT and Total Proteins were 
exceedingly susceptible to hepatotoxins. They assist as markers of inflammation 
of liver cells or death of some cells due to liver damage and oxidative stress, 
which stimulate the release of amino transferases from hepatocytes into the 
blood. 
   The changes associated with Carbon tetrachloride induced liver damage of the 
present study appeared similar to the acute viral hepatitis. 
  In CCl4 induced hepatotoxicity, the administration of the toxicant CCl4 showed 
a distinct rise in the levels of serum marker enzymes namely AST, ALT, ALP, 
GGT and Total protein as shown in the Table. 
 The protective effects of Pitha Kamalai Choornam and silymarin on the effect 
of liver serum marker enzymes are exposed in Table.   
 The serum enzymes like AST, ALT, ALP, GGT, and Total Protein of treated 
animals were significantly reduced by seven days pretreatment of Pitha Kamalai 
Choornam at two dose levels 100mg/kg and 200mg/kg, when compared with 
CCl4 treated control. No significant clinical abnormalities in other groups. 
 This study reveals that increase in the activity of the serum enzymes AST. ALT, 
ALP, GGT and Total Proteins were detected in wister Albino rats treated with 
normal saline and CCl4 (Group 1 and 2). However, the activities of these serum 
enzymes were significantly (P < 0.01) lower in rats treated with Pitha Kamalai 
Choornam (Group 3 and 4) than in Group 1 wister Albino rats. 
 Reduction in the levels of AST, ALT, ALP, GGT and Total protein toward the 
normal value is an indication of regeneration process. The protective effect 
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exhibited by PKC at dose level of 200 mg/kg was comparable with the standard 
drug. 
 These findings suggested that the administration of PKC has significantly 
neutralized the toxic effects of Carbon tetrachloride and helped in regeneration 
of hepatocytes. 
 This present study confirmed that CCl4 induced a marked rise in oxidative stress 
and cellular degeneration in wister Albino rat’s liver. Both the doses of Pitha 
Kamalai Choornam treatment (100 and 200 mg/kg body wt.) significantly 
improved the effect of CCl4 induced oxidative stress damage and reduced the 
expression of inflammatory and apoptotic proteins. As a result this protective 
effect of Pitha Kamalai Choornam could be correlated directly to its antioxidant 
property. 
 Therefore the reduction in the activity of these enzymes may result in a number 
of deleteriousn effects by administration of PKC increased the activities against 
CCl4 induced liver damage in rats to prevent the accumulation of excessive fats 
and protected the Liver
[105]
. 
 This was further confirmed by histopathological injuries. 
Effect of Pitha Kamalai Choornam on liver injury induced by paracetamol in 
wister albino rat 
Table: 30. Effect of Serum enzymes with PKC 
 
Groups Treatment ASTU/liter ALT U/liter ALP U/liter 
Group 1 Positive Control 36.96±0.13 35.18±0.29  
 
32.11±0,14 
 
Group 2 Negative Control 
Paracetamol – 1.25ml/kg 
142 ±0.12  173.07±0.24  
 
96.85±0.12 
 
Group 3 Standard 
(Silymarin -100mg/kg) 
53.94±0.14
** 
 
63.71±0.17
** 
 
40.58±0.21
** 
 
Group 4 PKC – 100 mg 66.98±0.13
* 
 
87.30±0.18  
 
73.52±0.18 
* 
 
Group 5 PKC – 200 mg 56.44±0.16
** 
 
72.05±0.25
*
  
 
47.83±0.20
** 
 
 
   Statistical analysis ANOVA followed by Dunnett t-test.  
* P< 0.05; ** P˂ 0.01; *** P < 0.001 as compared with group I, a group II  
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Table: 31. Effect of Liver Volume and Liver Weight with PKC 
Group 
 
Treatment Liver Volume(ml) Liver Weight(g) 
A 
 
Positive Control 2.73±0.15 4.23±0.04 
B 
 
Negative Control 
Paracetamol – 1.25ml/kg 
5.83±0.12 5.87±0.05 
C 
 
Standard 
(Silymarin -100mg/kg) 
3.63±0.15
** 
4.53±0.08
** 
D 
 
PKC – 100 mg 4.89±0.10* 5.14±0.14* 
E 
 
PKC – 200 mg 3.94±0.12* 4.84±0.18* 
 
     Statistical analysis ANOVA followed by Dunnett t-test.  
    * P< 0.05; ** P˂ 0.01; *** P < 0.001 as compared with group I, a group II  
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Table: 32. Effect of Triglycerides with PKC 
Group 
 
Treatment Triglycerides (mg/dl) 
                 A 
 
Positive Control 0.65±0.01 
                 B 
 
Toxicant Control(Paracetamol-
1.25ml/kg) 
2.621±0.17 
                  C 
 
Standard(Silymarin-100mg/kg) 0.850±0.01
*** 
                  D 
 
PKC – 100 mg 1.97±0.05* 
                  E 
 
PKC – 200mg 0.905±0.03** 
 
        Statistical analysis ANOVA followed by Dunnett t-test.  
      * P< 0.05; ** P˂ 0.01; *** P < 0.001 as compared with group I, a group II  
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Table: 33. Effect of Cholesterol with PKC 
Group 
 
Treatment Cholesterol (mg/dl) 
A 
 
Positive Control 134.8±1.30 
B 
 
Toxicant Control(Paracetamol-
1.25ml/kg) 
334.6±1.28 
C 
 
Standard(Silymarin-100mg/kg) 165.2±1.14
*** 
D 
 
PKC – 100 mg 289.5±4.35* 
E 
 
PKC – 200mg 225.6±1.25** 
 
        Statistical analysis ANOVA followed by Dunnett t-test.  
       * P< 0.05; ** P˂ 0.01; *** P < 0.001 as compared with group I, a group II  
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Table: 34. Effect of Direct Bilirubin and Total Bilirubin with PKC 
Group 
 
Treatment Direct Bilirubin 
mg/dl 
Total Bilirubin 
mg/dl 
A 
 
Positive Control 0.16±0.01 0.27±0.01 
B 
 
Negative Control 
Paracetamol – 1.25ml/kg 
1.65±0.01 1.7±0.08 
C 
 
Standard 
(Silymarin -100mg/kg) 
0.24±0.01
*** 
0.46±0.01
*** 
D 
 
PKC – 100 mg 1.26±0.01* 1.35±0.01* 
E 
 
PKC – 200 mg 0.53±0.01** 0.75±0.01** 
 
      Statistical analysis ANOVA followed by Dunnett t-test.  
     * P< 0.05; ** P˂ 0.01; *** P < 0.001 as compared with group I, a group II  
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Table: 35. Effect of Direct Duration of Sleep and Onset of Time with PKC 
Group 
 
Treatment Duration of Sleep 
(sec) 
Onset of Time 
(min) 
A 
 
Positive Control 175.8±0.95 93.2±1.56 
B 
 
Negative Control 
Paracetamol – 1.25ml/kg 
66±0.96 251±12.13 
C 
 
Standard 
(Silymarin -100mg/kg) 
155.2±1.07
** 
118.2±1.47
** 
D 
 
PKC – 100 mg 105±1.32 188±2.39 
E 
 
PKC – 200 mg 135.5±1.34* 151.6±2.3* 
 
     Statistical analysis ANOVA followed by Dunnett t-test.  
   * P< 0.05; ** P˂ 0.01; *** P < 0.001 as compared with group I, a group II  
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HISTOPATHOLOGY OF PKC 
Group I: Control rat showing normal central vein and normal hepatocytes 
Group II: Showing dilated central vein and hepatocytes with degeneration  
Group III: Liver tissue of rats treated with PKC at 100 mg /kg showing mild degree of 
necrosis (N) with normal cells (C)  
Group IV: Central vein showing normal hepatocytes with regenerating hepatocytes and 
mild inflammation in the portal area.  
Group V: Photo micrograph of liver tissue treated with silymarin showing normal 
hepatocytes, portal vein (V), portal Artery. 
 
Interpretation 
 
 Paracetamol induced hepatotoxicity is the generally used screening 
method for testing the hepato protective nature of drugs. The hepatic 
damage increases the level of serum marker enzymes like ALT, AST, 
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ALP. This indicates the cellular damage as well as loss of the functional 
integrity of cell membrane in liver. 
 The test was also conducted to compare the Liver Volume and liver 
weight of Paracetamol induced rat and the rat with effect of Pitha 
Kamalai Choornam. 
 In paracetamol treated Wister albino rat the levels of serum marker 
enzymes (ALT, AST, and ALP) elevated significantly and Triglycerides 
level. These increased levels of serum levels were depicted in Table. 
 Owing to damage of hepatocytes the cell necrosis occurs. The increased 
production of serum enzymes in blood was related with 
central/submissive necrosis of liver which causes severe hepatic injury.  
 There are no significant changes in liver weight in rats with the effect of 
Pitha Kamalai Choornam when compared to the standard drug. 
 The hepatoprotective effect of Pitha Kamalai Choornam may be because 
of the antioxidant activity. The in vitro antioxidant activity of Pitha 
Kamalai Choornam such as GPx, GSH, CAT, SOD increase suggest the 
ability of Pitha Kamalai Choornam to reduce biological oxidative stress. 
 Moreover, the increased levels of the serum enzymes were significantly 
decreased by the treatment with Pitha Kamalai Choornam  at 100 mg/kg 
and 200 mg/kg , implying that the drug prohibited the liver damage. 
 The Pitha Kamalai Choornam treatment confirmed dose dependent 
activity, Pitha Kamalai Chooram at 200 mg/kg revealed good result than 
100mg/kg which is given in Table 25 for the determined levels of 
various serum enzymes. 
  This was further confirmed by decreased amount of histopathological 
slides. 
 
RESULTS OF ANTI-OXIDANT ACTIVITY OF PITHA KAMALAI 
CHOORANAM 
Due to various factors of the fast moving life style like fast foods, change in 
daily routines, the level of oxidants or reactive oxygen species are increased in the body. 
It has been established that oxidative stress is the major causative factor in the induction 
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of many chronic and degenerative diseases including atherosclerosis, ischemic heart 
disease, ageing, diabetes mellitus, cancer, immune suppression, neurodegenerative 
diseases and others. The free radicals are scavenged from the body by various 
mechanisms to enable good functioning of the organs. 
The scavenging activity for free radicals, DPPH has widely used to evaluate the 
anti-oxidant activity of natural product from plant and natural sources. In this in vitro 
study of anti oxidant activity of Pitha kamalai  chooranam DPPH was used as a free 
radical.  
 The preliminary phytochemical screening of Pitha kamalai chooranam shows  
flavonoids, phenols, quinones, glycosides, terpenoids, steroid, and alkaloids followed by 
other accessions. 
The presence of flavonoids, phenols, quinones were given a strong support to do 
the Qualitative analysis of antioxidant activity of Pitha kamalai  chooranam.  
Qualitative analysis of antioxidant activity of PKC extract:  
The antioxidant activity of PKC extracts was determined by standard method. 50 
μl of PKC extracts was taken in the micro titer plate. 100 μl of 0.1% methanolic 1,1-
diphenyl- 2-picrylhydrazyl (DPPH) was added over the samples and incubated for 30 
minutes in dark condition. The samples were then observed for discolouration. The 
PKC extracts showed the colour changes from purple to yellow; it denotes the strong 
positive of the antioxidant activity. The antioxidant positive samples were subjected for 
further quantitative analysis.  
Table: 36. DPPH Assay of Pitha Kamalai Choornam 
            Sample 
concentration(µg/ml) 
              Absorbance       Percentage of 
Inhibition  
 
      Drug    Standard      Drug    Standard 
Control 0.5341 0.322 - - 
1.25 0.4132 0.278 22.6363 13.67 
2.50 0.3246 0.192 39.2249 40.37 
5 0.2164 0.165 59.4833 51.76 
10 0.1682 0.112 68.5078 65.22 
20 0.1242 0.094 76.7460 79.81 
µg/ml: microgram per millilitre. Drug: PKC (5-20µg/µl). Standard: Ascorbic 
acid (10mg/ml DMSO) 
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                                           Graph: 9 
Interpretation 
In the present study, the extract of PKC was found to possess concentration 
dependent scavenging activity on DPPH radicals. The values of DPPH free radical 
scavenging activity of the PKC extract was given in the (Table:   ), The extract of PKC 
showed the highest DPPH scavenging activity (76.75%) at 20µg/ml and the lowest 
percentage of inhibition (22.63%) at 1.25µg/ml. Ascorbic acid (Standard) showed 
highest percentage of inhibition (79.81%) at 20µg/ml and the lowest percentage of 
inhibition (13.65%) at 1.25µg/ml. 
              This indicated that % of inhibition with increase with increase in concentration 
of both the standard and PKC extract. The PKC extract has more or less equal DPPH 
scavenging activity 
[106]
.                      
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 CONCLUSION 
Siddha system of medicine believes that herbal formulation is one of the effective 
medicines for chronic diseases as is have no side effects. Herbal formulations are gaining 
popularity worldwide due to its nanomedicine form, increased bioavailability, minimal side 
effect, longer shelf life period and need less dosage. 
 Pitha Kamalai Choornam, a traditional Siddha herbo-mineral drug was prepared as 
per the procedures mentioned in Siddha literature. The chemical finger print was engaged by 
using modern analytical techniques like Inductively Coupled Plasma Optical Emission 
Spectroscopy (ICP-OES) and Fourier Transform Infra-Red Spectroscopy (FTIR). In addition, 
the particle size and qualitative analysis of chemical elements of Pitha Kamalai Choornam 
were also assessed by Scanning Electron Microscope (SEM).  
The qualitative and quantitative elemental analysis of Pitha Kamalai Choornam was 
carried out by X-Ray Diffraction Study (XRD). The instrumental analysis report reveals the 
heavy metals like Hg, As, Cd, Pb and trace element like Ni were not detectable. It proves the 
safety of the drug.  
The acute toxicity study exposes that the LD50 of Pitha Kamalai Choornam is more 
than 2000mg/kg, body weight in Wister Albino rat. 28-day repeated oral toxicity 
demonstrates that there was no Observed Adverse Effect Level of Pitha Kamalai Choornam.  
The pharmacological analysis showed that the drug has got significant 
Hepatoprotective efficacy. And also the Pitha Kamalai Choornam has potent antioxidant 
activity. 
In conclusion, the safety and efficacy of the Pitha Kamalai Choornam proves that it 
has remarkable medicinal value against the disease Kamalai.   
 
                                                                                                                     SUMMARY 
 
HEPATOPROTECTIVE ACTIVITY OF PITHA KAMALAI CHOORNAM Page 142 
 
 SUMMARY 
The trial drug Pitha Kamalai Choornam  was selected from the text “Korakkar 
Maruththuvam” for the validation of safety, efficacy and its potency in 
hepatoprotective effect.  
The raw drugs were collected from the Ramasamy pillai shops, at Paris corner, 
Chennai. The raw drugs were authenticated by the Botanist and Proffesor in 
Gunapdam Department in Government Siddha Medical College, Arumbakkam, and 
Chennai-106. .  
Various collections of Siddha and Modern science about the ingredients of the 
drug supported the fact of hepatoprotective activity.  
 The shelf life of Choornam is mentioned in Siddha literature as 3 months. But 
the recent report has been published by the AYUSH and mentioned that the shelf life 
of Choornam is only 1 years.  
 Physico-chemical analysis 
 The pH of Pitha Kamalai Choornam was 5.63 which is  acidic in nature. 
Acidic drugs are essential for Bioavailability and effectiveness. Acididic drugs are 
better absorbed in stomach. Hence, the drug does not produce any harmful effect to 
the mucus membrane of the GI tract.  
 Choornam is one of the basic medicines in Siddha system. The medicines on 
this order have fine particle size and low moisture content. The fine particle size 
enhances the pharmacokinetic actions and the low moisture content indicates the 
longer shelf life period of the drug.  
Instrumental analysis: 
Based on the results, Pitha Kamalai Choornam is preferably non-toxic to 
human in its therapeutic dose. The standardization of the drug was evaluated by 
chemical characterization with heavy metal analysis, functional group analysis, 
elemental analysis and determination of particle size by ICP-OES, FTIR, XRD and 
SEM respectively.  
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ICP-OES reveals high concentration of K in Pitha Kamalai Choornam (44.801 
mg/l). It also has physiologically important minerals like Na, Mg, P and Ca. In Pitha 
Kamalai Choornam the heavy metals like As, Cd, Pb and trace element like Ni were 
not detectable level. This reveals the safety of the drug. 
The FTIR results showed the presence of O-H Stretching and bend, C-H 
Stretching and bend, C=O Stretching as functional groups. The shift of C=O 
stretching frequency indicates a bounding of the calcium and oxygen nanoparticles 
through this group. 
XRD pattern of the trail drug Pitha Kamalai Choornam shows some good 
crystanility. The majar diffraction peaks are identified after XRD analysis. The 
crystalline may be due to the presence of the ingredients of the Pitha kamalai  
choornam. 
The SEM picture shown the presence of nanoparticle of size 1µm – 500 nm in 
the drug Pitha Kamalai Choornam. Further, the study shows that Pitha Kamalai 
Choornam is a kind of nanomedicine which favours the advantages of bio availability, 
better absorption and non toxic with minimal dose level. 
The Physico chemical analysis shows the presence of Calcium, phosphorus, 
sodium, magnesium which is physiologically important. In Pitha Kamalai Choornam 
the heavy metals like Arsenic, Cadmium, and Mercury were not detectable. This 
reveals the safety of the drug. 
Pharmacokinetic aspect: 
 The week acidic medicines were absorbed in alkaline medium. That is the 
Pitha Kamalai Choornam may be absorbed in small intestine.   
Toxicity studies: 
From the acute toxicity study as per OECD guideline 423, it was concluded 
that the test drug Pitha Kamalai Choornam is a safest drug. No mortality was 
obtained. 
In Conclusion, no toxic effect was observed up to 400mg/kg of Pitha Kamalai 
Choornam treated over a period of 28 days (OECD 407). So, it can be concluded that 
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the Pitha Kamalai Choornam can be prescribed for therapeutic use in human with the 
dosage recommendations of up to 100mg/kg body weight p.o. 
Hepatoprotective activity aginst CCl4 and Paracetamol: 
The present study showed that Pitha Kamalai Choornam produce protective 
action against the hepatotoxicity induced by CCl4 and paracetamol. The 
hepatoprotective role of Pitha Kamalai Choornam might be due to its chemical 
constituent. Pitha Kamalai Choornam produces antioxidant activity so this 
mechanism suggesting that the Pitha Kamalai Choornam may be useful to prevent the 
oxidative stress induced damage in liver. Hence Pitha Kamalai Choornam may be act 
as prophylactic as well as curative drug in treating hepato toxic conditions. Further 
studies needs to isolate the active constituents and also to evaluate the exact 
mechanism of action. 
Thus the author validated Pitha Kamalai Choornam as a new hepato-
protective drug which is cost effective and without any side effects. 
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FUTURE SCOPE 
Trial drug for the study PITHA KAMALAI CHOORNAM, was taken from the 
classic Siddha Literature Korakkar Maruththuvam, by Siddha Maruththuva Nool 
Veliyeetu Pirivu, Indian Medicine and Homeopathy Department, Chennai 106. Its 
validation for its Hepatoprotective and Anti Oxidant action were completed at 
preliminary level. The result enhanced and assured its Hepatoprotective property against 
CCL4 and Paracetamol induced Hepatotoxicity. More specific experiments on animal 
models and also clinical trials are required to understand the exact molecular 
mechanism of action. So it could be used worldwide in safe treatment as 
Hepatoprotective. 
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INGREDIENTS 
 
         
           Black Pepper                      Fenugreek Seeds                Bishops Weed 
            
         Cumin Seeds                      Indian mustard        Anise seeds 
              
               Turmeric                               Garlic                            Dried Ginge                      
 
                
                                   Long Pepper                              Asafoetida 
HISTOPATHOLOGY: SUBACUTE ORAL TOXICITY STUDY 
 
 
Control group:                                                                             High Dose: 
                 Kidney                                                                               Kidney 
                                                  
 
             Liver                                                                                          Liver 
                                                    
 
              Spleen                                                                                 Spleen 
                                               
                                                                  
                                 Figure: 12 Histopathological slides 
 
HISTOPATHOLOGICAL SLIDES OF HEPATOPROTECTIVE ACTIVITY OF 
PITHA KAMALAI CHOORNAM AGAINST CCL4 INDUCED 
HEPATOTOXICITY  
 
                           
     Fig 13a: GroupI Control                            Fig 13b: Group II. CCL4 treated 
 
                       
Fig 13c:GroupIII.CCL4+PKC100mg    Fig 13d: GroupIV CCL4+PKC200mg 
 
                                       
 
                                   Fig 13e GroupV CCL4+Silymarin  
